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Summary 
Neutrophils are the most abundant class of white blood cell in humans. They are 
among the first inflammatory cells to respond during infection or tissue damage, 
and their excessive recruitment to synovial joints in rheumatoid arthritis has 
been implicated in the progression of the disease. The process of neutrophil 
extravasation from blood vessels involves a rapid expansion of the available cell 
surface area. This ~200% increase is facilitated by the release of cell membrane 
microridges. As ezrin forms crucial cross-links between the plasma membrane 
and cortical F-actin, in neutrophils and other myeloid cells, it is thought to 
maintain the structure of these microridges, which act as a reservoir of plasma 
membrane for spreading. It has been suggested that elevating the cytosolic Ca2+ 
concentration, thereby activating the Ca2+-activated cysteine protease µ-calpain, 
would break the ezrin link and permit cell spreading. This thesis has investigated 
the relationship between, µ-calpain, ezrin and Ca2+ concentration. 
 
Through immunocytochemistry, confocal microscopy of live phagocytosis and 
chemotaxis experiments, observations in neutrophils have been complemented 
by investigations in a RAW 264.7 model cell line, amenable to transfection. By 
generating the novel genetically encoded Ca2+ indicator EPIC (Ezrin Peripheral 
Indicator of Ca2+), it has been possible to experimentally measure the cytosolic 
Ca2+ concentration in ezrin-rich microdomains beneath plasma membrane 
microridges, in transfected myeloid cells, during Ca2+ influx. It has thus been 
found that sub-membranous cytosolic Ca2+ in these microridges reaches high-
micromolar concentrations, well within the range required to activate µ-calpain 
and result in ezrin cleavage. 
 
The work in this thesis contributes to the understanding of the molecular 
mechanisms which govern neutrophil morphological changes during events such 
as phagocytosis and extravasation. It is hoped that these findings will help 
contribute towards the body of research aimed at influencing the design of 
novel therapeutics to treat autoimmune conditions. 
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1.1 The immune system 
Humans, as with all higher order organisms, have developed immune systems as 
a means of protection from opportunistic invasion by micro-organisms including 
bacteria, viruses, fungi and parasites. The role of the immune system is to 
combat and destroy foreign pathogens entering the body, yet it must also 
recognise and remove host cells which have become damaged, senescent or 
cancerous. The ability of the immune system to be able to distinguish between 
self and non-self is critical to its success, and therefore to the survival of the 
organism.  
Ilya Metchnikov (also written as Elie Mechnikoff), a Russian scientist credited as 
one of the forefathers of immunology, considered multicellular organisms to be 
intrinsically disharmonious, such that the state of ‘physiological inflammation’ 
involved the normal and regular activity of immune cells to restore ‘harmony’ 
(fig. 1.1). ‘Pathological inflammation’, he proposed, was due to the introduction 
of injury; infection and/or cell death in the organism. Immunity was therefore 
deemed to be the objective activity of an organism to defend itself from 
infection. Metchnikov speculated that phagocytic cells behave as the sentinel 
cells of the immune system, charged with effectively restoring harmony by 
patrolling the organism for foreign or dangerous bodies and removing them by a 
process called phagocytosis (Tauber, 1991; Tauber, 2003). It is crucial that every 
component of this very complex immune system is tightly regulated, to avoid 
the launch of an inappropriate or uncontrolled immune response, which may 
result in damage to the organism itself. 
 1.1.1 Innate immunity 
Innate immunity, as the name suggests, is intrinsic to the organism. Humans are 
born with a complete innate immune system, and many other higher organisms 
also possess some components of it. Because it does not require the production 
of antibodies, the innate immune system is able to target a broad spectrum of 
pathogenic infections. It is composed of a very complex network of factors, both  
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Figure 1.1: Metchnikov’s pyramid of immunity 
Metchnikov’s hypothesis was that all organisms are intrinsically disordered, but 
striving to achieve harmony within their biological systems. Physiological 
inflammation is the typical condition of an organism as it aspires to reach harmony. 
The various states of disharmony increase towards the top of the pyramid, where 
pathological inflammation is the active restoration of imbalance, culminating in 
immunity, which is the specific resolution of disorder in the system, typically during 
tissue damage or infection. (Figure amended from Tauber, 1991). 
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cellular and molecular, that cooperate to counteract any invasion by pathogenic 
micro-organisms.  
The cellular components of the innate immune system include phagocytic cells, 
of which neutrophils are the most abundant. The function of neutrophils in 
innate immunity will be discussed in this thesis. 
The molecular aspect of the innate immune response is called complement. This 
is composed of a collection of proteins in the blood circulation, which work in a 
chain-like manner whereby each component interacts with the next in a cascade 
of proteolytic interactions to generate subsequently active molecules. The final 
result is the accumulation of complement components in the membrane of 
targeted cells to generate pores which kill the cell by causing lysis. Some 
members of the complement cascade also work together with cellular 
components and mark targeted cells (with complement component 3bi (C3bi)) 
for removal by phagocytic cells, in a process of opsonisation. Other complement 
components generate a chemotactic gradient (of complement component 5a 
(C5a)) which recruits phagocytic cells to the vicinity. In all instances, the 
resultant cell debris is swept away by the foot soldiers of the innate immune 
system – the phagocytic cells, including neutrophils. 
1.1.2 Adaptive immunity 
Vertebrates possess the unique ability to acquire immunity. That is to say that 
their immune systems have the ability to recognise and ‘remember’ a pathogen, 
in order to launch a faster and more accurate immune response upon re-
infection with the same pathogen; this is called the adaptive immune response. 
By its nature it is a much more specific response, and as such it involves many 
different cellular and molecular components, some of which have a cross-talk 
relationship with those of the innate immune response. 
Upon first infection with a micro-organism, a chain of events is started in which 
white blood cells (WBCs) generate antibodies specific to the invading pathogen. 
8 
 
These antibodies communicate with other cells of the adaptive immune system 
to label the micro-organism for destruction. Another function of the adaptive 
response is the maturation of memory B cells which retain a biological memory 
of the infection for the lifetime of the organism, thus giving the system the 
ability to launch a much more rapid and intensive response during subsequent 
encounters with the same pathogen. The blueprint of the adaptive immune 
system varies between individuals because its memory is continuously acquired 
throughout the lifetime of the organism, sculpted by an individual’s exposure to 
various infectious agents.  
1.1.3 White blood cells 
Paul Ehrlich first divided WBCs into subpopulations based on differences in their 
morphologies (1898) (fig. 1.1.3). One subgroup, he noted, appeared to contain 
multiple clustered nuclei – two to five per cell – instead of a single nucleus. 
However, upon further inspection he observed the appearance of nuclear 
‘lobes’, which were distinct but remained connected by fine tethers. He called 
them ‘cells with polymorphous nuclei’ (Ehrlich, 1898). This group of cells became 
the focus of much attention, and were later renamed in 1905, by the Russian 
scientist Ilya Mechnikov, as ‘polymorphonuclear leukocytes’ (PMNLs) to be a 
more accurate description. PMNLs (or PMNs) is the term still used to describe 
this subpopulation of WBCs. 
PMNLs are also called granulocytes, because they contain granules within their 
cytoplasm. The differentiation of leukocytes into granulocytes is called 
granulopoesis, and occurs in the bone marrow. Figure 1.1.3 also shows the 
lineage of PMNL cells from pluripotent haemopoietic stem cells to granulocytes, 
of which there are three principle sub groups; eosinophils, basophils and 
neutrophils. The three subgroups were named accordingly based on their 
characteristic properties when stained with coal tar dyes. The differential 
staining technique was achieved using a mixture of acidic dyes which bind 
mainly to proteins, and basophilic dyes which bind mainly to negative charges, 
e.g. the phosphate backbone of deoxyribonucleic acid (DNA). Eosinophils were   
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found to stain strongly with the acidic dye eosin, basophils stained with the basic 
dye methylene blue. Neutrophils were so-called because of their propensity to 
stain with neutral dyes. 
1.1.3.1 Phagocytes  
Phagocytes (from the ancient Greek phagein, meaning ‘to devour’ and kytos, 
meaning ‘cell’), are a class of cells that act as the ‘vacuum cleaners’ of the 
immune system, by sweeping up any potentially dangerous cell debris and 
micro-organisms. Phagocytosis (from the ancient Greek phagein, kytos and osis, 
meaning ‘process’) is the mechanism by which cells, namely phagocytes, 
internalise foreign bodies within internal compartments known as phagosomes, 
and proceed to degrade them (Metchnikoff, 1893; 1901; 1905).  
Vertebrates have well established phagocytic cells, which are crucial to their 
innate immune response to invading pathogens. The process of phagocytosis is 
notably similar to endocytosis, which is performed by many different cell types. 
Metchnikov proposed that the emergence of phagocytic cells occurred early on 
in evolution (Tauber, 1991; Tauber, 2003) and the process most likely first 
appeared in unicellular eukaryotes such as amoeba, which take up their 
nutrition by engulfing and digesting bacteria. For example the amoeba 
Dictyostelium discoideum captures the bacteria it feeds on through engagement 
of membrane proteins on its cell surface (Cosson & Soldati, 2008). The main 
adhesion receptor for this process is probably SibA on the D. discoideum, which 
also bears similarities to β-intergrins on the surface of neutrophils (Cornillon et 
al., 2006). Interaction of these receptors results in subsequent phagocytosis, and 
the bacteria are then digested within the cell and absorbed as nourishment. 
Other lower organisms also utilise phagocytosis as a means of sustenance. For 
example, Coelenterates have inner cavities which are coated in phagocytic cells, 
and the organism derives its nutrition through the phagocytosis of the cavity’s 
contents (McNeil, 1981; Bigger and Hildemann, 1982). Through evolution, higher 
organisms have moved away from phagocytosis as a means of sustenance and 
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developed more complex digestive systems. Phagocytic cells have not become 
redundant though, and are crucial for the maintenance of what Metchnikov 
referred to as the ‘harmony’ of the organism. Phagocytes remove harmful 
material from the organism, be it invasive extracellular pathogens or cell debris. 
Several different cell types are capable of performing phagocytosis, these are 
deemed ‘professional’ or ‘non-professional’ according to their capabilities 
(Rabinovitch, 1995). The principal ‘professional’ phagocytes include the 
subgroup of WBCs derived from the bone marrow; i.e. monocytes, macrophages 
and PMNLs, including neutrophils. 
1.2 Neutrophils 
Neutrophils are the most abundant type of WBC in whole blood, contributing 
approximately 40-80% of the WBCs in the circulation (7x109 cells/L) (Lewis et al., 
2006). They are phagocytic cells, and form part of the first line of the innate 
immune response by removing invading extracellular pathogens, such as fungi 
and bacteria, through the process of phagocytosis (Metchnikoff, 1893; 1901; 
1905) and proteolytic degradation following fusion with lysosomes (Coico and 
Sunshine, 2009).  
1.2.1 History of the neutrophil 
Throughout much of the 19th century there was significant confusion about the 
role of the neutrophil in infection and inflammation. Early observations of 
abundant neutrophils at inflamed sites in the body, and the high concentrations 
of neutrophils found in pus and mucus initially suggested a role for neutrophils 
as the agents of infection. It was speculated that neutrophils were 
spontaneously generated at sites of inflammation, and accumulated bacteria 
within themselves for the purpose of disseminating pathogens further around 
the body, thus propagating the infection. In 1846, drawing conclusions from his 
experiments in toads, Waller disproved this paradigm by discovering that 
neutrophils migrated out of blood vessels at sites of inflammation by 
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extravasation “de toute pièce” through the capillaries (Waller, 1846). He 
recognised that the WBCs exited the bloodstream without damage to or 
perforation of the blood vessel wall, but rather by the process of diapedesis – 
between endothelial cells of the blood vessel wall (Cohnheim, 1867a, b; 1967). 
However the role of neutrophils once at the site of infection and inflammation 
still remained in question until the late 19th and early 20th Centuries. 
At the beginning of the 20th Century two leading researchers, Metchnikov and 
Ehrlich, were jointly awarded the 1908 Nobel Prize in Physiology or Medicine, in 
recognition of their enormous contribution towards the understanding of the 
immune system (and within that neutrophils); as such they are considered by 
many to be the Founding Fathers of immunology. 
1.2.1.1 Ilya Metchnikov (also written Elie Mechnikoff) (1845-1916) 
While working in a private laboratory in Messina, Russia in 1882, investigating 
comparative embryology, Metchnikov (fig. 1.2.1.1) conducted his now famous 
experiment on starfish larvae, that led to his discovery of the process of 
phagocytosis (Tauber 2003; Nobelprize.org). He had postulated that the mobile 
blood cells he had observed to extravasate (now understood to be neutrophils) 
may help to protect the organism from infection. This led him to perform the 
famous ‘thorn in the starfish’ experiment.  
Metchnikov inserted a thorn from a rose bush (some sources describe a 
tangerine tree; from Metchnikov’s own account of events, it is understood that 
the tangerine tree had been ‘decorated’ for Christmas, and the rose thorns were 
taken from this (British Society for Immunology (2017); Desowitz, 1988)). The 
intention was to generate a wound that would render the starfish larvae 
vulnerable to infection. Upon inspecting the puncture caused by the thorn the 
next day, Metchnikov recognised an accumulation of cells around the wound.  
Having already been impressed by Virchow and Cohnheim’s descriptions of 
diapedesis (Cohnheim, 1867a, b; 1967), and thus aware of the ability of   
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Figure 1.2.1.1: The Founding Fathers of immunology: Ilya Metchnikov and Paul 
Erhlich 
Metchnikov Photographed circa 1875, aged ~30 years old. (Figure reprinted from  
Metchnikoff, O. N., Life of Ilya Ilyitch Metchnikoff, State Publishing House, Moscow, 
Leningrad 1926.) Ehrlich Photographed circa 1908, aged ~54 years old. (Figure 
reprinted from Kay AB. 2015. The early history of the eosinophil. Clin Exp Allergy 
45:575–582.) 
14 
 
leukocytes to extravasate from the bloodstream in organisms with vasculature, 
he subsequently concluded that the observed accumulation of cells were 
leukocytes which had migrated from the blood towards the site of injury. It was 
this finding that led to his breakthrough discovery about the role of leukocytes in 
infection.  
The previous paradigm had presumed that neutrophils were spontaneously 
generated at the site of infection, and Robert Koch had proposed that they 
served as agents of the infection by accumulating bacteria and transporting 
them to the inflamed area (Desowitz, 1988). In contrast, Metchnikov 
hypothesised that the role of these migratory cells was in fact to accumulate at 
the site of injury in response to infection, and to then digest invading pathogens 
in order to remove them from the body, in a process coined phagocytosis 
(Metchinkov 1893; 1901; 1905). In a paper he presented in Odessa in 1883, 
Metchnikov explained his theory of phagocytosis, after discussions with Claus, a 
Viennese professor of Zoology who was actually the first to propose the term 
phagocyte (Gordon, 2008). Metchnikov concluded that the cells he had observed 
were capable of carrying out phagocytosis, and named them macrophages and 
microphages, on account of their different cell sizes (from the Latin for ‘big’-
‘eaters’ and ‘small’-‘eaters’ respectively). The terminology of microphages has 
since been changed to the cells we now know as neutrophils, however the term 
macrophages remains in use. 
1.2.1.2 Paul Ehrlich (1854-1915) 
Paul Ehrlich’s (fig. 1.2.1.1) research in immunology began with an interest in the 
activity and production of antibodies, from his time working in Robert Koch’s 
laboratory in 1890. Ehrlich was the first to propose “horror autotoxicus”; i.e. the 
possibility that the immune system can react “against the organism’s own 
elements” (Tauber, 1991). This speculation was made with regard to the 
generation of autoantibodies which may attack the ‘self’. However, it is at odds 
with Metchnikov’s theory that the immune response was reactive to disharmony 
within the organism, without the potential to create it. Although Ehrlich and 
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Metchnikov had somewhat contrasting views on the function and purpose of the 
immune response, both were credited with their contributions towards the 
modern field of immunology. 
Ehrlich first encountered neutrophils as part of his work developing staining 
techniques to differentiate between different cell types. Noticing that 
neutrophils did not stain with acidic or basic dyes (unlike eosinophils and 
basophils respectively) he developed triacid, a mixture of orange G, acid fuchsin 
and methyl green. He coined the term “epsilon” to describe those cells which 
stained with neutral dyes; the neutrophil (Kay, 2016). Ehrlich’s work developing 
techniques to stain blood films, and consequently his differential identification 
of blood cell types, paved the way for modern studies on blood leukocytes. 
1.2.2 Lifecycle of a neutrophil 
Neutrophils have three distinct stages in their lifecycle, associated with their 
abundance at different locations in the body. The transition between each stage 
involves significant dynamic changes within the cell; these occur in the bone, in 
circulation and finally also in tissues. Under resting basal conditions the main 
population of neutrophils reside in the bone marrow (approximately 2.3 x 109 
cells per kg of body weight). However, in response to chemical inflammatory 
signals, indicative of infection or tissue damage, the pool of neutrophils can be 
rapidly mobilised and released into the blood. The number of neutrophils 
circulating the blood in a healthy individual is about 7 x 108 cells per kg (Athens 
et al., 1961). 
Human neutrophils have a very short half-life in the circulation, approximately 6-
8 hours (Summers et al., 2010), before they exit the circulation and undergo 
programmed cell death by apoptosis (Savill et al., 1989). In fact, in the time 
taken to read thus far into this section, some billions of the reader’s own 
neutrophils will have begun their departure from the circulation, by migrating 
between the endothelial cells of blood vessels and out into the extravascular 
space. Consequently, the population of neutrophils is in a state of constant 
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turnover throughout the lifetime of an individual. Because of the vital role they 
play in the innate immune system, it is important that neutrophil numbers in the 
blood remain consistently high enough to be able to quickly respond to an 
infection. The rate of neutrophil production in a healthy individual is typically 5-
10 x 1010 cells/day, in order to replenish the pool of circulating neutrophils 
(Summers et al., 2010). During infection, and the resultant inflammatory 
cascade, neutrophils become activated and respond to chemical factors which 
increase their longevity, in order to provide enough primed neutrophils to be 
able to combat the infection (Summers et al., 2010). 
It is likely that the unusually short life-span of neutrophils evolved as an 
inherently protective mechanism. Given the high reactivity of neutrophils, their 
accumulation in the blood stream without sufficient removal could lead to 
systemic propagation of the inflammatory response, and unregulated tissue 
damage. Furthermore, since a primary role of neutrophils is the ingestion of 
pathogenic extracellular micro-organisms, a rogue cell which was not itself 
readily disposed of (as neutrophils are by apoptosis and subsequent engulfment 
by macrophages) could become vulnerable to colonisation by invasive 
pathogens; which could lead to systemic dissemination of the infection. 
1.2.2.1 Myelopoiesis 
Neutrophils are generated from myeloid stem cells in the bone marrow by a 
differentiation process called myelopoiesis (fig. 1.2.2.1). Myelopoiesis also 
generates other granulocytes, such as eosinophils and basophils, as well as 
platelets, monocytes and erythrocytes. Each cell type arises from pluripotent 
stem cells in the bone marrow, which differentiate in successive mitotic divisions 
stimulated by a number of different chemical signals, to result in the variety of 
different cellular components of the blood. At each stage of mitotic division the 
cells become increasingly more distinct from each other. Together these cells 
are referred to as the myeloid progenitor pool, and thus each one gives rise to 
cells of distinct myeloid lineage. The process of neutrophil myelopoiesis is tightly 
regulated, and dependent on the timely recognition of several cytokines and   
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Figure 1.2.2.1: Neutrophil production by myelopoesis  
In the myeloid lineage the CFU-GEMM gives rise to neutrophils through a series of 
mitotic divisions mostly occurring in the bone marrow. With each division the daughter 
cell becomes more committed to its fate. The commitment to become a neutrophil 
occurs at the division of the myeloblast, followed by subsequent divisions and 
maturation into a neutrophil (adapted from Arif and Mufti, 1998; drawn using Servier 
Medical Art.) 
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hematopoietic growth factors. There are three key stages beginning with the 
multiplication of progenitor cells, their maturation and finally functional 
differentiation. Multipotential hematopoietic stem cells in the bone marrow first 
lose their ability to self-replicate and differentiate into colony-forming unit-
granulocyte, erythrocyte, monocyte, megakaryocytes (CFU-GEMMs). These are 
then known as the common myeloid progenitor cells, and are also found 
abundantly in the umbilical cord. The CFU-GEMMs can further differentiate to 
produce erythrocytes and megakaryocytes. The major growth factors 
responsible for CFU-GEMM maturation down the myeloid lineage are 
interleukin-1 (IL-1), interleukin-3 (IL-3), interleukin-6 (IL-6), granulocyte 
macrophage-colony stimulating factor (GM-CSF) and stem cell factor (SCF). In 
response to these factors CFU-GEMMs differentiate into colony forming unit-
granulocyte macrophages (CFU-GMs). CFU-GMs mark the pivotal point between 
committed differentiation towards either granulocytes or macrophages. The 
decision to differentiate into colony forming unit-granulocytes (CFU-Gs) occurs 
in response to IL-3, adhesion Ig super family molecules (SF), GM-CSF and G-CSF. 
Together with the stem cells, CFU-Gs constitute the neutrophil progenitor pool 
(Kannwar and Cairo 1993; Wheeler 1993). 
In response to GM-CSF, IL-6 and IL-3 the CFU-Gs further differentiate into 
myeloblasts (the earliest recognisable stage of myeloid lineage), promyelocytes 
and subsequently neutrophilic myelocytes via a series of mitotic divisions. Each 
of these three cell-stages is the product of consecutive mitotic divisions and take 
approximately one week to complete. The final stages of granulocyte maturation 
begin after these mitotic divisions. Cytokines, including GM-CSF, IL-6 and IL-3 
promote the differentiation into monocytes and the PMNLs; neutrophils, 
basophils and eosinophils.  
The neutrophil storage pool consists of neutrophils at varying stages of 
differentiation, following mitotic maturation from CFU-G progenitor cells and 
includes band cells, metamyelocytes and neutrophils. Factors such as GM-CSF, 
CSF and IL-3 regulate the final stages in neutrophil maturation, which involve 
dynamic changes in their cellular properties, when the cells acquire motility and 
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become deformable; characteristics which facilitate the exit of mature 
neutrophils from the bone marrow. Among these factors G-CSF interacts with 
Cluster of Differentiation 114 (CD114), a member of the family of hematopoietic 
cytokine receptors, on the surface of granulocytic precursors and promotes the 
release of neutrophils from the bone marrow. G-CSF/CD114 interaction also 
down-modulates CD114 expression on neutrophils and stimulates degranulation 
(Jilma et al., 2000). 
Differentiation in the bone marrow takes about two weeks in total. Within the 
bone marrow there is a reserve pool of neutrophils which is about 20 times 
greater than the total population of circulating neutrophils. Mature neutrophils 
are released into the circulating blood via endothelial pores in sinusoids of the 
bone marrow. Upon entering the bloodstream the neutrophils become part of 
what is known as the circulating neutrophil pool (CNP). Regulation of neutrophil 
maturation and release is controlled by IL-3, GM-CSF and CSF (Okuda et al., 
1992). Terminally differentiated neutrophils are unable to divide further. For a 
long time it was assumed that they also had little or no ability to perform de 
novo protein synthesis, because of their limited synthetic machinery. However, 
it is now understood that ‘primed’ neutrophils exposed to the stimulatory 
bacterial peptide N-Formylmethionine-leucyl-phenylalanine (fMLP), show 
increased protein synthesis via increased levels of both transcription and 
translation (Hughes et al., 1987; Humphreys et al., 1989).  
1.3 Neutrophil morphology 
Neutrophils belong to the class of PMNLs and granulocytes, on account of the 
multi-lobed appearance of their nucleus, and their numerous cytoplasmic 
granules respectively. They are of myeloid lineage, originating in the bone 
marrow, and have one of the shortest lifespans of any cell once in the 
circulation. As terminally differentiated cells their structure is specialised to suit 
their phagocytic functions. They are small, spherical cells in the circulation, with 
a diameter of approximately 9-10 µm (Wintrobe, 1967). Upon receiving a 
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chemical inflammatory signal they undergo a process called cell spreading, 
which sees their average diameter increase to approximately 20-30 µm. During 
cell spreading neutrophils assume a flattened and adherent morphology, in 
which the height of the cell is limited only by the volume of the nucleus (Dewitt 
et al. 2013) (fig. 1.3i).  
Three distinct aspects of neutrophil morphology distinguish them from other 
types of WBC: (i) multi-lobed or segmented appearance of the nucleus, (ii) fewer 
than average mitochondria and (iii) numerous cytosolic granules. 
(i) All PMNLs have a segmented nucleus, in which each lobe is 
connected via fine tethers. When stained with DAPI the nucleus 
occupies a significant 20% of the cytosol (Schmid-Schonbein et al., 
1980), and is a distinguishable characteristic of these cells. The 
number of lobes increases from two up to five as the cell ages 
(Campbell et al., 1995; Olins and Olins, 2005; Fuchs et al., 2007; 
Hoffmann et al., 2007). 
 
(ii) In neutrophils the mitochondria constitute only 0.6% of the total 
organelle volume, in comparison to hepatocytes in which the 
mitochondria make up approximately 20% of the entire cell volume 
(Hallett and Lloyds, 1997). They also lack substantial endoplasmic 
reticulum and golgi apparatus, making up less than 1% of the average 
volume of a cell (Hallett, 1989). This has indicated that mitochondria 
are not necessary for typical cellular functions in a neutrophil such as 
energy production, protein synthesis and storing Ca2+. Instead, 
neutrophils employ glycolysis to produce energy, and Ca2+ is 
sequestered within other organellular structures resembling 
calciosomes (Krause et al., 1989). However more recently it has been 
found that neutrophils do possess an extensive intracellular network 
of mitochondria throughout their cytoplasm which is necessary for 
proper neutrophil functioning, but not required for acute bouts of   
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activity such as phagocytosis or the respiratory burst (Fossati et al., 
2003). 
(iii) Neutrophils are a type of granulocyte, and contain abundant 
heterogeneous cytoplasmic granules. These are clearly visible in 
electron micrographs (fig. 1.3ii), occupying approximately 15-16% of 
the total cell volume (Schmid-Schonbein et al., 1980). They contain an 
arsenal of sequestered toxic host defence proteases (Borregaard and 
Cowland, 1997). 
1.3.1 Neutrophil granules 
Neutrophils have an average density of 1.08-1.09 g/mL (Clark and Nauseef, 
2001), which is much denser than other WBCs, and this is largely due to the 
abundance of their cytoplasmic granules (Bretz and Baggionlini, 1974). Their 
characteristic density facilitates neutrophil isolation by dextran sedimentation. 
The contents of neutrophil granules can be released by controlled fusion with 
phagosomes, in order to destroy material that has been engulfed by the process 
of phagocytosis. The granular contents can also be released into the 
extracellular matrix, as in frustrated phagocytosis (Hallett and Lloyds, 1995). The 
latter can have damaging effects on other tissues, for example in the inflamed 
synovial junctions in rheumatoid arthritis (Edwards and Hallett, 1997).  
Neutrophil granules can be divided into three categories based on their contents 
(Boxer and Smolen, 1988). The contents of the granules is dependent on at 
which stage of myeloid differentiation they were produced, and they are 
specialised to the functions of the cell at each stage of its life-cycle (Abramson 
and Wheeler, 1993). The three classes of granules are: azurophilic (primary), 
specific (secondary) and small (storage). The granules are dense intracellular 
structures (Bretz and Baggionlini, 1974) and occupy approximately 15-16% of the 
total cell volume (Schmid-Schonbein et al., 1980). They contain numerous 
cytotoxic enzymes for the purpose of digesting foreign pathogenic material and 
cell debris. Granule membranes are covered in signalling proteins, receptors and 
adhesion molecules (Borregaard and Cowland, 1997).  
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Figure 1.3ii: Neutrophil lobes and granules, viewed by electron microscopy 
Three nuclear lobes and multiple cytoplasmic granules can be seen in the 
cell cytoplasm. Also of note is the absence of definable golgi apparatus, 
mitochondria or endoplasmic reticulum. 
(Figure amended from Ohio State University, Microscopy and Imaging 
Facility.) 
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Granules mature along with progenitor cells in the stages of neutrophil 
development. The specific combination of enzymes and cytotoxic substances 
within the granules is dictated by the stage of myeloid cell differentiation at 
which protein synthesis occurs (Borregaard and Cowland, 1997), and not 
because of any specific granule sorting. This means there can be some similarity 
between the contents of granules. The primary azurophilic granules are first 
recognised in the promyelocyte. They make up approximately 1/3 of the 
granules in the mature neutrophil. Azurophilic granules contain the protease 
myeloperoxidase, which gives the neutrophils their characteristic green hue 
when viewed by bright field light microscopy. Myeloperoxidase is also 
responsible for breaking down bacterial cell walls during infection (Klebanoff et 
al., 2013), and its abundance in pus and mucus can give both a greenish 
appearance. The secondary, or specific granules are smaller in size and can be 
identified in both myelocytes and metamyelocytes. They form the basis of the 
neutrophilic bands observed in the final stages of maturation. The small storage 
granules contain gelatinases and cathepsins. A fourth subgroup of granules has 
also been identified as the secretory vesicles (Borregaard et al., 1987). They are 
formed by the process of endocytosis.  
1.3.2 Neutrophil plasma membrane 
The neutrophil plasma membrane has characteristics that distinguish it from any 
other cell type. Because neutrophils are able to both receive and relay signals to 
and from other cells of the immune response, they are equipped with a vast 
array of membrane receptors, between 0.5 and 1 million, to recognise a variety 
of inflammatory stimuli (Hallett, 1989). These receptors are sensitive to subtle 
chemical gradients in the extracellular matrix, and enable the neutrophil to 
detect and respond to inflammatory stimuli at considerable distances from the 
point of source, and as low as 0.1% over the length of the cell (Zigmond, 1977; 
Mak and Saunders, 2006). They recognise soluble inflammatory signals 
including: tumour necrosis factor-α (TNFα), cytokines, interleukins, bacterial 
components (formylated peptides and lipopolysaccharide endotoxin) and 
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members of the complement cascade (e.g. C5a). Ligation of these receptors, 
through specific ligand interaction, triggers a cascade of secondary intracellular 
messengers within the neutrophil (Hallett, 1989). The perceived signals from the 
neutrophil plasma membrane receptors may evoke a response in the cell to 
upregulate/downregulate other membrane receptors, or result in the 
degranulation and secretion of proteins sequestered within granules. 
 
Neutrophils also have receptors which directly engage with the surface of other 
cells, including: selectins, integrins and immobilised C3bi (Lee et al., 2003), which 
assist neutrophil binding to the vascular endothelium, prior to extravasation; or 
the surface of opsonised material prior to phagocytosis.  
 
The ability of a neutrophil to change morphology is crucial to its success at 
performing phagocytosis, extravasation and chemotaxis during inflammation. 
This morphology change from a ‘spherical’ neutrophil in circulation, to a 
‘flattened’ adherent cell about to extravasate involves an apparent membrane 
expansion of about 200% (Hallett and Dewitt, 2007), much greater than the 4% 
expansion facilitated by the mechanics of the phospholipid membrane (Hamill 
and Martinac, 2001). During the process of extravasation the neutrophil makes 
several receptor-mediated interactions with endothelial cells of the blood vessel 
wall. A summary of the receptors involved in neutrophil adhesion to, and 
extravasation through, the endothelial layer is listed in table 1.3.2. The process 
of extravasation will be discussed in more detail in subsequent sections. 
1.4 Neutrophil behaviour 
Neutrophils are the first line of defence against bacterial and fungal infection 
within the innate immune system. Their primary function is phagocytosis and 
they have been nicknamed ‘professional phagocytes’ by Rabinovitch (1995). The 
circulating neutrophil pool constitutes only ~50% of neutrophils in the vascular 
compartment at any one time. The remaining 50% of neutrophils adhere to the  
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Table 1.3.2: Receptors involved in neutrophil/endothelial cell interaction 
The receptors and ligands involved specifically in neutrophil/endothelial cell 
adhesion and subsequent neutrophil extravasation through the endothelial lining of 
the blood vessel wall. 
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endothelial lining of small blood vessels, constituting the marginal neutrophil 
pool (MNP). Cells from the MNP are poised ready to respond to inflammation, 
and interact with endothelial cells via integrins and selectins, on their cell 
surface and on the surface of the neutrophil (Zarbock and Ley, 2008) (table 
1.3.2). These interactions position the marginal neutrophils at the blood vessel 
wall so that they are ready to respond to inflammatory signals and exit the 
bloodstream via the process of extravasation, before migrating into tissues 
towards the source of inflammatory stimuli. This is a crucial, yet little 
understood, hurdle in the neutrophils’ ability to respond to inflammation and 
accumulate at sites where they may be required to perform phagocytosis.  
1.4.1 Response to inflammatory signals 
Circulating neutrophils have an apparently spherical morphology, the smallest 
surface area to volume ratio to enclose any given volume (Hallett and Dewitt, 
2007). Upon recognition of inflammatory chemical signals such as the 
chemokines (e.g. TNFα, IL-1, IL-6, IL-8 and C5a) through extracellular receptors 
(e.g. TNF-receptor (TNF-R), cytokine receptors and C5a receptor (C5aR)) (Futosi 
et al., 2013), neutrophils respond by migrating along the gradient of 
chemoattractant towards sites of infection and inflammation (fig 1.4.1).  
Neutrophils play an active role in the propagation of the inflammatory cascade, 
as well as having a direct role in the resolution of inflammation. Migration from 
the blood into the surrounding issue involves the extravasation of neutrophils 
through junctions in the vascular endothelial layer (Ley et al., 2007). This process 
involves a dramatic change in cellular morphology, specifically from the 
apparently spherical morphology of circulating neutrophils to a flattened 
morphology of adherent neutrophils; the immediate prelude to neutrophil 
extravasation, which facilitates the exit of neutrophils from the vasculature (fig. 
1.4.1). The mechanism of neutrophil spreading and extravasation will be 
discussed further in the context of Ca2+ signalling in later sections.  
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Upon leaving the bloodstream and entering the extravascular space, neutrophils 
continue to be guided towards sites of inflammation by interactions with the 
extracellular matrix (Hynes, 1992), and also by a chemotactic gradient of 
chemical inflammatory stimuli. These chemoattractants are generated by the 
organism (‘self’), such as the complement component C5a and cytokines IL-8 and 
leukotriene B4 (LTB4), and also by pathogenic bacteria such as the bacterial 
peptide fMLP (Zigmond, 1977; Murphy, 1994; Gerard and Gerard, 1994). 
The concentration gradient of these stimulants guide the neutrophils, like 
breadcrumbs, towards tissue damage and/or infection. Cell surface receptors on 
the neutrophil are able to detect concentrations of chemoattractant as low as 
0.1% over the cell length (Zigmond, 1977; Mak and Saunders, 2006). It has also 
been suggested that presence of these agents may actively increase the 
neutrophil’s life span up to 1-2 days (rather than the typical half-life of 6-8 
hours). Neutrophils will continue to proceed in the direction of chemoattractant, 
by extending protrusions of the plasma membrane, called pseudopodia, and 
retracting their trailing edge, as long as they continue to sense further increases 
in chemoattractant concentration (Mak and Saunders, 2006). When they arrive 
at the source of inflammatory stimuli, neutrophil chemotaxis arrests. 
Neutrophils themselves secrete additional chemoattractants to recruit nearby 
lymphocytes, and also begin their primary job of clearing away any invading 
extracellular pathogens. 
1.4.2 Neutrophil Extravasation  
The first stage in neutrophil extravasation from the bloodstream involves 
recruitment of cells to begin the migration process. Neutrophils are alerted to 
the need to extravasate by receptor engagement with inflammatory stimuli. 
Within the circulation there exists two sub-populations of neutrophils; the CNP 
and the MNP. Cells move from the CNP to the MNP in response to inflammatory 
stimuli, and integrins and selectins on both the neutrophil and endothelial cell 
surfaces engage to tether the neutrophil at the vascular wall. The interactions 
are weak, e.g. hydrogen-bonds, and easily sheered by the exertive force of the 
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blood flow. Neutrophils in the MNP ‘roll’ along the vascular endothelial lining by 
forming and breaking interactions between selectins, under the flow pressure of 
the blood (McEver 1991; Bevilacqua et al, 1991). 
The slow rolling enables the neutrophil to assess the environment next to the 
endothelial cells, and detect local inflammatory factors such as platelet 
activating factor (PAF), which alerts the cell to a state of inflammation (Lorani et 
al., 1995; Abbassi et al, 1993). Neutrophils may then increase the externalisation 
of integrin receptors CD11b/CD18 (Mac-1). Inflamed endothelial cells in the 
vicinity of underlying tissue inflammation respond to TNF generated locally by 
tissue macrophages in response to cell injury or infection (Macconi et al, 1995). 
Endothelial cells upregulate expression of intercellular adhesion molecule-1 
(ICAM-1) on their luminal cell surface. The slow ‘rolling’ of neutrophils in the 
MNP, relative to those in the CNP, facilitate CD11b/CD18 integrins on the 
neutrophil cell surface to recognise and engage with ICAM-1 molecules on the 
endothelial cells. These interactions are much stronger than the hydrogen bonds 
formed by selectin interactions, and in combination with lipid mediators such as 
PAF, the adhesiveness of neutrophil cell surface receptors is increased to 
facilitate firm binding and neutrophil ‘arrest’ on the endothelial lining (Lawrence 
and Springer, 1991; Lorani et al., 1995). 
Inflammatory mediators responsible for ICAM-1 upregulation include: LPS, TNF-
α, IL-1 and PAF. These molecules act as signposts, leading the neutrophil to 
perform extravasation adjacent to the source of the inflammatory signal. The 
relatively high concentration of TNF-α also has a priming effect on neutrophils, 
which triggers a much greater oxidative response upon secondary stimulation 
(Hallett and Lloyds, 1995; Lloyds et al., 1995). 
Key to neutrophils’ functions outside of the bloodstream in the tissues, is their 
ability to exit from the bloodstream intact, and without causing damage or 
rupture to themselves, or to the blood vessel wall. This process of extravasation 
was first reported by Virchow and Cohnheim in 1867 (Cohnheim, 1867a). Once 
recruited to the inflammatory response, the neutrophils must undergo a 
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dramatic change in cell morphology which is the immediate prelude facilitating 
extravasation from the blood capillaries. The mechanism of neutrophil 
extravasation is the focus of the work presented in this thesis. 
1.4.3 Neutrophil phagocytosis 
Upon reaching their final destination, at the site of inflammation, neutrophils 
perform their ‘professional duty’ and go about the controlled removal and 
destruction of invading extracellular microbes, via the process of phagocytosis.  
Neutrophils recognise the invading bacteria and fungi by their CD11b/CD18 
(Mac-1) receptors engaging with the complement component opsonin C3bi, or 
via their Fc IIa and III receptors engaging with opsonising antibodies on the 
surface of microbes (Anderson and Looney, 1986; Fossati et al., 2002; van Spriel 
et al., 2001). This receptor engagement triggers a conformational change in 
neutrophil morphology, which enables them to perform phagocytosis. Cells 
extend pseudopods towards the particle and encircle it. The offending microbe 
is engulfed by the neutrophil and held within a newly formed intracellular 
vacuole called the phagosome (Thelen et al., 1993). 
Neutrophils contain abundant cytoplasmic granules, as previously described. In a 
process called degranulation, the cytoplasmic granules fuse with the phagosome 
containing the foreign particle (Hirsch and Cohn, 1960; Zuckerfranklin and 
Hirsch, 1963; Pryzwansky et al., 1979). A change in pH within the phagosome 
creates an environment which activates the arsenal of toxic enzymes 
sequestered within the granules. The phagosomal membrane also has specific 
proteins which when activated aggregate to form non-mitochondrial NADPH 
oxidase, and produce reactive oxygen species (ROS) (Baggiolini and Wymann, 
1990; Barbior, 1984; Segal and Jones, 1978). The combination of ROS and the 
arsenal of cytotoxic contents of neutrophil granules efficiently destroy the 
engulfed microorganism, without causing damage to surrounding host tissues. 
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Similarly to the membrane expansion required to perform phagocytosis, the 
process of neutrophil extravasation from the bloodstream also necessitates a 
dramatic change in cell surface morphology; more precisely an apparent ~200% 
expansion of the plasma membrane (Hallett and Dewitt, 2007). The apparent 
expansion of the plasma membrane will be discussed in the context of Ca2+ 
signalling in later sections, and phagocytosis will be used as a model of localised 
membrane expansion for some of the results presented in this thesis. 
1.5 Neutrophils in disease  
Whilst the primary role of neutrophils is to defend the host from disease caused 
by the infection of pathogenic microorganisms, there are some instances in 
which aberrant neutrophil behaviour makes them the causative factor in some 
disease conditions. For example, impaired neutrophil activity can be devastating, 
such as in chronic granulomatous disease where a genetic defect in the 
neutrophil oxidase pathway prevents neutrophils from functioning correctly 
(Segal, 1987; 1996). Conversely, over activation of neutrophils can cause damage 
to host tissue; such as during the inappropriate release of neutrophil elastase in 
chronic obstructive pulmonary disease (COPD) (Nadel, 2000), or the excessive 
infiltration of neutrophils into synovial junctions in rheumatoid arthritis 
(Edwards and Hallett, 1997).   
1.5.1 Rheumatoid arthritis 
Rheumatoid arthritis is a chronic inflammatory autoimmune disease, and one of 
the most prevalent autoimmune disorders in the world, affecting approximately 
1% of the global population (Alamanos & Drosos, 2005; WHO 2017). It is a 
systemic condition and can also lead onto secondary disorders including 
pulmonary fibrosis and cardiovascular disease, with rheumatoid arthritis 
patients being two-fold more likely to suffer myocardial infarction, and having 
an increased incidence of mortality (Zegkos et al., 2016). 
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The most common and physically prominent symptoms of rheumatoid arthritis 
are presented in the joints, typically the hands, where inflammation causes 
debilitating pain and deformity (see fig. 1.5.1). Both environmental and genetic 
factors contribute to the disease prognosis in rheumatoid arthritis patients, with 
those patients presenting recognised risk factors such as Rheumatoid factor (RF) 
and genetic factors such as HLA-DRB1, being necessarily more susceptible to the 
cumulative effect of environmental factors. RF can be detected in the circulation 
of individuals many years before the onset of symptoms, yet there is still little 
understanding of the events triggering the pathophysiology of the disease, and 
none of the available medications prove effective at preventing the condition.  
Rheumatic joints appear swollen due to the large infiltration of immune cells 
into the synovial junction, leading to inflammation of the synovial lining (fig. 
1.5.1), which is typically only two to three cells thick in a healthy joint (Wright et 
al., 2014). There is also an excessive accumulation of synovial fluid, which can 
exceed 30 mL in volume, containing up to 5x109 neutrophils (Edwards and 
Hallett, 1997). This not only contributes to the physical swelling of the joints, but 
a reduction in viscosity of the synovial fluid further decreases lubrication in the 
joint, contributing to difficulty in movement and ultimately further damage to 
the cartilage. The inflamed synovial lining also becomes enriched with new 
blood vessels and a new granular pannus tissue composed of macrophages, 
lymphocytes, activated synovial fibroblasts and neutrophils extends across the 
articular cartilage (Shiozawa et al., 1983; Wright et al., 2014). Invasion of these 
cells contributes to bone and cartilage damage due to the secretion of pro-
inflammatory chemokines, cytokines and prostaglandins, and the high 
concentration of destructive collagenases and metalloproteases (Shiozawa et al., 
1983; McCachren et al., 1990; Brinckerhoff, 1991; Wright et al., 2014). 
Neutrophil elastase, cathepsin G, proteinase 3 and some matrix 
metalloproteinases (namely MMP-8 and 9) are produced by neutrophils and 
further contribute to matrix degradation at the pannus-cartilage junction 
(Murphy et al., 2008).  
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Figure 1.5.1: Damage to joints in rheumatoid arthritis 
(a) X-ray images comparing a healthy hand (left) (Adams, 2013) with the distorted 
joints in a hand afflicted with rheumatoid arthritis (right). (b) Cross-section of a 
healthy joint showing progression to a rheumatic joint. The diseased joint is swollen 
and due to excessive synovial fluid, infiltration of immune cells and the growth of new 
pannus tissue. Bone and cartilage degradation occurs due to the release of damaging 
ROS and enzymes from neutrophils and other immune cells. Amended from Wright et 
al., 2014 – drawn using Servier Medical Art). 
(a) 
(b) 
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Neutrophils respond to chemical signals produced by immune cells at the site of 
inflammation and are recruited from the circulation to the joint, where they 
then exacerbate the inflammatory state. Upon arriving at the synovial junction, 
neutrophils become activated by immune complexes deposited locally by other 
cells as part of the inflammatory response. Neutrophils recognise the immune  
complexes via engagement with their Fcγ receptors (FcγR) (Fossati et al., 2001; 
2002) and react by releasing their arsenal of destructive enzymes and ROS from 
cytosolic granules, in a process termed ‘frustrated phagocytosis’, due to 
incomplete phagosome formation (Hallett & Lloyds, 1995). Release of these 
cytotoxic products directly onto the articular cartilage and bone causes erosion 
of the joint.  
The effect of increased neutrophil recruitment to the inflamed joint is not 
limited to the destructive capabilities of their cytotoxic products. It is 
understood that neutrophils also play a regulatory role in the progression of 
inflammation, by orchestrating the activity of other immune cells in the vicinity, 
and coordinating the immune ‘self-attack’ (Mantovani et al., 2011). Neutrophil 
organisation of the other immune cells is achieved through several activities, 
including; (i) secretion of chemical factors such as cytokines and chemokines 
that stimulate and recruit immune cells to infiltrate the joint, (ii) release of some 
proteases which regulate the activity of the cytokines and chemokines, (iii) 
direct cell-cell interactions which activate cells such as natural killer cells, and 
(iv) upregulation of specific receptors on the neutrophil plasma membrane, such 
as the major histocompatibility class (MHC) II proteins, enabling antigen 
presentation to T cells in the matrix (Wright et al., 2014). 
Neutrophils isolated from patients with rheumatoid arthritis also have different 
characteristics to those isolated from healthy individuals. Synovial fluid 
extracted from the joints of rheumatoid arthritis patients contains a larger 
majority of activated neutrophils, than in the synovial fluid of healthy individuals 
(Wittkowski et al., 2007). These neutrophils are primed for the release of ROS 
(Eggleton et al., 1995) and they secrete a number of cytokines and chemokines 
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which in turn regulate the activity of osteoclasts and B lymphocytes in the 
afflicted joint. Furthermore, the hypoxic environment of a rheumatic joint, in 
combination with the occurrence of antiapoptotic cytokines such as TNFα, IL-8 
and GM-CSF, has the effect of prolonging the neutrophil’s lifespan from the 
typical 24 hours up to several days (Raza et al., 2006; Weinmann et al., 2007). 
These factors make neutrophils both antagonists of the rheumatic condition, 
and also effectors of the tissue destruction; as such reducing neutrophil 
recruitment to the joints is a prominent target for developing novel therapies to 
treat rheumatoid arthritis. 
1.6 Ca2+ signalling  
Calcium is one of the most abundant elements on Earth, superseded only by 
silicon, aluminium, iron and oxygen (Case, 2007). As Ca2+ ions have a high affinity 
for electrostatic interaction with carboxylate oxygen (Jaiswal et al., 2001; Saris 
and Carafoli, 2005), this may have led to the evolution of Ca2+ binding proteins 
with ‘effector functions’. Within cells, Ca2+ concentration is therefore tightly 
regulated. The Ca2+ ion is a ubiquitous signalling system in various cell types, and 
is involved in a vast range of cellular processes including fertilisation and smooth 
muscle contraction. Its tendency to interact with carboxyl groups, such as those 
on amino acids, means that high intracellular Ca2+ concentrations can lead to 
protein aggregation, disruption of the integrity of the plasma membrane, 
aggregation of nucleic acids and the precipitation of phosphates, sulphates and 
carbonates. As such, elevated concentrations of Ca2+, if unregulated, are 
undesirable in biological systems. For example calcification, where the 
inappropriate deposition of insoluble calcium salts in soft tissues causes them to 
harden. High concentrations of aqueous Ca2+ will also react rapidly with 
phosphate, producing calcium phosphate (the main insoluble component in 
bone). Since the energy currency in most eukaryotic cells is ATP, there is an 
abundance of ATP in cellular systems (1-5mM) fuelling protein phosphorylation, 
which in turn is a substrate for phosphatases which liberate inorganic 
phosphate. This is an important reason for the tight regulation of Ca2+, and it is 
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essential that the free Ca2+ concentration within the cell does not typically 
exceed 100 nM, to reduce the likelihood of Ca2+/phosphate interaction. This is 
achieved via Ca2+ sequestering molecules and transmembrane Ca2+ pumps in the 
plasma membrane and the membrane of intracellular Ca2+ stores; which actively 
maintain a comfortable homeostasis, by expelling excessive Ca2+ into the 
extracellular milieu, or entrapping it within organelles.  
Gradients of Ca2+ across the membrane of intracellular organelles, and across 
the plasma membrane, enable Ca2+ influx or efflux, thus generating a biological 
signal for the cell to react. The ‘Ca2+ toolkit’ refers to the numerous Ca2+ 
signalling mechanisms achievable in cellular systems, although not every cell has 
every component of the ‘toolkit’, suggesting that the Ca2+ signalling mechanisms 
of different cell types are tailored to suit their proper functions. The way the 
‘Ca2+ toolkit’ is tailored to suit neutrophil function is not fully understood, and 
this thesis will discuss the relationship between Ca2+ influx and the localised 
activation of membrane-proximal cytosolic proteases. 
1.6.1 Ca2+ homeostasis in neutrophils 
The levels of cytosolic Ca2+ regulate important neutrophils behaviours, including 
extravasation, chemotaxis and phagocytosis. Ca2+ exists in the neutrophil 
cytosol, either free or bound to a Ca2+ chelator, and sequestered within 
intracellular Ca2+ storage organelles. The cytosolic free Ca2+ in healthy 
neutrophils is highly regulated both at rest and in the activated state. At rest, the 
concentration of free Ca2+ in the neutrophil cytosol is 100 nM (Hallett and 
Lloyds, 1997), whereas, extracellular Ca2+ concentrations exist in the milimolar 
range. This creates a concentration difference of 10,000-fold across the plasma 
membrane. This gradient is maintained by the active removal of Ca2+ from the 
cell by transmembrane Ca2+ pumps (Na2+/Ca2+ exchangers (Reuter and Seitz, 
1968; Blaustein and Hodgkin, 1968) and Ca2+-ATPase pumps (Volpi et al., 1983), 
coupled with the relatively low permeability of the plasma membrane to 
extracellular Ca2+. 
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Where acute fluctuations in cytosolic Ca2+ concentration across the cell 
membrane occur, they are buffered by soluble chelators sequestered within 
organelles such as calciosomes (Krause et al., 1989). Ca2+-ATPase pumps are 
required to stabilise resting levels of intracellular Ca2+ concentration between 
100-200 nM (Schatzmann, 1966). They are activated by the Ca2+ binding protein 
calmodulin (Larsen and Vincenzi, 1979; Vincenzi, 1979), which has a high affinity 
for Ca2+. As a result of maintaining a low concentration of free Ca2+ in the global 
cytosol, Ca2+ that enters the cell has a significant effect on the free Ca2+ 
concentration, and thus serves as a signalling ion.  
Upon neutrophil activation, the release of Ca2+ from intracellular Ca2+ stores, as 
well as Ca2+ influx across the plasma membrane, can cause the average 
concentration of the global cytosol to reach up to 1 µM (Demaurex et al., 1992). 
Because of the high Ca2+ buffering within the cytosol, Ca2+ elevations may be 
greatest in the subcellular domain immediately adjacent to the site of Ca2+ 
influx. Computer models by Brasen and colleagues (2010) have predicted that 
localised Ca2+ hotspots of 30 µM could exist within the cytosolic microdomains 
beneath neutrophil plasma membrane microridges (Brasen et al., 2010). This 
property means that Ca2+ signalling can be localised to parts of the cell 
periphery. This could be important in neutrophils, as they exhibit highly localised 
responses, such as pseudopodia extension and phagocytic cup formation. 
However, at the moment it is not possible to measure Ca2+ at this defined intra-
wrinkle subdomain (see Chapter 5).  
1.6.2 Ca2+ storage and distribution in human neutrophils 
Neutrophils are anything but a ‘typical’ cell, particularly in regard to their Ca2+ 
signalling behaviours. The Ca2+ distribution in the human neutrophil is not yet 
fully understood, and is the subject of work presented in this thesis.  
When the cytosolic Ca2+ level becomes high, Ca2+ is removed from the cytoplasm 
by the activity of Ca2+ pumps in the plasma membrane and across the 
membrane of intracellular organelles. Neutrophils appear to have more than 
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one site for storing intracellular Ca2+, and these may be involved in different 
cellular functions, utilising different mechanisms to liberate their Ca2+ for 
secondary signalling (Pettit and Hallett, 1998). One site of high Ca2+ in the 
neutrophils is located at the perinuclear space. Typically 50% of the Ca2+ in an 
average cell is sequestered within the nucleus (Hallett and Campbell, 1983), and 
antimony staining of neutrophils has revealed that the nucleus is indeed a Ca2+ 
hotspot (Hoffstein 1979; Cramer and Gallin, 1979), with the juxtanuclear space 
implicated as a Ca2+ storage site. A second site of localised Ca2+ concentrations in 
neutrophils is in the peripheral cytosol beneath the plasma membrane. High 
levels of sub-membranous Ca2+ concentration were identified beneath the 
plasma membrane in neutrophils (Pettit and Hallett, 1996a, 1996b, 1995, 1997; 
Al-Mohanna et al., 1997) using the Ca2+ chelator chlortetracycline which binds to 
Ca2+ with a Kd of 0.4 mM (Caswell, 1979). When bound to Ca2+ it becomes 
membrane impermeable, and will accumulate within the cell where there is high 
Ca2+. This sub-membranous location of high Ca2+ concentration may also play a 
role in the activation of β2-integrins (Pettit and Hallett, 1998) during cell arrest 
and extravasation. Approximately 95% of the Ca2+ in the neutrophil can be 
accounted for in regions of high Ca2+ concentration at the cell periphery and the 
juxtanucelar site (fig. 1.6.2), which may function as physiological Ca2+ storage 
sites.  
It is now also understood that neutrophils possess a much more substantial 
mitochondrial system than previously thought (Fossati et al., 2003), and these 
organelles may also act as conventional intracellular Ca2+ storage sites in 
neutrophils (Montero et al., 2004). Other small mobile organellular structures 
resembling the sarcoplasmic reticulum of muscle cells or calciosomes (Volpe et 
al., 1988; Krause et al., 1989; Favre et al., 1996a,b) are estimated to contain up 
to 5% of cellular Ca2+ concentration in neutrophils.  
Where Ca2+ is sequestered within the cell for future signalling capabilities, it is 
sequestered into ‘calciosomes’, small Ca2+ storage organelles via the sarco-
endoplasmic reticulum Ca2+-ATPase (SERCA) pumps. Neutrophils express several 
isoforms of the SERCA proteins, including SERCA III (Lominadze et al., 2005) and   
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F µm 
µm 
Figure 1.6.2: Ca
2+ 
distribution in the neutrophil 
Physiological Ca
2+ 
stores in a resting neutrophil identified by chlortetracycline 
fluorescence (1:50 chlortetracycline in DMSO, 45 mins). (a) Bright-field and (b) 
fluorescent images. (c) Ca
2+ 
intensity map across 2D image. Chlortetracycline 
distribution shows regions of high Ca
2+ 
concentration at the cell edge and 
centrally close to nuclei. (Amended from Al-Mohanna, 1997). 
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SERCA IIb which was found to be specifically associated with ‘calciosome’ 
organelles (Favre et al., 1996a). The ‘calciosome’ storage organelles also contain 
abundant proteins with Ca2+ binding properties, such as calreticulin (Favre et al., 
1996a; Krause et al., 1989; Stendahl et al., 1994; Volpe et al., 1988), for 
sequestering Ca2+ within the membrane-bound structures. They also have 
receptors for the soluble secondary messenger inositol 1,4,5-trisphosphate (IP3),  
which is important in the signal transduction involved during the biphasic Ca2+ 
response in neutrophils. 
1.6.3 Ca2+ signalling in human neutrophils 
Neutrophils are autonomous cells. Therefore in order to coordinate a unified 
response amongst a population sensing the same chemical stimuli, the signalling 
cascade within each neutrophil must involve a multitude of complex 
interactions. Neutrophils are equipped with an array of cell surface receptors, 
and the way in which their activation brings about a secondary Ca2+ signalling 
response varies. It is worth exploring some of these behaviours in detail, since 
this will provide some background for the experimental approach and results 
presented in subsequent chapters.  
Neutrophils are non-excitable cells and represent a specific niche of cell 
behaviour. They respond to a vast array of different stimuli via engagement with 
a number of different types of receptor. In the 1960s Woodin and Weineke 
demonstrated that neutrophils treated with Streptolysin A became activated. 
They concluded this was due to increased membrane permeability to Ca2+, thus 
indicating an important role of cytosolic Ca2+ signalling in neutrophil signalling 
and activation (Woodin and Wieneke, 1963; 1964). Since then much work has 
been carried out to investigate the mechanisms of Ca2+ entry and Ca2+ store 
release in neutrophils. 
Classically, the large rise in the cytosolic Ca2+ concentration of neutrophils, which 
occurs when they are stimulated, involves a biphasic Ca2+ response. An initial 
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rise in cytosolic Ca2+ is achieved by release from intracellular Ca2+ storage 
organelles, followed by an influx of Ca2+ ions from the extracellular milieu. The 
typical concentration of extracellular Ca2+ concentration is around 1 mM, which 
generates a 10,000 fold concentration gradient across the cell membrane, where 
the resting intracellular Ca2+ concentration is around 100 nM (Hallett and Lloyds, 
1997). The result is an overall 10-fold increase in cytosolic Ca2+ concentration in 
the neutrophil cytosol (Demaurex et al., 1992). This is possibly the most 
dramatic change in intracellular chemical properties that the neutrophil 
experiences and is a significant event for the cell, being necessary for a number 
of neutrophil effector functions (Hallett and Campbell, 1984). 
1.6.3.1 G protein coupled receptors  
G protein coupled receptors (GPCRs) are a family of seven transmembrane 
(7TM) receptors on the surface of many different cell types. Neutrophils have a 
number of heterotrimeric pertussis toxin-sensitive GPCRs, of the Gi/o family, 
which recognise a wide range of chemoattractants including: the bacterial 
peptide fMLP, LTB4, C5a and PAF (Futosi et al., 2013). Engagement of the 
receptors with their respective ligands causes a dissociation of the Gαβγ 
subunits on the inner leaflet of the plasma membrane.  
GPCR activation in neutrophils triggers a biphasic Ca2+ signal (fig. 1.6.3.1). The 
first phase is mediated by activation of phospholipase C β (PLCβ), which cleaves 
phosphatidylinositol 4,5-bisphosphate (PIP2) to produce IP3 and diacylglycerol 
(DAG). DAG remains associated with plasma membrane phospholipids, whilst IP3 
translocates to intracellular Ca2+ stores where it engages with the IP3 receptor 
(IP3R) to release sequestered Ca2+ into the cytosol. There is a slight delay 
between GPCR activation by extracellular ligand, and the subsequent increase in 
cytosolic Ca2+ levels from both intracellular store release and from Ca2+ influx 
across the plasma membrane (Pettit and Hallett, 1998a,c; Favre et al., 1996b). 
This delay correlates with the diffusion of IP3 signalling molecules from the 
plasma membrane to the Ca2+ stores (Hallett and Lloyds, 1997). The Ca2+ 
liberated from IP3 sensitive Ca2+ stores can activate the plasma membrane   
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channel Melastatin-related Transient Receptor Potential cation channel 2 
(TRPM2) (Du et al., 2009). As such, it is suggested that this may be one 
mechanism that facilitates the secondary Ca2+ influx phase, which occurs after 
intracellular store release.  
1.6.3.2 Fc receptor and integrin mediated Ca2+ signalling 
Neutrophils have both FcRs, which recognise IgG-opsonised pathogens, and 
integrin receptors which recognise both molecules expressed on the surface of 
endothelial cells during transmigration, and C3bi-opsonised pathogens. Both 
types of receptor are activated by cross-linking, which generates an intracellular 
Ca2+ signal (Pettit and Hallett, 1998a,b, 1996a) through separate yet similar 
mechanisms to GPCR mediated Ca2+ release. 
Neutrophils express a number of integrins which are involved in cell-cell 
adhesion and the process of transendothelial migration. The integrin family are a 
group of heterodimeric transmembrane glycoproteins, and are expressed on 
almost all mammalian cells, but the most important type expressed on the 
neutrophil cell surface is the β2 integrin family member CD11b/CD18 (Hellberg et 
al., 1996), which is significant in neutrophil adhesion, migration and 
phagocytosis (Anderson and Springer, 1987). During inflammation, CD11b/CD18 
on the neutrophil interacts with ICAM-1 on endothelial cells and C3bi opsonised 
pathogens (Plow et al., 2000). This stimulates downstream tyrosine kinase 
dependent release of Ca2+ from IP3-sensitive intracellular stores, via 
Phospholipase C y2 (PLCy2) activity which in turn cleaves PIP2 to generate DAG 
and IP3 (Hellberg et al., 1996). A secondary global Ca2+ signal is achieved by Ca2+ 
influx through plasma membrane channels (Davies and Hallett, 1995a,b).  
Neutrophils also have other classes of FcR on their surface, but the most 
important FcRs on neutrophils belong to the class of low affinity FcγRs (Bruhns, 
2012). The primary role of these receptors (including FcγRIIA and FcγRIIIB) is the 
recognition of and engagement with IgG-opsonised pathogens for removal by 
phagocytosis. Upon activation by extracellular ligands, the receptors undergo 
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conformational changes. Cross-linking of the cytoplasmic tails of both FcγRs and 
integrins triggers the Src-family kinases to phosphorylate the immunoreceptor 
tyrosine-based activation motif (ITAM) domains, recruiting the Syk tyrosine 
kinase to the plasma membrane (Mocsai et al., 2002, 2010). Activation of Syk 
leads to further signalling pathways inside the cell, including activation of PLCγ2 
(Jakus et al., 2009) and PI3K isoforms essential for neutrophil effector functions 
(Kulkarni et al., 2011), and also Ca2+ release from IP3-sensitive intracellular stores 
(Davies and Hallett, 1995b). 
Both mechanisms of activation display a lag time between receptor stimulation 
and the Ca2+ signal, which can be explained by the time taken for receptors to 
laterally diffuse along the plasma membrane in order to form aggregates which 
are able to generate the Ca2+ response (Roberts et al., 1997).  There is a delay 
(~500 ms) in generating the Ca2+ signal by soluble stimuli, such as fMLP which 
also triggers IP3-dependent Ca2+ release from intracellular Ca2 stores, and is 
followed by the larger Ca2+ influx across the plasma membrane (Pettit and 
Hallett, 1995). In contrast, when neutrophils are stimulated by the cross-linking 
of integrin receptors in the plasma membrane, the lag time in Ca2+ influx is 
longer, and a second Ca2+ influx occurs ~10-100 s after the initial liberation of 
Ca2+ from storage sites (Pettit and Hallett, 1996b). Therefore, it is possible that 
initial release of Ca2+ comes from different Ca2+ storage locations, depending on 
the mechanism of neutrophil activation, in order to achieve the desired effector 
function of the neutrophil, e.g. chemotaxis vs. cell arrest/spreading.  
Downstream Ca2+ signals are inhibited in the presence of tyrosine 
phosphorylation inhibitors (Morgan et al., 1993) as well as small molecule 
inhibitors of protein L-plastin (Rosales et al., 1994) which suggests that the actin 
cytoskeleton also plays an important role in signal transduction from the plasma 
membrane. 
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1.6.4 Ca2+ influx through plasma membrane channels 
Significant changes in cytosolic Ca2+ concentration occur when Ca2+ channels in 
the plasma membrane are opened. There are three main groups of Ca2+ channel, 
which can be categorised based on their mechanism of activation, they are: (i) 
receptor operated channels (ROCs), (ii) voltage operated channels (VOCs) and 
(iii) store operated channels (SOCs).  
(i) ROCs are found in non-excitable cells, including endothelial cells. The 
receptors can be activated either by ligation of the extracellular 
domains (e.g. with ATP, glutamate and acetylcholine) or the 
intracellular domains (e.g. with aracadonic acid or DAG). Binding of a 
ligand with the ROC induces a conformational change in the tertiary 
structure of the receptor which causes the channel to open enough 
to enable Ca2+ ions to flow into the cell along a concentration 
gradient. The ROCs can also be coupled with downstream activator 
proteins, such as kinases and phosphatases, which also become 
activated upon ROC engagement with a ligand.  
(ii) VOCs are expressed in excitable cells, such as muscle cells and 
neurons, which respond to a change in potential difference across the 
cell plasma membrane. Depolarisation of the plasma membrane in 
these cells causes a conformational change in the receptor, and 
facilitates Ca2+ entry into the cell. Neutrophils require voltage-gated 
proton channels to produce ROS via the electrogenic enzyme NADPH 
oxidase (Henderson et al., 1987), but not for global Ca2+ influx across 
the plasma membrane (Demaurex et al., 1994). 
(iii) SOCs facilitate Ca2+ influx across the plasma membrane in 
coordination with Ca2+ release from intracellular stores, and are also 
known as Ca2+ release activated Ca2+ channels (CRACs). The 
interaction between the two Ca2+ release mechanisms is logical, since 
opening of Ca2+ channels in the plasma membrane, following the 
depletion of intracellular stores, is necessary to replenish the stores 
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for future activity. The mechanism of store operated Ca2+ entry 
(SOCE) is recognised as the primary mechanism of Ca2+ entry into 
neutrophils (Davies and Hallett, 1998). 
 
Inhibition of VOCs does not prevent Ca2+ influx across the plasma membrane 
(Demaurex et al., 1994) therefore the predominant Ca2+ channels involved in 
influx across the plasma membrane are not thought to be voltage-gated. 
Furthermore, neutrophil Ca2+ channels are not activated by engagement with 
extracellular ligands. Instead, their activity is closely linked to the Ca2+ status of 
intracellular Ca2+ stores (von Tscharner et al., 1986). When stores are depleted, 
the channels open and Ca2+ ions flood into the cell down the concentration 
gradient (via SOCE). Inhibition of the Ca2+ influx through plasma membrane Ca2+ 
channels prevents neutrophils from carrying out downstream effector functions 
(Hallett and Campbell, 1984; Marks and Maxfield, 1990a,b).  
 
While SOCE has long been recognised as the predominant mechanism of Ca2+ 
entry in neutrophil cell signalling (Pettit and Hallett, 1998a,b; Itagaki et al., 
2002), unravelling the complexities of the mechanism has taken several years, 
mainly due to the lack of specific  SOCE inhibitors and reliance on the artificial 
manipulation of external Ca2+ concentrations. Over the last two decades, 
significant advances have been made with the discovery of two Ca2+-sensing 
proteins, Stromal interaction molecule 1 (STIM1) (Zhang et al., 2005) and ORAI 
Ca2+ release-activated Ca2+ modulator 1 (ORAI1) (Prakriya et al., 2006), and with 
them the ability to study the consequences of genetic mutations in these two 
molecules. 
 
STIM1 is a Ca2+ sensing protein on the ER membrane, which undergoes a 
conformational change in low Ca2+ conditions. When Ca2+ stores are high, The N-
terminal luminal EF-hand domain of STIM1 binds Ca2+. Depletion of Ca2+ from 
intracellular stores causes dissociation of Ca2+ ions from the ER-luminal domains, 
and a clustering of STIM1 molecules at ER/plasma membrane proximal sites in 
the ER membrane (Soboloff et al., 2012) (fig. 1.6.4). This enables direct   
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engagement between STIM1 and ORAI1 channels on the plasma membrane 
(Roos et al., 2005; Zhang et al., 2005). Clustered STIM1 molecules bind to the 
STIM1-binding site on the C-terminal domain of ORAI1, triggering a 
conformational change in the core of ORAI1 which is sufficient for channel gating 
(Zhou et al., 2016). This facilitates the formation of puncta sites between the ER 
membrane and the plasma membrane. Activation of ORAI1 by its intracellular 
ligand STIM1 plays a significant role in SOCE, triggering CRAC channels to open 
and facilitating Ca2+ influx (Zhang et al., 2005) to refill intracellular stores (Feske, 
2007; Hogan et al., 2010). 
Neutrophil activation and inflammatory response functions such as 
phagocytosis, neutrophil rolling arrest and transendothelial migration may be 
regulated by the activity of SOCE via ORAI1 and STIM1 interaction (Schaff et al., 
2010; Steinckwich et al., 2011). Studies in mice have found that Stim1-/- knock-
out neutrophils show almost complete inhibition of Ca2+ influx stimulated by 
receptor cross-linking, and displayed a 50-70% reduced ability to perform 
phagocytosis of opsonised Staphylococcus aureus (Zhang et al., 2014). This 
suggests that in mouse neutrophils, mutations in STIM1/ORAI have a significant 
effect on neutrophil function and therefore immunodeficiency (Clemens and 
Lowell, 2015).  
Surprisingly, STIM1/ORAI1 deficient human neutrophils exhibit normal Ca2+ 
responses, chemotaxis, adhesion, ROS production and phagocytosis (Elling et al., 
2016). Furthermore, STIM1/ORAI1 depletion only mildly diminishes the SOCE 
activity, but does not abrogate Ca2+ influx in the same way as Ca2+ chelators. 
Taken together, the implication is that an alternative Ca2+ channel may also be 
contributing to SOCE in neutrophils, and this suggests that neutrophils may have 
multiple mechanisms for generating intracellular Ca2+ signals. This is not unlikely 
since phagocytes are the first line of defence against invasive pathogens, 
neutrophils may have evolved mechanisms to circumnavigate the Ca2+ blocking 
activity of intracellular pathogens such as Leishmania, Franciscella and 
Mycobacterium tuberculosis, during phagocytosis (Demaurex and Nunes, 2016).  
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Mouse knock-out models have also revealed that the two proteins are both 
important but have different significances in conferring the ability of neutrophils 
to carry out typical cellular functions. For example ORAI1, but not STIM1, is 
necessary to achieve Ca2+ influx following ROC/agonist interaction during 
neutrophil migration; whilst STIM1 is crucial to SOCE (Zhang et al., 2014).  
Prior to the identification of ORAI1, it was suggested that the TRP family of Ca2+ 
channels, including TRPM2 (Du et al., 2009), were responsible for CRAC. Indeed, 
more recently TRPM2 has been found to mediate the efflux of cations across the 
phagosomal membrane during phagosome maturation (Di et al., 2017). Thus 
TRPM2 is essential for the proper functioning of phagocytosis, and may also be 
an important key player together with STIM1/ORAI1, in mediated Ca2+ influx 
(Liao et al., 2007) involved in the second stage of the biphasic Ca2+ signal. 
1.6.5 Measuring cytosolic Ca2+ levels 
Cytosolic free Ca2+ is commonly measured in live cells using fluorescent calcium 
chelators conjugated to acetoxymethyl esters (AM), which make the probes lipid 
soluble, masking the Ca2+ binding site and enabling them to diffuse across the 
cell membrane. Non-specific esterases in the cell cytosol cleave the ester 
linkage, revealing the Ca2+ binding site and also rendering the probe hydrophilic. 
This effectively engineers the equilibrium of diffusion to favour movement of the 
probe across the plasma membrane and into the cell, where it then becomes 
trapped in the cytoplasm and can report Ca2+ concentration (Hallett and Lloyds, 
1997). This also prevents the probe from being lost from the cell, enabling an 
accurate measurement of the Ca2+ within the cell. 
Fura-2-AM is one such traditionally used probe, with a Kd of approximately 200 
nM. Since the resting Ca2+ concentration in neutrophils is considered to be 100 
nM, Fura-2-AM allows detection of Ca2+ fluctuations in the mid-physiological 
range. Extraction of data from Ca2+ measurements using Fura-2 requires 
ratiometric imaging, since both the bound and un-bound forms are fluorescent, 
and excited at different wavelengths (Tsein and Poenie, 1986). However, the 
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wavelengths for excitation are in the UV spectrum, which is problematic in 
neutrophils because they contain many small molecules which may become 
activated in response to UV light, such as NAD(P)H (Monsel et al., 2014).  
An alternative probe which avoids this problem, is Fluo4. With a Ca2+ affinity of 
around 345 nM (Gee et al., 2000) its fluorescence increases around 100-fold in 
the Ca2+ bound form, making it useful to measure sensitive changes in Ca2+ 
concentration. Fluo4 is excited by longer wavelengths (488 nm), which also 
reduces the occurrence of auto fluorescence. Fluo4 does not induce a shift in the 
emission wavelength when binding Ca2+, and therefore fluorescence must be 
visualised using confocal microscopy techniques and optical slicing (Hallett and 
Lloyds, 1997). 
The probes described here diffuse through the cytosol, and therefore report the 
Ca2+ concentration across the global cytosol. However, it is known that some cell 
types display patterns of cytosolic Ca2+ signalling, including waves and 
oscillations (Rooney and Thomas, 1993), and the cytosolic Ca2+ concentration in 
cells is not uniform across the cytosol. Presently there is no established method 
for measuring changes in Ca2+ concentration at discrete sub-membranous 
cytosolic locations in single cells, which would be useful to identify the existence 
of transiently high Ca2+ concentrations which are important in the Ca2+-regulated 
activity of some cytosolic enzymes. 
1.6.6 Ca2+-regulated enzymes in neutrophils 
It has been highlighted that Ca2+ signalling is very important for enacting the 
appropriate response to extracellular stimuli. One possible effector of Ca2+ 
signalling in neutrophils, is the enzyme calpain. The calpain family of proteases 
become activated upon sensing high concentrations of cytosolic Ca2+, and their 
engagement has been reported in the migration of neutrophils (Saez et al., 
2006). It has been proposed that calpains may have important roles in regulating 
neutrophil behaviour; particularly in the morphological rearrangements that 
enable neutrophils circulating in a spherical shape to spread during adhesion to 
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endothelial cells during transendothelial migration, and the projection of 
pseudopodia during engulfment of foreign particles in phagocytosis. Calpains 
may also be involved in detachment of neutrophils from the extracellular matrix 
by lysis of adhesion complexes, and play a role in neutrophil apoptosis 
pathways. However, the role of Ca2+-regulated calpain activity in neutrophil 
functions, specifically morphology changes, is not fully understood. Since this 
mechanism presents possibilities for small molecule therapeutic intervention to 
control neutrophil activity in autoimmune disease, it is important that calpain 
activity in neutrophils is explored. 
1.7 µ-Calpain 
The calpain family consists of several Ca2+ activated cysteine proteases, within 
the larger papain super-family (Murachi et al., 1980; Berti and Storer, 1995). The 
name calpain is derived from calmodulin and papain, in a nod to its Ca2+ 
interacting and proteolysing properties respectively. It was first purified from 
soluble fractions of rat brain in in the 1960s (Guroff, 1964). Although the 
calpains are a relatively large protein family, with 15 known isoforms, the two 
most studied members are µ-calpain (also known as calpain-1) and m-calpain 
(also known as calpain-2), which share 62% sequence similarity (Imajoh et al., 
1988). The two calpains were named µ-calpain and m-calpain because of the 
differences in their sensitivity to Ca2+ concentration; ~20-60 µM and ~0.3-1.3 
mM respectively (Goll et al., 2003). These concentrations were experimentally 
found to activate the two calpain isoforms in vitro, however, both 
concentrations exceed the levels of cytosolic free Ca2+ found in vivo, initially 
suggesting a role for other modulatory factors in the intracellular activation of 
calpains. 
 
Both µ-calpain and m-calpain are ubiquitously expressed cytosolic proteases in 
vertebrates (Johnson, 1990; Hayashi et al., 1999), and are known as modulator 
proteases because of the way they alter the activity of their substrates. Unlike 
caspases and proteasomes, calpains do not hydrolyse their protein substrates to 
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destruction. Instead, they modify the activity or the behaviour of the protein, 
with consequences on cellular function (Ono and Sorimachi, 2012). This thesis 
will focus on the intracellular activity of µ-calpain, the predominant isotype of 
calpain found in neutrophils (Goll et al., 2003). 
1.7.1 Structure of µ-calpain 
µ-calpain is involved in many different physiological processes. However, 
elucidating its precise role in neutrophils has proved difficult to achieve 
experimentally, mainly because of the need for specific calpain inhibitors 
(Carafoli and Molinari, 1998), and the difficulty in generating crystals for 
structural determination by x-ray crystallography. To date, the structure of full 
length µ-calpain has not yet been solved by crystallography, however the 
structure of m-calpain and a µ-calpain/m-calpain hybrid have proved useful in 
the study of calpain domain interactions (Wendt et al., 2004). 
 
µ-calpain is a heterodimeric protein composed of a large 80 kDa subunit 
(CAPN1), with proteolytic activity, encoded on chromosome 1, and a smaller 28 
kDa regulatory subunit (CAPNS1) which is also common to m-calpain, encoded 
on chromosome 19 in humans (Aoki et al., 1986; Imajoh et al., 1988; Goll et al., 
2003; Sorimachi et al., 2011) (fig. 1.7.1). The two subunits of µ-calpain are 
further sub-divided into smaller domains, with different properties (fig. 1.7.1). 
Presently, the only full-length calpain structures have been solved with m-
calpain, although these have made the classification of common subdomains 
possible. For example the small regulatory subunit, common to both, contains 
domains V and VI, of which domain VI has a calmodulin-like domain consisting of 
five EF hand motifs which bind Ca2+ (Blanchard et al., 1997; Ohno et al., 1986). 
 
Domain I of the larger proteolytic subunit does not have any sequence homology 
to any other protein. The catalytic activity of µ-calpain arises from its catalytic 
triad of histidine, asparagine and cysteine in domain II of the larger subunit, 
which together attack the carbonyl group of the targeted substrate peptide   
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Figure 1.7.1: Structure of µ-calpain 
Schematic diagram of the structure of human µ-calpain CAPN1 (large subunit) and 
CAPNS1 (small subunit), with domain regions predicted from its amino acid sequence. 
The large subunit is made up of three smaller subunits. The N terminal domain of 
CAPN1 (yellow) is an alpha helix; domain II forms the Proteolytic Core, known as CysPc, 
and is itself divided into two halves (PC1 and PC2); domain III resembles the C2 
phospholipid binding domains of phospholipases; domain IV is the Ca
2+
 binding domain 
containing four of the six EF-hand motifs (white bars). The smaller subunit is made up of 
two subdomains. The N-terminal contains a glycine rich domain (GR), and another Ca
2+
 
binding domain, with five EF-hand motifs. Figure adapted from Goll et al., 2003. 
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bond by hydrolysing it (Goll et al., 2003; Polgar, 1989). However, at present the 
preferred cleavage site among substrates of µ-calpain is unknown. Domain II is 
also the region that interacts with the endogenous calpain inhibitor, calpastatin. 
Domain III of the large subunit may have some regulatory function, as it 
resembles a C2-like domain and enables µ-calpain to translocate to the plasma 
membrane through binding to phosphatidylserine. This allows µ-calpain to 
associate with the plasma membrane in regions of elevated Ca2+ concentration 
(Tompa et al., 2001). The fourth domain of the large subunit, IV is partially 
homologous to the Ca2+ binding protein calmodulin, and contains four EF motifs 
(Goll et al., 2003), similar to domain VI of the smaller subunit. 
 
The only characterised endogenous calpain inhibitor is calpastatin, which acts 
exclusively on both µ-calpain and m-calpain (Wendt et al., 2004; Saez et al., 
2006). Inhibition of calpain by calpastatin is irreversible, and requires calpain to 
be in the active state bound to Ca2+ (Otsuka and Goll, 1987). This suggests that in 
vivo calpastatin mediated inhibition occurs to ‘switch-off’ or limit calpain activity 
once activated. This may be an important regulatory mechanism, since calpain is 
a cytosolic protein with multiple substrates, therefore unregulated calpain 
activation could prove detrimental to the cell. Indeed, calpain activity has been 
implicated in the process of apoptosis (Squier et al., 1994), and neuronal 
degeneration (Wingrave et al., 2003). Calpastatin is made up of five domains, 
which make up three regions of inhibitory activity. A number of peptide based 
inhibitors have been designed to inhibit calpains, based on the sequence of the 
inhibitory region B of calpastatin. The regulation of µ-calpain activation by Ca2+ 
will be explored in detail in this thesis. 
1.7.2 µ-calpain activation by Ca2+ 
Ca2+ signalling in neutrophils has previously been discussed. It is thought that µ-
calpain is a key enzyme which is activated in neutrophils, upon Ca2+ influx. µ-
calpain is involved in the mechanism which facilitates migration in many cells, 
including neutrophils (Saez et al., 2006), and there is convincing evidence that µ-
56 
 
calpain activation is important in the morphological changes that neutrophils 
undergo during adhesion and detachment from the extracellular matrix. This has 
further suggested the involvement of µ-calpain in the regulation of neutrophil 
behaviour; to complete cellular functions such as phagocytosis, chemotaxis and 
cell spreading for extravasation. µ-calpain-mediated regulation of neutrophil 
function is therefore a possible target for therapeutic intervention. However, the 
question of µ-calpain activation in neutrophils remains. µ-calpain has a Kd of 
~20-60 µM Ca2+, which as previously discussed is much higher than the Ca2+ 
concentration of the global cytosol. With a broad range of many different 
substrates, it is therefore important that µ-calpain activation is tightly regulated, 
both spatially and temporally.  
 
Both µ-calpain and m-calpain are found exclusively in the cell cytoplasm, 
although their distribution throughout the cytosol varies depending on the cell 
type and the nature of its activity. In unstimulated cells, calpains are found to be 
located in cytosolic regions close to the nucleus (Gil-Parrado et al., 2003). 
However, being cytosolic, calpains are able to move in response to soluble 
signals, and may coordinate translocation to peripheral regions of cytosol close 
to the plasma membrane in response to elevated Ca2+, through their C2-like 
domains (Goll et al., 2003). This relocation is observed when cells are artificially 
stimulated with Ca2+ ionophores. This suggests that calpain activity is required at 
the cell periphery upon cell activation and during Ca2+ signalling. In human 
neutrophils, it has been predicted that the Ca2+ concentration during influx 
reaches high enough concentrations to activate µ-calpain located beneath 
plasma membrane microridges (Davies and Hallett, 1998; Brasen et al, 2010), 
although this has not been possible to measure experimentally. It seems likely 
that the location of Ca2+ hotspots may correlate with areas of µ-calpain activity 
during Ca2+ influx and neutrophil effector functions. 
 
µ-calpain is inactive at cytosolic Ca2+ concentrations, in the range 50-100 nM 
(Pietrobon et al., 1990), and exists as a pro-enzyme. Under physiological 
conditions, µ-calpain becomes activated by transient cytosolic domains of high 
57 
 
Ca2+ concentration, which regulate its activity in cooperation with the 
endogenous inhibitor calpastatin, in regions of the cell where µ-calpain activity is 
required for appropriate cell function (Suzuki and Sorimachi, 1998). It is 
understood that Ca2+ binding to the calmodulin-like domain of µ-calpain reduces 
the Ca2+ concentration required for calpain activation, and can trigger autolysis 
of the N-terminal domains of both µ-calpain subunits. This causes dissociation of 
the subunits in the pro-enzyme, generating an active µ-calpain protein (Suzuki 
and Sorimachi, 1998). The proteolytic activity of µ-calpain is derived from its 
catalytic triad. In un-activated (i.e. unbound to Ca2+ calpain), the triad is not fully 
formed. Upon Ca2+ binding to the EF-hands, the protein undergoes a 
conformational change and reorganises the arrangement of the active site to 
assemble a functional catalytic triad (Hosfield et al., 1999a,b). The concept of 
calpain autolysis in calpain activation has been controversial. It is known that 
both m- and µ-calpain will perform autolysis when incubated with activating Ca2+ 
concentrations (Cong et al., 1993). However, oxidation of µ-calpain has been 
found to inhibit its proteolytic, but not its autolytic activity (Guttmann et al., 
1997), suggesting that the two events are not connected and that autolytic 
calpain activity is not involved in the mechanism of calpain activation. Another 
two-step mechanism has been proposed, whereby Ca2+ binding to the EF motifs 
may bring about subtle conformational changes in domains IV and VI. This may 
promote disassociation of the larger and smaller subunits, leading to 
reorganisation of the catalytic site (Khorchid and Ikura, 2002). In either case, a 
two-step mechanism for µ-calpain activation introduces another safety measure 
to protect the cell against unregulated µ-calpain activity. 
 
A second mechanism of calpain activation proposes that high cytosolic Ca2+ 
concentrations trigger inactive calpain to translocate to the cell edge, where it 
becomes activated by association with phospholipids in the cell membrane 
(Suzuki and Sorimachi, 1998). Furthermore, conversion of the 80 kDa proenzyme 
to a 76 kDa active enzyme occurs upon µ-calpain interaction with the 
cytoplasmic face of the cell membrane (Hayashi et al., 1999), suggesting that 
autolysis occurs during the process of calpain activation at the cell membrane. In 
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both instances a rise in cytosolic Ca2+ is involved in µ-calpain activation, and 
these activities place active µ-calpain in the vicinity of membrane-skeletal 
binding proteins which may be involved in enabling morphological changes. It is 
therefore of interest to investigate the relationship between Ca2+ concentration, 
µ-calpain activation and the downstream modification of µ-calpain substrates, in 
the regulation of neutrophil functions, which rely on morphological changes at 
the cell membrane.  
1.7.3 µ-calpain substrates 
More than 100 substrates of µ-calpain have been discovered and recorded 
following numerous in vitro assays. They can be broadly categorised into three 
main groups, including (i) transcription factors, (ii) kinases/phosphatases, (iii) 
cytoskeletal and membrane associated proteins (Goll et al., 2003). Of these 
groups, it is the relationship between µ-calpain and the cytoskeletal binding 
proteins that is of particular interest to the mechanism of neutrophil 
morphology change. Presently, there is no commonly recognised µ-calpain 
cleavage site among µ-calpain substrates.  
 
The main role of µ-calpain activity in neutrophils appears to be associated with 
the cytoskeletal reorganisations that occur during cell shape changes. µ-calpain-
mediated cleavage of the β-integrin family proteins is a prelude to disassembly 
of the focal adhesion molecule (Pfaff et al., 1999), and talin cleavage also seems 
to be important in their turnover, since µ-calpain deficiency decreases the 
number of focal adhesions (Lebart and Benyamin, 2006). 
 
µ-calpain mediated cleavage of membrane-linker proteins is also significant in 
the context of cell spreading. Although there is currently no recognised µ-calpain 
cleavage site, µ-calpain cleaves the ezrin/radixin/moesin (ERM) family protein 
ezrin, but not moesin (Shcherbina et al., 1999). This displays a level of selectivity 
for ezrin as a substrate, rather than its structurally and functionally similar 
cousin moesin, which indicates that a sensitive mechanism to distinguish 
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between substrates does exist. This thesis will focus on the affects and 
regulation of Ca2+ mediated µ-calpain cleavage of the linker protein ezrin. 
1.8 Ezrin  
Ezrin is a member of the ERM family of membrane-cytoskeletal linker proteins. It 
was previously known as p81, the epidermal growth factor (EGF) receptor 
tyrosine kinase substrate, villin-2 and cytovillin. The name ezrin was coined in 
1983 by Bretscher, which was derived from the name of the co-founder of the 
University in which it was first purified: Ezra Cornell, co-founder of Cornell 
University, in New York (Bretscher, 1983; 1991). It was first purified from the 
microvilli of epithelial cells in the intestinal brush border (Bretscher, 1983). Ezrin 
and moesin are the only members of the ERM family present in neutrophils. 
1.8.1 Structure and function of ezrin 
Ezrin has two main functional domains, located at the N and C termini (fig. 
1.8.1i). The phosphorylation status of ERM proteins correlates with their 
functional activity as cross-linkers between the plasma membrane and the actin 
cytoskeleton (fig. 1.8.1ii). Where ERM proteins are phosphorylated, they are 
found associated with the cortical cytoskeleton. Where ERM dephosphorylation 
occurs, inactive ERM proteins are unstable and cytosolic (Grune et al., 2002), 
returning to the soluble monomeric form, concurrent with the disassembly of 
membrane and cytoskeletal interactions (Mackay et al., 1997; Tran Quang et al., 
2000). ERM proteins can be directly phosphorylated by protein kinase C, MRCK 
and AKT (Ivetic and Ridley, 2004; Shiue et al., 2005) at tyrosine, serine and 
threonine residues. 
 
Monomeric ezrin is found abundantly in the cell cytoplasm, where the N-
terminal and C-terminal domains self-associate (Gary and Bretscher, 1995). This 
finding led to the suggestion that in unbound monomeric ezrin, head-to-tail 
association of the amino- and carboxy-terminal domains inhibits the binding   
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Figure 1.8.1i: Structure of ezrin 
The structure of ERM family proteins is conserved, with all three having a similar 
structure. (a) The N-terminal FERM domain (purple) is made up of three smaller sub-
domains (F1, F2, F3 or A, B, C (Hamada et al., 2000)). The C-terminal ABD (orange) 
contains the site of threonine phosphorylation responsible for the activation and self-
dissociation of the molecule (Thr567), and also the F-actin binding site. The central 
region between these two functional domains is largely α-helical, forming a coiled coil, 
and is connected to the ABD via a proline rich linker region. Figure adapted from Fehon 
et al., 2010. (b) The two conformational states of ezrin Head-to-tail self-associated 
ezrin is inactive until phosphorylated at Thr567 in the C-terminal domain. 
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activity of either domain. In fact, ezrin exists in two conformational states, and 
conversion between the two is proposed to act as a switch to regulate ezrin 
activity (Bretscher et al., 1997). The first state is an unphosphorylated closed, 
inactive conformation where the N-terminal ERM domain self-associates with 
the C-terminal actin binding domain (ABD) (Ohtani et al., 2002), masking plasma 
membrane and actin binding sites. The second is an open, active conformation 
where the two domains are separate. The ‘open’ conformation is achieved 
through PIP2 binding (Ivetic and Ridley, 2004) and phosphorylation at the 
conserved threonine 567 (Thr567) residue (Gautreau et al., 2000; Fievet et al. 
2004; Shiue et al., 2005), which causes a change in the intramolecular binding 
properties between the two domains, facilitating ezrin self-dissociation and 
subsequent F-actin binding (Viswanatha et al., 2013) (fig. 1.8.1ib).  
 
The ERM family of proteins associate with several ERM binding membrane 
proteins (EBMPs) at the plasma membrane via direct or indirect interactions 
(Yonemura et al., 1999). Ezrin was first suggested to play a role in crosslinking 
the plasma membrane to the F-actin cytoskeleton by Gould and colleagues 
(1989) on account of its similarity to talin and band 4.1, which binds to 
glycophyrin C (Correas et al., 1986). Algrain and colleagues (1993) performed 
transfection experiments which confirmed the interactions between the N-
terminal FERM domain of ezrin and the plasma membrane. They found that the 
amino terminal domain localised to the dorsal plasma membrane, and was 
readily extracted following treatment with non-ionic detergents; suggesting 
interaction with the plasma membrane (Algrain et al., 1993). The ERM domain of 
ezrin also forms a complex with the cytosolic tail of L-selectin (Ivetic et al., 2002), 
which anchors ezrin at the plasma membrane. The C-terminal ABD of ezrin binds 
to the F-actin cytoskeleton at the carboxyl terminus, which co-localises with 
actin filaments beneath the plasma membrane, and remains associated with 
these following treatment with detergent (Algrain et al., 1993). This 
demonstrates a role of ezrin as a bridge between the cortical actin cytoskeleton 
and the plasma membrane, given the affinity of its functional domains to both 
structures. Furthermore, mutations in the ezrin-binding domain of L-selectin 
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impair neutrophil functions such as rolling, both in vitro and in vivo (Dwir et al., 
2001; Kansas et al., 1993). This is further evidence to support the role of ezrin as 
an important linker protein between the plasma membrane and the 
cytoskeleton, specifically during morphological rearrangements of the cell 
cortex. 
 
ERM proteins are known to bind phosphatidylinositol 4-phosphate (PIP) and PIP2 
(Barret et al., 2000; Gautreau et al., 2002; Ivetic and Ridley, 2004), increasing the 
affinity of ezrin for EBMPs in the plasma membrane (Gautreau et al., 2002), and 
enabling Thr567 phosphorylation (Fievet et al., 2004). Therefore the regulation 
of phosphoinositide phosphorylation is considered important in the relationship 
between plasma membrane associated EBMPs and the cortical F-actin 
cytoskeleton. Indeed, Rho, a small GTP-binding protein, has been associated 
with phosphatidylinositol turnover (Nakamura et al., 1999) and thus has been 
implicated in the activation of ERM protein cross-linking activity (Gautreau et al., 
2002). Specific inhibition of Rho, by C3 toxin, suppresses ERM-EBMP interactions 
in vitro (Matsui et al., 1998), and Rho regulation by the Rho guanine nucleotide 
dissociation inhibitor (GDI) is closely involved in ERM protein complex 
interactions (Bretscher et al., 2002). Further evidence of Rho involvement comes 
from the observation that Myc-tagged Rho co-localises with ERM proteins in 
MSCK cells (Matsui et al., 1998). Rho has been found to regulate the activity of 
serine/threonine kinases (Nakamura et al., 1999), which may be involved in ERM 
protein phosphorylation at threonine residues, critical to ezrin domain 
interactions and conformational changes. It is not unlikely that Rho activity could 
play a role in mediating membrane-cytoskeletal interactions via regulation of 
ERM protein phosphorylation. 
 
Within dynamic structures of the plasma membrane such as in microvilli and 
gastric parietal cells, the ezrin to actin ratio is almost 1:1 (Berryman et al., 1995). 
Given its relative abundance at sites proximal to dynamic cytoskeletal structures, 
it is likely that ezrin is involved in the mechanisms of actin/plasma membrane 
reorganisation. Ezrin also contains a G-actin binding site (Roy et al., 1997), which 
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loses actin binding activity when the N-terminal ERM domain is truncated 
(Martin et al., 1997), However, the isolated carboxyl terminal domain of ezrin is 
able to bind to filamentous actin with high affinity (Badour et al., 2003; Lee et 
al., 2003; Cao et al., 2005), suggesting that ERM binding to the plasma 
membrane is important for the F-actin cross-linking activity of full length ezrin. 
 
Ezrin and ERM protein involvement in the mechanism of cell adhesion and 
morphogenesis, where the cross-linking interactions are necessarily altered, is 
not yet fully understood. It is likely that ezrin is involved in the molecular 
mechanism for releasing the membrane to perform cellular functions such as 
cell spreading and phagocytosis, both of which require enormous 
rearrangements of the cytoskeleton and plasma membrane. 
1.8.2 Sensitivity to µ-calpain 
Ezrin, but not the structurally similar ERM family protein moesin, is susceptible 
to cleavage by µ-calpain (Shcherbina et al., 1999). Although the exact cleavage 
site is not known, it is predicted to be in the linker region between the two 
functional binding domains (Dewitt and Hallett, 2007; Hallett and Dewitt, 2007). 
Therefore cleavage of ezrin would terminate its cross-linking activity and disrupt 
any relationship between the cytoskeleton and the plasma membrane (Algrain 
et al., 1993) (fig. 1.8.2). There is strong experimental evidence to support the 
hypothesis that selective sensitivity to µ-calpain serves as a discriminatory 
mechanism for specifically terminating ezrin linkage activity. In gastric parietal 
cells, µ-calpain-mediated cleavage of ezrin is associated with reduced ability to 
accumulate protons (Yao et al., 1993). More specifically related to cell 
morphological functions, endothelial cells have shown that ezrin cleavage by µ-
calpain correlated with cellular locomotion, and completely disrupted ezrin-actin 
interaction (Shuster and Herman, 1995). 
 
Ezrin and moesin are capable of forming heterodimers in vivo (Gary and 
Bretscher, 1993), and the two ERM proteins have been found to co-localise in   
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Fig. 1.8.2: Schematic of neutrophil microridge structure 
(a) Phosphorylated ezrin in the ‘open’ active conformation forms a cross-link between 
the plasma membrane and the actin cytoskeleton. Ca
2+
-activated calpain cleaves the 
active ezrin cross-link (b), allowing the microridges to relax. 
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membrane structures such as microvilli in resting lymphocytes. Stimulated 
lymphocytes undergo extensive remodelling of their cytoskeleton during 
polarisation (Dustin et al., 1998; Stewart et al., 1998), and fluorescence 
microscopy of activated T-lymphoblasts has identified moesin as the only ERM 
protein in the uropods of polarised cells (Serrador et al., 1997). This suggests 
that although ezrin and moesin may function in a coordinated manner in the 
initial cross-linking interactions at the cell membrane, lymphocyte stimulation 
and µ-calpain activation disrupts only the ezrin linkages. In support of this, ezrin 
was also found evenly distributed in the cell cytosol of polarised lymphocytes 
(Serrador et al., 1997). 
 
Ezrin and moesin constitute the only ERM family proteins expressed in cells of 
the blood. Although the exact cleavage site in ezrin is still unknown, it is a known 
substrate of Ca2+-activated µ-calpain. Since µ-calpain displays selectivity for ezrin 
cleavage in lymphocytes during polarisation, it is likely that the µ-calpain-ezrin 
relationship is also important in the reorganisation of the cell membrane in 
neutrophils. 
1.9 Mechanisms of neutrophil spreading 
During important cellular functions such as extravasation prior to 
transmigration, chemotaxis and phagocytosis, the neutrophil undergoes 
dramatic changes in its morphology. As discussed, these events have complex 
regulatory mechanisms which govern their activity. Among these regulatory 
steps, there is one mechanism that has been overlooked, yet it is perhaps the 
most obvious hurdle in the process of neutrophil morphological changes. This is 
the apparent expansion of the plasma membrane. 
1.9.1 A question of surface area 
Circulating neutrophils have a ‘spherical’ morphology, which was initially 
thought to be a smooth surface area which could easily be calculated. However, 
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electron micrographs reveal a markedly contoured or ‘ridged’ surface (fig. 1.3i). 
Upon engagement with the endothelial cell surface during transendothelial 
migration, the neutrophil undergoes a massive change, assuming a flattened 
morphology as it spreads out onto the blood vessel wall. This activity is 
accompanied by an apparent surface area increase of about 200% (Dewitt and 
Hallett, 2007) (fig. 1.3i). A number of mechanisms which could provide 
additional plasma membrane for this process have been proposed. These 
include ER ‘swallowing’, endocytosis/exocytosis cycling and unravelling of 
plasma membrane microridges. The simplest assumption to explain this would 
be that the neutrophil membrane simply stretches, akin to the inflation of a 
balloon. However, biophysical characterisation of the lipid bilayer shows that the 
plasma membrane can only stretch by ~4% before lateral forces disrupt the 
hydrophobic interactions between fatty acids in the membrane, causing it to 
tear (Hamill and Martinac, 2001). Therefore it is not possible that membrane 
stretching accommodates the necessary 200% expansion observed in spreading 
neutrophils.  
 
Whilst in macrophages there is evidence that the ER lies proximal to the plasma 
membrane and may be involved with phagosome formation (Gagnon et al., 
2002), it is unlikely that the ER provides the additional membrane for neutrophil 
expansion. The reasons for this are two-fold: (i) neutrophils have markedly less 
ER than macrophages (Bessis, 1973), and (ii) the ER in neutrophils is not close 
enough to the plasma membrane to fuse with a new phagosome. Furthermore, 
unlike macrophages, neutrophil phagosomes do not display the ER marker 
glucose-6-phosphate (Gagnon et al., 2002), providing further evidence that 
membrane fusion does not occur. 
 
Kay and colleagues have previously discussed the “surface-area problem” during 
chemotaxis (Kay et al., 2008), with a particular focus on the endocytic cycle as a 
mechanism for providing additional membrane. They dismissed a role of plasma 
membrane folds or microridge involvement in the mechanism of membrane 
expansion, citing that perturbation of the endocytic cycle consequently reduced 
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pseudopod formation and cell motility in Dictyostelium. However, this 
explanation significantly underestimates the apparent increase in cell surface 
observed in neutrophils changing morphology (~200% (Hallett and Dewitt, 
2007). Observation of scanning electron micrographs of neutrophils reveals that 
neutrophil plasma membranes are far from smooth. Indeed, a striking feature of 
the neutrophil plasma membrane is their wrinkled structure (fig. 1.3i) (Bessis, 
1973; Hallett et al., 2008). Upon osmotic swelling, and neutrophil spreading, 
these wrinkles in the membrane are reduced. Furthermore, quantification of the 
potential membrane stored in these microridge ‘membrane reservoirs’ indicates 
that they could contribute a further 100% to the cell surface area, when 
flattened (Ting-Beall et al., 1993). This suggests a mechanism for releasing folded 
plasma membrane within microridges may exist, in order for neutrophils to carry 
out the necessary morphological changes for them to perform phagocytosis, 
chemotaxis and extravasation. 
1.9.2 Plasma membrane microridges 
Neutrophil plasma membrane ‘microridges’ are suggested to play a role in the 
neutrophil’s ability to change morphology, necessary for processes such as 
phagocytosis, chemotaxis and extravasation. It has been estimated that the 
surface of a neutrophil contains approximately 85% more plasma membrane 
than is required to enclose the cell volume (Hogg, 1987), and it is possible that 
this excess membrane serves as a reservoir for the necessary membrane 
expansion required for neutrophils to perform proper cellular functions. Rather 
than stretching the membrane, with the risk of shearing the phospholipid barrier 
and lysing the cell, the excess membrane stored in the wrinkles is proposed to 
be released by way of a molecular ‘Velcro’ mechanism (Dewitt and Hallett, 2007; 
Hallett and Dewitt, 2007), thus facilitating the apparent membrane expansion 
required for the cells to squeeze between the vascular endothelium, and also to 
project pseudopodia and engulf particles by phagocytosis.  
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A number of elegant characterisations of the biophysical properties of the 
neutrophil plasma membrane have been performed using micropipettes 
attached to a vacuum pump at moderate power. When it was drawn up into the 
pipette tip under suction, there was a measurable 5% expansion of the 
neutrophil membrane (Evans et al., 1993; Herant et al., 2005; 2006), but 
significantly further expansion of the membrane could be achieved under 
greater suction pressure (Herant et al., 2003; Dewitt and Hallett 2007; Hallett 
and Dewitt 2007). These findings were consistent with the works of Hamill and 
Martinac (2001) who calculated an approximate 4% slack in the plasma 
membrane was available under moderate suction. However, this suggests an 
additional mechanism is required to release ‘stored’ membrane from ‘Velcro-
like’ microridges (Herant et al., 2003, Hallett and Dewitt, 2007), which must also 
be strong enough to resist osmotic pressure. 
 
During neutrophil phagocytosis, the amount of force required to ‘undo’ the 
‘Velcro-like’ microridges is considerably reduced, and the amount of available 
slack in the plasma membrane increases (Herant et al., 2005). This slack 
membrane, visibly devoid of microridges, can be seen in classic SEMs of 
neutrophils (fig. 1.3i), and is conceivably enough to enable the morphological 
changes that the neutrophil exhibits during cell spreading (Hallett and Dewitt, 
2007).  
 
Although this perceived membrane reservoir would provide the material to 
enable expansion, it does not in itself elicit any directionality over the 
membrane protrusions. During phagocytosis or chemotaxis, neutrophils project 
discrete pseudopodia, thus relying on a mechanism for selecting which areas of 
the membrane should expand. The underlying cortical actin cytoskeleton 
provides a scaffold beneath the plasma membrane, which is able to push/pull 
the membrane into different morphologies as necessary. The cytoskeleton is 
composed primarily of actin (Stossel, 1989), one of the most abundant proteins 
found in mammalian leukocytes (Southwich and Stossel, 1983). Actin assembly 
into the cytoskeleton requires polymerisation of G-actin into F-actin, and is a 
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dynamic process within the cell. The ratio of G-actin to F-actin can be influenced 
by recognition of extracellular stimuli. Neutrophil activation can shift the 
equilibrium towards F-actin, and increase the polymerisation of G-actin to F-
actin by up to 4-fold (Stossel, 1989), thereby enabling the neutrophil to rapidly 
respond to external stimuli and prompt dramatic changes in cell morphology.  
 
Crawling neutrophils exhibit two distinct protrusions of the cell membrane: 
lamellipodia and filopodia. Both formations are supported by a network of 
polarised F-actin, which forms a broad mesh beneath lamellipodia, and focal 
bundles in filopodia (Atilgan et al., 2006). The cortical F-actin network is 
organised by members of the WASP and WAVE protein families which bind to G-
actin through VCA regions and generate points of F-actin nucleation (Takenawa 
and Miki, 2001). F-actin polymerisation in pseudopodia is restricted by the 
presence of the plasma membrane, and protrusions are achieved via the 
Brownian Ratchet model of unidirectional filament growth (Peskin et al., 1993). 
Dynamic fluctuations within the cell membrane and between surrounding 
proteins create opportunities for F-actin polymerisation, enabling filament 
extension which would be otherwise restricted by the tension of the plasma 
membrane (Peskin et al., 1993). Therefore the ‘stretchiness’ of the plasma 
membrane influences the extent of actin polymerisation that the cell is capable 
of. If plasma membrane tension were to be relaxed, the dynamic fluctuations 
would favour continued F-actin polymerisation in the direction of the ‘slack’ 
membrane. It has been suggested that plasma membrane microridges contain 
the membrane ‘reservoirs’ (Hallett and Dewitt, 2007) required for large scale 
changes in cell morphology. Therefore disruption of the mechanism which holds 
these microridges intact would provide the membrane slack which is favourable 
for F-actin polymerisation, via the Brownian Ratchet model. 
 
The intracellular molecular mechanisms responsible for maintaining, and also 
liberating, neutrophil microridge structures are not completely established, but 
two models have been proposed, which connect the plasma membrane to the 
cytoskeleton via the linker proteins talin or ezrin (Dewitt and Hallett, 2007; 
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Hallett and Dewitt, 2007). In the first model the plasma membrane is linked to 
the cytoskeleton via talin, at the base of microridges. In the second ezrin 
connects the two within microridges, along the length of the structure. The two 
models may cooperate to regulate microridge structure, depending on L-selectin 
(in the protrusion) and β2-integrin (at the base) linkages to the plasma 
membrane. This is also a reasonable explanation for their unequal distribution 
across the neutrophil surface (Dewitt and Hallett, 2007; Hallett and Dewitt, 
2007). 
1.9.3 Mechanisms of membrane expansion 
Large rises in global cytosolic-free Ca2+ have long been associated with 
neutrophil and macrophage spreading (Kruskal et al., 1986; Jaconi et al., 1991). 
The rate of neutrophil spreading has also been found to accelerate upon 
manipulations of Ca2+ elevation, resulting from the controlled uncaging of 
cytosolic Ca2+ (Pettit and Hallett, 1998b) or uncaging of cytosolic IP3 (Dewitt et 
al, 2013). Lymphocyte spreading upon β2-integrin adhesion depends on µ-
calpain activity (Stewart et al., 1998; Leitinger et al., 2000). Similarly, in 
pseudopod extension around a selected particle for phagocytosis, acceleration 
of µ-calpain activity and membrane expansion has been connected to Ca2+ 
elevation (Dewitt and Hallett, 2002; Carafoli and Molinari, 1998). µ-calpain has 
been implicated in the mechanism of neutrophil membrane expansion and 
spreading because it lists among its substrates a number of cytoskeletal linker 
proteins (Franco and Huttenlocher, 2005). Therefore Ca2+-mediated µ-calpain 
activation could provide the trigger to release the ‘Velcro-like’ structure of 
plasma membrane microridges, to enable changes in neutrophil morphology. 
Given that cell spreading represents a major hurdle in neutrophil extravasation, 
from the blood towards sites of inflammation, the µ-calpain-ezrin axis may 
provide a potential target to interfere with and disrupt this mechanism. 
Investigating this may be of great interest to the development of novel 
pharmaceuticals to target key cellular processes involved in the exaggerated 
immune responses seen in rheumatoid arthritis patients. 
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1.10 Aims 
This study aims to unravel a key intracellular molecular mechanism governing 
neutrophil morphology change in response to Ca2+, namely the relationship 
between µ-calpain and ezrin. It is hoped that by further understanding the 
interactions between these proteins within the cell at the molecular level, we 
will be better placed to inform the directed development of novel therapeutics 
to target autoimmune conditions. 
 
The primary objectives of the work presented in this thesis are: 
1. To investigate the effect of Ca2+ influx on ezrin distribution in myeloid 
cells. 
2. To develop novel techniques of measuring peripheral cytosolic Ca2+ 
concentrations. 
3. To probe the relationship between Ca2+ concentration, and the Ca2+-
mediated cleavage of ezrin. 
4. To determine the importance of plasma membrane microridges in 
this relationship. 
 
Freshly isolated neutrophils are notoriously problematic to study experimentally, 
owing to their short half-life, tendency to become activated, and also their 
predisposition to spontaneously perform apoptosis. However, their involvement 
in both the resolution and instigation of disease states makes any advance in our 
understanding of their function, however incremental, very valuable. In the 
approach to tackle any disease indication, a clear understanding of the biological 
system is first necessary. The work presented in this thesis has used a RAW 
264.7 cell line to compliment neutrophil studies, to overcome some of the 
challenges faced when working with freshly isolated human neutrophils. 
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2. General methods 
The materials and methods described in this section are non-specific and 
relevant to the results presented in multiple chapters in this thesis. Descriptions 
of the materials and methods specific to individual chapters will be given at the 
start of each chapter.   
2.1 Preparation of Krebs and Krebs-BSA 
Hepes buffered Krebs [120 mM NaCl, 25 mM Hepes, 4.8 mM KCl, 1.2 mM 
KH2PO4, 1.2 mM MgSO4•7H20, 1.3 mM CaCl2•2H20] was prepared in dH20 and 
adjusted to pH 7.4 with NaOH. The buffer was stored at 4°C. Krebs-BSA was 
prepared by adding 0.1% (w/v) BSA. 
2.2 Preparation of the balanced salt solution 
The balanced salt solution (BSS) [130 mM NaCl, 2.6 mM KCl, 8 mM Na2HPO4 and 
1.83 mM KH2PO4] was prepared in dH20 and adjusted to pH 7.4 with NaOH. 
2.3 Preparation of Dextran 
6g of Dextran (Mr 70,000) was dissolved in 100 mL of BSS at room temperature 
on a magnetic mixer. 
2.4 Isolation of human neutrophils from peripheral blood 
Human neutrophils were isolated from blood donated by healthy volunteers, as 
described by (Davies and Hallett, 1998). 10 mL of blood was collected into a 
universal container containing 100 µL of Heparin (CP Pharmaceuticals). Dextran 
(6%) was added at one quarter the volume of blood taken (typically 2.5 mL of 
Dextran to 10 mL of whole blood). The suspension was gently inverted and 
allowed to sediment at room temperature for approximately 30 minutes 
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(sedimentation times varied between donor samples). The whole blood 
separated into three layers, and the middle ‘buffy coat’ layer containing the 
white blood cells (WBC) was carefully aspirated using a Pasteur pipette, and 
centrifuged at 1,400 x g for 1 minute at room temperature. The supernatant was 
discarded and red blood cell lysis was carried out by re-suspending the cell pellet 
in 1 mL of dH2O for 10 seconds, before the osmolarity was recovered by the 
addition of 20 mL of balanced salt solution (BSS). 
 
The cells were centrifuged at 1,400 x g for a further 2 minutes, and the 
supernatant was discarded and the resultant pellet was re-suspended in 1 mL of 
bovine serum albumin (BSA) supplemented Krebs (Krebs-BSA). The cleanness of 
the prep was checked by observing the cell population on a bright field 
microscope, and the number of cells was assessed with a Nexcelom Cellometer 
(Nexcelom Bioscience). The typical neutrophil count from this isolation 
procedure was around 1x106 cells/mL. 
2.5 Isolation of normal human serum from whole blood 
Blood was taken from healthy donors as previously described. 1 mL of whole 
blood was collected into a glass vial without heparin and left to clot at room 
temperature for 30 minutes, before centrifuging at 700 x g for 10 minutes to 
pellet the clot. Normal human serum was aspirated from the supernatant using 
a Pasteur pipette, and kept on ice until use the same day. Every effort was made 
to ensure serum and neutrophils from the same donors were used in 
experiments, although sometimes serum from another donor was used. 
2.6 Immunocytochemistry 
100 µL of isolated neutrophils ~106 cell/mL were pipetted onto glass slides and 
left to settle for 10 mins at 37°C. The cells were fixed and permeabilised in 4% 
formalin and 0.1% Triton respectively. 4% goat serum was used to block non-
specific antibody binding, prior to overnight incubation with 1:100 primary 
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antibody at 4°C, and subsequently 1:20 secondary antibody, for 1 hour at room 
temperature. Slides were imaged on the Leica SP5 confocal inverted microscope 
(Leica Microsystems, Heidelberg) with resonance scanner, laser scanning, [63x 
immersion objective; 488 nm argon laser].  
2.7 Protein extraction and preparation of cell lysates 
Isolated neutrophils were spun down and re-suspended in neutrophil lysis buffer 
(50 mM HEPES, 150 mM NaCl, 10% Glycerol, 1% Triton X100, 5 mM EDTA, 5 mM 
EGTA, 1 mM Na3VO4, 1.5 mM NaF, 0.1% SDS, 1.5 mM MgCl2) and PIC was added 
at 1:1000. Samples were incubated on ice for 1 hour and vortexed every 15 
minutes to increase the efficacy of cell lysis. If used for Western Blotting the 
samples were boiled for 10 minutes and then centrifuged for 5 minutes at 
13,000 x g.  
2.8 Assessment of protein concentration 
Protein concentration was assessed using the PierceTM BCA Protein Assay Kit 
(Life Technologies), according to manufacturer’s protocol, or using the 
NanoDrop™ Lite. 
2.9 Western blotting 
10 µg protein was loaded per well of the pre-cast 7% NuPAGE® Tris-Acetate Gel 
(Life Technologies), and the gel was run at constant 150 V for 1 hour in the 
NuPAGE Tris-Acetate buffer system (Invitrogen). A test gel was run and stained 
with InstantBlue (Expedon) to check for the presence of protein bands. 
 
Electroblotting to a PVDF membrane (GE Healthcare Life Sciences) was carried 
out at constant 350 mA for 1 hour. The PVDF membrane was stained with 
Ponseau S (Sigma-Aldrich) to assess the success of the electroblotting 
procedure. Blocking was performed in 5% milk (Marvel) or BSA, in TBS-T for 2 
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hours at RT prior to incubation with 1:1000 primary antibody overnight at 4°C, 
and subsequently 1:1000 secondary antibody for 2 hours at RT. Protein bands 
were detected using the SuperSignalTM West Dura Extended Duration Substrate 
(Life Technologies) and the G:BOX imager (Syngene), at five 30 second intervals 
to achieve the best exposure. 
2.10 Preparation of fMLP solution 
The bacterial peptide fMLP was purchased from Sigma-Aldrich in powder form. 
A 1 mM stock solution was made by diluting 1 mg of powder in 2.3 mL DMSO. In 
neutrophil experiments the stock solution was further diluted to 1 µM in Krebs-
BSA. 
2.11 RAW cell culture, maintenance and storage 
RAW 264.7 cells, originally from American Type Culture Collection, were 
cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 
10% heat inactivated foetal bovine serum (FBS) and 1% Penicillin and 
Streptomycin. Cells were incubated at 37°C in 5% CO2.  
 
Aliquots were routinely frozen for long-term storage in liquid nitrogen, to 
maintain cell stocks. Cells were harvested from culture flasks at about 70% 
confluence, by cell scraping. The cells were then centrifuged at 2000 rpm for 2 
minutes, and re-suspended in 90% DMEM, 10% DMSO. One cryovial was frozen 
from each confluent T25 flask (approximately 5x106 cells). 
 
Cells were defrosted from long-term storage by rapid thawing in a water bath at 
37°C, then immediately transferred to 15 mL of pre-warmed supplemented 
DMEM. The cells were left to recover for 20 minutes in an incubator at 37°C with 
5% CO2, then centrifuged at 2000 rpm for 2 minutes. The cells were then re-
suspended in 15 mL of fresh pre-warmed and supplemented DMEM and put into 
T25 culture flasks, to incubate at 37°C with 5% CO2. 
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2.12 Plasmid amplification 
Plasmids were purchased from Addgene (Michael Davidson lab), gifted (from 
Sabrina Marion) or novel (Chapter 4). In order to amplify stocks for mammalian 
transfection experiments in RAW 264.7 cells, the plasmids were amplified via 
bacterial transformation. One Shot™ TOP10 Chemically Competent E. coli were 
chemically transformed according to the manufacturer’s protocol. Transformed 
bacteria were streaked out onto agar plates with appropriate antibiotic, at 3 
different dilutions (200 µL, 50 µL and 20 µL), because the competency of the 
bacteria was unknown.  
2.13 Preparation of Lysogeny broth 
The lysogeny broth (LB) was made by dissolving 10 g Lennox powder (Sigma-
Aldrich) in 500 mL dH20. The solution was sterilised in a benchtop autoclave, and 
left to cool before the addition of appropriate antibiotics. 
2.14 Preparation of agar plates 
LB broth was prepared as described and supplemented with 3.75 g agar powder 
(Sigma-Aldrich) prior to autoclaving. 30 mL of warm agar was transferred to 
labelled sterile petri dishes and left to set at room temperature for at least 30 
mins. The plates were then inverted and stored at 4°C until needed. When they 
were to be used, the plates were removed from the fridge 30 mins before 
plating bacteria, to allow the temperature of the agar to come up to room 
temperature. 
2.15 RAW 264.7 cell line transfection by nucleofection  
RAW cells were cultured to approximately 70% confluence and transfected using 
the Cell Line Nucleofector™ Device (Lonza), according to the manufacturer’s 
protocol. 2x106 cells were harvested by scraping, and centrifuged at 750 rpm for 
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10 minutes, then re-suspended in 100 µL Amaxa® Cell Line Nucleofector® Kit V 
(Lonza). 2-4 µg of plasmid DNA was added to the suspension, which was 
transferred to the electroporation cuvette. The cells were electroporated using 
programme D-032 on the nucleofector device, quickly recovered in 500 µL pre-
warmed DMEM, then transferred to 5 mL warm DMEM. 0.9 mL of recovered cell 
suspension was transferred to glass-bottomed petri dishes and supplemented 
with an additional 1.1 mL of pre-warmed DMEM. The cells were left to incubate 
at 37°C in 5% CO2 for 3-4 hours, before imaging. 
2.16 Opsonisation of zymosan particles 
Zymosan were opsonised by incubation with excess NHS (prepared as described 
section 2.5), at 37°C for 30 mins. The zymosan were then spun down and re-
suspended in 1 mL Krebs-BSA. 100 µL zymosan suspension was added to the 
cells on the cover slide and allowed to ‘rain down’ onto the cells. Cells within 
proximity of the opsonised zymosan (i.e. <5 µm) were imaged on the Leica SP5 
confocal inverted microscope, using the 488 nm laser to record changes in Ca2+ 
concentration. 
2.17 Confocal microscopy 
Confocal images were taken using the Leica SP5 confocal inverted microscope 
(Leica Microsystems, Heidelberg) with resonance scanner, equipped with a 543 
nm, 633nm and argon 488 nm lasers. The fluorescent photo multiplier tubes 
were set to the maximum gain of approximately 1200, and the phase contrast 
(PC) gain was set to approximately 300. Laser intensities were adjusted 
accordingly to achieve the optimum signal from fluorescent probes. For some 
experiments more than one fluorophore was imaged at the same time, in this 
instance sequential imaging was used. This allowed for fluorescent emissions at 
each appropriate wavelength to be detected simultaneously, with minimal 
interference between channels. 
80 
 
2.18 Statistical analysis 
Neutrophil experiments were carried out on at least three occasions and with 
blood from different healthy donors in the lab. All data shown is representative 
of at least three similar results, with standard error of the mean (SEM). 
Statistical analysis was performed using GraphPad Prism 5 for Windows, Version 
5.00.
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3.1 Introduction 
Ezrin is an important cross-linking protein in the architecture of plasma 
membrane structures (Gould et al., 1989). Its two functional domains, the N-
ERMAD and C-ERMAD, bind to the plasma membrane and cortical F-actin 
respectively (Algrain et al., 1993; Ivetic et al., 2002; Badour et al., 2003; Lee et 
al., 2003; Cao et al., 2005), thus stabilising the connection between the bi-lipid 
boundary of the cell, and the internal cytoskeleton. The regulation of ezrin cross-
links are therefore important in the morphological rearrangements undergone 
by cells which receive signals to spread, such as neutrophils during an 
inflammatory response. Disruption of the ezrin tether would release the plasma 
membrane from cytoskeletally orchestrated microridge structures, and this 
release of membrane ‘reservoir’ has been suggested as the mechanism by which 
cells such as neutrophils are able to drastically alter their morphology in 
processes such as extravasation, which may require up to an approximate 200% 
apparent expansion in plasma membrane area (Dewitt and Hallett, 2007). 
 
Since proteolytic cleavage of ezrin would serve to sever the link between the 
plasma membrane and the cortical F-actin cytoskeleton, it is possible that the 
activity of ezrin is disrupted by µ-calpain activation (Dewitt and Hallett, 2013). 
The relationship between ezrin and µ-calpain may therefore be important in 
maintaining surface membrane microridges in the plasma membrane of 
neutrophils, and other myeloid cells. The hypothesis to be tested in this chapter 
is that elevating cytosolic Ca2+ will activate µ-calpain, thereby liberating its 
proteolytic capabilities in regions of high cytosolic Ca2+ concentration, such as 
the ezrin-rich microdomains beneath plasma membrane microridges. 
 
In order to investigate the relationship between ezrin, µ-calpain activation and 
the dynamic maintenance of cell surface membrane microridges in a myeloid 
cell plasma membrane, some novel approaches will be adopted. Previously, the 
link between the location of ezrin and µ-calpain activity has been shown in 
biochemical studies in neutrophils, by Western blotting of extracted proteins 
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(Fehon et al, 2010). Ezrin is a known neutrophil substrate of the cytosolic 
protease, µ-calpain (Shcherbina et al., 1999), and is known to be localised to 
microvilli in a number of cell types. Knocking out ezrin expression has shown 
that ezrin is clearly required for the assembly and maintenance of cell surface 
structures (Morales et al., 2004), such as microvilli on brush boarder cells 
(Bretscher, 1983). It for these reasons that ezrin was originally named cytovillin. 
In neutrophils however, it is proposed that the cell surface microridges are 
dynamic structures which can be ‘released’ when there is a requirement to 
produce additional cell surface area (Dewitt and Hallett, 2007). This proposal 
requires that ezrin is initially located within microridges at the cell surface of 
resting neutrophils, holding the plasma membrane and cortical actin network 
together, thus maintaining the plasma membrane in a ‘wrinkled’ topography. 
Furthermore, this would suggest that the ezrin cross-link is disrupted during, and 
for the purpose of, membrane expansion. This process may be driven by the 
Ca2+-activated cleavage of ezrin by µ-calpain (Shcherbina et al., 1999; Dewitt and 
Hallett, 2007; Hallett and Dewitt, 2007). 
 
In order to test these hypotheses a methodology which explores both the 
subcellular location of ezrin and, ideally, its cleavage state is required. It has 
been shown that by attaching a fluorophore to ezrin, it is possible to monitor the 
dynamics of ezrin localisation and re-distribution, in live cells. The fluorescent 
domain can be conjugated to ezrin either at the N-terminal ERMAD, the C-
terminal ERMAD or at an intra-domain position (fig. 3.1). The approach that has 
been adopted in the work presented in this chapter is therefore based on 
fluorescent ezrin which can be imaged microscopically, as a surrogate marker of 
the dynamic activities of endogenous ezrin. However, the major disadvantage of 
this approach is that it cannot be applied directly to neutrophils, because as 
terminally differentiated cells they cannot be transfected to produce the 
required fluorescent proteins. A myeloid cell line with the required 
characteristics will therefore be used. 
  
84 
 
  
Figure 3.1: Fluorescently tagged ezrin 
Structures of the fluorescently-tagged ezrin constructs used in this thesis. 
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3.1.1 Myeloid cell lines 
A number of myeloid cell lines could be considered, in which to investigate the 
dynamics of fluorescently-tagged ezrin constructs. An important characteristic to 
note is the ability of cells to perform phagocytosis. The most widely used 
myeloid cell line in this regard has perhaps been the HL60 cell line, or its 
subclone PLB-985 (Pivot-Pajot et al., 2010). After appropriate differentiation 
these cells readily perform phagocytosis of C3bi-opsonised zymosan particles 
(Tohyama and Yamamura, 2006), whereas the undifferentiated cells do not. As a 
consequence of this, the ‘differentiated’ cell populations invariably contain a 
mixture of (i) un-differentiated non-phagocytic cells, (ii) newly differentiated 
phagocytic cells, and (iii) older differentiated but non-phagocytic cells which are 
progressing towards apoptosis. In addition, the differentiation of HL60s usually 
also corresponds to a marked decrease in their novel protein synthetic 
capability. Therefore, it is difficult to achieve cells with adequately high 
expression of the fluorescent protein constructs, but that are also phagocytic. 
 
For these reasons, a cell line which is phagocytic without the need for 
differentiation has been used: RAW 264.7 cells. These cells are murine and were 
derived from the ascites infiltrate of a tumour in a male mouse, induced by 
intraperitoneal injection of Abelson Leukaemia Virus (ECACC Data base). RAW 
264.7 cells are capable of antibody-dependent phagocytosis of sheep 
erythrocytes and tumour targets. They will also perform phagocytosis of 
zymosan, and their phagocytic capabilities are especially apparent when the 
zymosan has already been opsonised with C3bi, from mouse serum. RAW 264.7 
surface membranes are also covered in microscopic surface microridges, which 
resemble the microridges seen in neutrophils. Fluorescent protein expression 
can be detected about 1 hour post transfection by electroporation, but is 
optimal at about 4 hours after transfection. Furthermore, the RAW 264.7 cell 
line is semi-adherent, therefore cells can be harvested from culture flasks 
mechanically, and without the need for additional extracellular proteases; thus 
avoiding the potential of degrading cell surface receptors important for 
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phagocytosis. For these reasons, the RAW 264.7 cell line is an ideal model for 
these studies. 
3.1.2 Aims and Objectives 
The aim of the work presented in this chapter is to express fluorescent 
constructs of ezrin in a myeloid cell line (RAW 264.7); in order to document ezrin 
subcellular location in resting cells, and also in dynamic cells during an 
experimentally induced elevation of Ca2+ influx, and phagocytosis. A further aim 
is to establish whether cleavage of ezrin by µ-calpain occurs, by using constructs 
that place the fluorescent marker either side of the predicted µ-calpain cleavage 
site. In this way, ezrin cleavage within the cell would be detectable. As this is a 
novel approach, it will be necessary to establish the methodology. 
 
The specific objectives of the work in this chapter are therefore: 
1. To compare the subcellular location of fluorescent ezrin constructs 
expressed in RAW 264.7 cells. 
2. To establish the dynamic changes in subcellular location of ezrin using 
fluorescent constructs expressed in RAW 264.7 cells. 
3. To establish a new methodology to monitor ezrin cleavage within living 
cells. 
4. To use this new methodology to investigate whether ezrin cleavage 
occurs during experimentally induced Ca2+ influx and phagocytosis 
events.  
3.2 Specific Materials and Methods 
3.2.1 Immunocytochemistry 
Human neutrophils were isolated from healthy donor blood, as previously 
described in Chapter 2. Fixed and permeabilised neutrophils were stained with 
mouse anti-ezrin primary antibody (Santa Cruz (3C12)) and goat anti-mouse FITC 
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conjugated secondary antibody (Santa Cruz IgG1-FITC). Cell staining was 
analysed using the Leica SP5 confocal microscope with 488 nm argon laser. 
3.2.2 RAW 264.7 cell transfection 
RAW 264.7 cells were electroporated to introduce ezrin plasmids: mCherry-
ezrin, ezrin-mEmerald, ezrin-mCherry and ezrin-GFPi (3 µg plasmid DNA/ 2x106 
cells) using the Cell Line Nucleofector™ Device (Lonza) as previously described 
(Chapter 2). The novel ezrin-GFPi plasmid (Marion et al., 2011) was verified by 
sequencing, which showed the intra-domain location of the GFP insert within 
the N-terminal FERM domain. This was before the linker region in ezrin, which is 
postulated to be the µ-calpain cleavage site. Cells were incubated at 37°C in 5% 
CO2 for 3-4 hours to enable expression of the newly introduced DNA, before 
imaging on the Leica SP5 confocal microscope.  
3.2.3 Confocal microscopy 
Confocal images were taken using the Leica SP5 confocal inverted microscope 
(Leica Microsystems, Heidelberg) with resonance scanner, laser scanning [63x 
objective; 633 nm and 488 nm argon laser] in a perfusion chamber at 37°C. 
Images were acquired from the two lasers by sequentially scanning alternate 
lines with each laser. In this way each image line was from a single laser 
excitation and there was no possibility of cross-over (by inadvertent excitation of 
both fluorophores). Sequential line imaging also gave simultaneous images from 
each laser excitation, as previously described in Chapter 2. 
3.2.4 Ezrin extraction from RAW 264.7 cells  
Transfected RAW 264.7 cells were harvested by scraping and DMEM growth 
medium was removed by centrifugation at 100 x g for 10 mins. The cell pellet 
was washed by resuspension in 1 mL BSS, and re-centrifuged to re-pellet the 
cells. Cell lysis was performed in the absence of free Ca2+ ions (10 mM EGTA) to 
avoid activation of µ-calpain, using ice cold Pierce™ IP Lysis Buffer (from the 
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Pierce™ Co-Immunoprecipitation Kit) with additional PIC (1:1000), and kept on 
ice for 5 mins, with pipetting. The lysates were centrifuged at 14, 000 rpm for 10 
mins. Supernatant was aspirated and the pellets containing the extracted 
protein were retained for immunoprecipitation. Ezrin was extracted from the 
RAW 264.7 lysates by co-immunoprecipitation with a rabbit anti-ezrin polyclonal 
antibody (Cell Signalling, 3145), using the Pierce™ Co-Immunoprecipitation Kit, 
according to the manufacturer’s instructions. 
3.2.5 µ-calpain cleavage of ezrin constructs 
The anti-ezrin antibody (RabMAb EP924Y) to residues surrounding Tyrosine 145 
in the N-terminal domain of ezrin, was plated onto a Greiner flat-bottomed high 
and medium binding 96-well plate (Sigma) at a 1:10 dilution in 50 µL BSS, and 
left overnight at 4°C to adhere (fig. 3.2.5). Non-adhered antibody was removed 
by aspiration and the plate was washed twice in BSS. 50 µL RAW 264.7 cell lysate 
containing ezrin-mCherry or ezrin-GFPi (prepared as previously described) was 
loaded per well, in triplicate, and left overnight at 4°C. Unbound lysate was 
removed by aspiration and the plate was washed twice in BSS. 
 
Neutrophil lysate (prepared as described in Chapter 2) was used as the source of 
µ-calpain. 40 µL of neutrophil lysate plus 10 µL of either Ca2+ (final concentration 
1.65 mM) or dH20 (Ca2+-free) water as a control. The reaction was allowed to 
proceed for 2 mins before the supernatant was extracted from the wells and 
placed in a flat clear-bottomed microtiter plate for further analysis. The Pierce™ 
IP Lysis Buffer was used as a blank. 
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Figure 3.2.5: Principle of differential fluorophore release following µ-calpain cleavage of 
ezrin-GFPi and ezrin-mCherry 
(a) The simplified structures of ezrin-GFPi and ezrin-mCherry are shown with the µ-calpain 
cleavage site indicated. (b) Schematic of ezrin immobilisation by antibodies to the FERM 
domain of ezrin. Following addition of µ-calpain and its activation by Ca
2+
, the ezrin fragment 
containing the mCherry is released, whereas the GFPi containing ezrin fragment remains 
attached to the antibody.   
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Fluorescence was recorded on the BMG FLUOstar OPTIMA. For ezrin-GFPi the 
excitation/emission settings used were 485 nm/520 nm, and using the top optics 
gave the highest reading. For ezrin-mCherry the excitation/emission settings 
used were 544 nm/590 nm, and bottom optics were selected to give the highest 
reading. The maximum value attainable was 65,000 (fig. 3.2.4). 
3.3 Results 
3.3.1 Native ezrin at the plasma membrane in neutrophils 
Immunocytochemistry of fixed human neutrophils shows that ezrin in the 
resting ‘spherical’ neutrophil is located at the cell periphery (fig 3.3.1). However, 
when undergoing phagocytosis, ezrin is absent from the base of the phagocytic 
cup and also from the phagosome membrane. These data show that ezrin is lost 
and must translocate away from the plasma membrane during phagocytosis (fig 
3.3.1). 
3.3.2 Ezrin constructs at the plasma membrane of RAW 264.7 cells  
In order to visualise the dynamics of changes in the subcellular location of ezrin, 
fluorescent ezrin constructs were expressed in the RAW 264.7 model myeloid 
cell line. Nucleofection using the Cell Line Nucleofector™ Device (Lonza) has 
previously been found to be the most effective method for successful 
transfection in our lab, and was therefore the chosen method of transfection in 
these experiments. RAW 264.7 cells were harvested by scraping and transfected 
with either mCherry-ezrin or ezrin-mEmerald alone, or co-transfected with both. 
Transfected cells were inspected and imaged using the Leica SP5. 
 
Constructs with the fluorophore at the plasma membrane binding N-terminus 
(e.g. mCherry-ezrin) remained free in the cytosol, but were excluded from the 
nucleus (fig. 3.3.2i), whereas constructs with the fluorophore attached at the C-
terminus (e.g. ezrin-mEmerald) were clearly located at the cell periphery   
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Figure 3.3.1i: Native ezrin location in human neutrophils 
Immunocytochemical detection of ezrin in (a) unstimulated human neutrophils, 
and (b) a human neutrophil performing phagocytosis of a zymosan particle 
(Roberts et al., 2017 – unpublished).   
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Figure 3.3.2i: mCherry-Ezrin expression in RAW 264.7 cells 
(a) Structure of mCherry-Ezrin. The fluorophore is attached to ezrin at the N-terminal 
FERM plasma membrane binding domain. (b) First panel: RAW 264.7 cells expressing 
cytosolic mCherry-Ezrin (red). Insert: Relative fluorescence quantification of mCherry-
ezrin distribution in a single RAW 264.7 cell, within a defined region of interest at the cell 
edge (yellow shaded box). Fluorescence intensity increases towards the cytosol and 
plateaus. Second panel: Pseudo coloured look-up table (LUT) applied to the same cells. 
Most ezrin reports uniform fluorophore intensity across the cytoplasm. Scale bar 20 µm; 
insert 5 µm. Representative of at least 20 cells.  
Cell edge 
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 (fig.3.3.2ii). This difference in subcellular location was further demonstrated by 
expressing the proteins simultaneously within individual cells, and was made 
strikingly apparent by overlaying images of both fluorophores (fig. 3.3.2iii). 
Therefore, the observed difference in subcellular location was not due to a 
competition between the two constructs, because the same pattern of 
localisation was observed in cells transfected with either construct, in the 
absence of the other.  
 
It was found that plasma membrane binding of ezrin via the FERM domain at the 
N-terminus was disrupted by the attachment of the fluorophore (e.g. mCherry). 
Since ezrin-mCherry remained cytosolic, it was concluded that the C-terminal 
domain actin binding activity alone was insufficient to maintain ezrin at the cell 
edge. This is in keeping with findings by Fritzsche and colleagues, whose work on 
the dynamics of ezrin turnover demonstrated that the N-FERM domain 
interaction is dynamically more important than the actin binding relationship, in 
ezrin localisation to the plasma membrane (Fritzsche et al., 2014). 
 
This may be in part be due to the dynamic nature of the cortical actin network, 
which is not a static molecular structure. The actin cytoskeleton undergoes 
monomeric actin (G-actin) additions and removals (known as ‘treadmilling’). This 
is in combination with the long length of F-actin, relative to its diameter, which 
makes it subject to Brownian perturbations. In contrast, placing the fluorophore 
at the C-terminus (e.g. ezrin-mEmerald or ezrin-mCherry) would have no effect 
of the FERM binding activity at the N-terminus, as shown here (fig. 3.3.2 ii). This 
configuration was presumably stable, because the FERM binding locks the N-
terminus to the plasma membrane, which holds the ezrin molecule in close 
enough proximity for it to bind F-actin with a lower affinity (Algrain et al., 1993; 
Fritzsche et al., 2014). Ezrin expressed in RAW 264.7 cells which is fluorescently-
tagged at the C-terminal domain, therefore gives the best representation of the 
ezrin location observed in unstimulated human neutrophils.  
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Figure 3.3.2ii: Ezrin-mEmerald expression in RAW 264.7 cells 
(a) Structure of Ezrin-mEmerald. The fluorophore is attached to ezrin at the C-terminal 
actin binding domain. (b) First panel: RAW 264.7 cells expressing Ezrin-mEmerald (green) 
at the cell edge. Relative fluorescence quantification of Ezrin-mEmerald distribution in a 
single RAW264.7 cell, within a defined ROI at the cell edge (yellow shaded box). 
Fluorescence intensity is highest at the cell edge, and decreases towards the cytosol. 
Second panel: LUT applied to the same cells. Ezrin is primarily located at the cell edge. 
Scale bar 10 µm. Representative of at least 20 cells.  
Cell edge 
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3.3.3 Dynamic changes in ezrin during Ca2+ influx  
The next consideration to explore, was whether or not the ezrin localisation at 
the cell periphery was disrupted by Ca2+ influx. Since RAW 264.7 cells do not 
have well-defined Ca2+ influx channels or receptor agonists which are linked to 
Ca2+ channel opening, it was necessary to employ a pharmacological approach. 
 
In most cells, Ca2+ channels can be opened by the SOCE system, whereby 
depletion of intracellular Ca2+ stores lead to the opening of Ca2+ channels at the 
plasma membrane. In order to deplete the Ca2+ stores experimentally, it is 
necessary to inhibit the ATP-driven SERCA pumps which pull Ca2+ into the stores. 
If this is done in the absence of extracellular Ca2+,  there is a resultant ‘trickle’ of 
Ca2+ out of the stores (which can also not be replaced, due to the lack of 
extracellular Ca2+) and the stores will become depleted of Ca2+ over a period of 
2-5 mins. The intracellular stores can be made even ‘leakier’ to Ca2+ (as can the 
plasma membrane) by the application of a Ca2+ specific ionophore, such as 
ionomycin. When extracellular Ca2+ is reintroduced there will be a short pulse of 
Ca2+ influx, when the Ca2+ channels are open but the stores have not yet refilled, 
up to a point that causes closure of the plasma membrane Ca2+ channels. In 
order to maximise the amount of influx, a steeper inward gradient of Ca2+ 
concentration can be achieved through supraphysiological extracellular Ca2+ 
concentrations. This tactic was therefore employed to induce a large Ca2+ influx 
in RAW 264.7 cells expressing the fluorescent ezrin constructs. A ‘cocktail’ of 
thapsigargin (an inhibitor of SERCA pumps); ionomycin (a Ca2+-specific 
ionophore) and EGTA (to chelate extracellular Ca2+) was administered, followed 
after a few minutes by Ca2+. When the cocktail was applied to RAW 264.7 cells 
expressing ezrin-mCherry or ezrin-mEmerald, there was a time dependent 
release of fluorophore from the cell periphery (fig. 3.3.3), accompanied by an 
expansion of the cell area (bloating) and sometimes blebbing. This 
demonstrated that the ezrin location at the cell edge could be disrupted by a 
Ca2+ influx, and a consequence of the loss of peripheral ezrin was morphological 
change in the cell, as a result of membrane expansion. 
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Figure 3.3.3: Ezrin location in RAW 264.7 cells treated with a high Ca
2+
 cocktail 
RAW 264.7 expressing C-terminal tagged ezrin-mEmerald. A high Ca
2+
 cocktail (40 µM 
thapsigargin, 20 µM ionomycin) was administered, and extracellular Ca
2+
 was 
elevated to 65 mM at the (*). Ezrin is lost from the cell edge concurrent with cell 
spreading. Representative of at least 3 cells. Scale bar 10 µm. 
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3.3.4 Dynamic changes in ezrin during myeloid phagocytosis  
In order to establish whether ezrin translocation away from the phagosomal 
membrane occurred in RAW 264.7 cells, in a similar way to that seen in 
neutrophils (fig. 3.3.1), RAW 264.7 cells expressing ezrin with a fluorophore 
attached at the C-terminal domain were challenged with C3bi-opsonised 
zymosan particles. The kinetics of ezrin re-distribution was monitored by 
imaging live cells performing phagocytosis. In all cells in which live phagocytosis 
events were captured (12 cells), there was a total loss of ezrin from the base of 
the phagocytic cup, before completion of phagocytosis (fig. 3.3.4i). No C-
terminally-tagged ezrin was present at phagosomes containing zymosan 
particles (31 phagosomes), despite clear peripheral ezrin located at the rest of 
the plasma membrane. When an individual cell attempted or completed two 
separate phagocytic events, loss of ezrin was observed at both phagocytic cups 
independently, at the time of cup formation (fig. 3.3.4ii). Thus, the loss of 
peripheral ezrin was both temporally and spatially synchronised with the onset 
of phagocytosis. These data show that ezrin (C-terminal region, at least) is 
released from the plasma membrane during periods of high cytosolic Ca2+; 
consistent with Ca2+-mediated cleavage by µ-calpain.  
 
Following proteolysis by µ-calpain, it is possible that the N-terminal domain of 
ezrin remains attached to the plasma membrane, via the N-terminal FERM 
domain. However, experiments with N-terminally tagged mCherry-ezrin have 
shown that ezrin-actin binding alone, via the C-terminus of ezrin, was not 
sufficient to maintain peripheral ezrin (section 3.3.2). Following cleavage of ezrin 
in the linker region, between the two functional domains, the downstream C-
terminal fragment of ezrin would no longer have sufficient binding strength to 
remain at the cell periphery. The C-terminal fragment, along with the attached 
fluorophore, would be lost from its location at the cell edge.  
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Figure 3.3.4i: Ezrin location in RAW 264.7 cells during phagocytosis 
RAW 264.7 cell expressing ezrin-mCherry, performing phagocytosis of a single 
zymosan particle. Ezrin is lost from the phagocytic cup at the onset of phagocytosis. 
ROI: white box. Scale bar 5 µm. 
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Figure 3.3.4ii: Ezrin loss is temporally and spatially synchronised 
with the onset of phagocytosis 
RAW 264.7 cell expressing ezrin-mCherry, performing phagocytosis 
of two zymosan particles (1 and 2). Ezrin is lost from the phagocytic 
cup of each phagocytosis event independently (white arrows). Scale 
bar 5 µm. 
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3.3.5 Evaluation of ezrin GFPi as marker of ezrin cleavage 
Although the global release of ezrin from the cell periphery, following global Ca2+ 
influx, was consistent with its cleavage by µ-calpain, other explanations of this 
re-distribution are possible. For example, elevated Ca2+ influx could activate 
processes which reduce either actin polymerisation (e.g. via gelsolin), or the PIP2 
content in the membrane (e.g. via activation of PLCβ), both of which would have 
an impact on ezrin localisation at the cell periphery. It was therefore important 
to seek further evidence for ezrin cleavage within the cell.  
 
A novel approach was adopted based on the knowledge that ezrin preferentially 
binds to the plasma membrane via its N-terminal FERM domain. Therefore, it is 
possible that when ezrin cleavage occurs, the N-terminal FERM fragment may 
persist at the plasma membrane, whereas the C-terminal actin binding domain 
would be released into the global cytosol. If fluorophores of different 
excitation/emission wavelengths were attached at either side of the µ-calpain 
cleavage site in ezrin, separation of the two signals may occur following ezrin 
cleavage. While it has been established that C-terminally tagged ezrin constructs 
display the membrane localising properties of endogenous ezrin, it has also been 
found that fluorophores located at the N-terminal domain inhibit typical ezrin 
behaviours. Therefore a fluorophore attached to the N-terminal end of ezrin 
would be no use, since it fails to locate at the cell periphery (section 3.3.2) 
 
One solution to this would be to use a fluorescent construct which does not 
mask the N-terminal binding domain, yet still marks the first half of the ezrin 
fragment (i.e. before the linker region). An ezrin construct with GFP inserted 
within lobe F3 of the FERM domain has previously been reported: ezrin-GFPi 
(GFP-intra) (fig. 3.1) (Marion et al., 2011). In order for ezrin-GFPi to be a useful 
tool for monitoring the cleavage of ezrin, two conditions must first be satisfied, 
these are: (i) ezrin-GFPi must behave as endogenous ezrin and localise to the cell 
edge of RAW 264.7 cells, and (ii) the GFPi fluorophore must be retained with the 
N-terminal fragment of ezrin, following proteolytic cleavage. 
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The first condition was satisfied by showing that in all RAW 264.7 cells 
expressing ezrin-GFPi, the fluorescent signal came from the cell edge (fig. 3.3.5i), 
and the location of ezrin-GFPi coincided with other fluorescently-tagged ezrin 
constructs. Furthermore, sequencing analysis of the ezrin-GFPi construct (a gift 
from Sabrina Marion), confirmed the location of GFPi in the N-FERM domain of 
ezrin (at position 234) (fig. 3.3.5ii – full sequence alignment in Appendix I). 
 
In order to test the second condition, namely that the C-terminal fluorophore 
but not the GFPi would be released by µ-calpain activity, ex vivo, the probes 
were extracted from RAW 264.7 cells expressing them, and subjected to Ca2+-
activated µ-calpain. Human neutrophil lysate was used to supply the µ-calpain. 
The ezrin-mCherry and ezrin-GFPi were immobilised by antibody capture 
directed to the FERM domain, in plastic wells, and µ-calpain was added in the 
absence of Ca2+. The addition of Ca2+ to the well, to activate µ-calpain, resulted 
in a full release of fluorophore from the C-terminus. However only 64% ± 4.37% 
of the GFPi was released (fig. 3.3.5iii). It is possible that under these in vitro 
conditions µ-calpain, which is remarkably non-specific (Goll et al., 2003), was 
able to cleave ezrin at other sites, albeit with slower kinetics and with lower 
affinity. The GFPi fluorophore may therefore have been released by cleavage at 
non-preferential sites in ezrin within the FERM domain, between the N-terminus 
and the GFPi insert site. While it was unclear as to why some GFPi was 
releasable in the in vitro assay, even under these severe proteolytic conditions, 
there was a clear distinction between the releases of the two fluorophores. 
3.3.6 Ezrin cleavage during Ca2+ influx  
As the Ca2+ conditions necessary to release ezrin from the cell periphery had 
been established (section 3.3.3), the question then arose as to whether this 
release was by ezrin cleavage of some other (perhaps non-physiological) 
mechanism. The ‘dual fluor’ approach, shown in section 3.3.5, was therefore 
applied to the RAW 264.7 cells expressing ezrin-mCherry and ezrin-GFPi.   
103 
 
  
Figure 3.3.5i: Ezrin-GFPi distribution in RAW264.7 cells 
RAW 264.7 cell expressing ezrin-GFPi, visible even in 
microridge structures (arrows). Scale bar 5 µm. 
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Figure 3.3.5iii: Differential fluorophore release following µ-calpain cleavage of  
ezrin-GFPi and ezrin-mCherry 
The percentage (±SEM) Ca
2+
-activated ex vivo release of ezrin fragments 
containing either the GFPi fluorophore (ezrin-GFPi) or mCherry (ezrin-mCherry). 
P<0.05 (two-tailed, un-paired T-test with equal variance), n=3. 
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In RAW 264.7 cells co-expressing both probes, both signals were found to come 
from the cell edge, and cells which expressed both probes at approximately 
comparable intensity levels were selected for further experimentation. When 
the Ca2+ influx strategy was applied, as before, cells often responded by bloating 
and assuming the maximal surface area to volume morphology (i.e. spherical) 
(fig. 3.3.6i). In these cells no ezrin-mCherry was detectable at the cell edge, but 
there was a delay in release of the ezrin-GFPi fragment, relative to the ezrin-
mCherry fragment, and some ezrin-GFPi remained located at the cell edge (fig. 
3.3.6ii). This was often at localised regions, associated with non-smooth zones 
e.g. small wrinkles (fig. 3.3.6i). When titrating the Ca2+ influx by two extracellular 
Ca2+ additions, so that Ca2+ influx was doubled at the second addition, it could be 
seen that the milder Ca2+ influx caused significant release of the mCherry 
fluorophore, without any release of GFPi (fig. 3.3.6iii). The subsequent larger 
Ca2+ influx caused both probes to be released. This was consistent with initial 
ezrin cleavage between the loci of the two fluorophores, i.e. the linker region; 
but that higher Ca2+ influx had an additional effect. The additional effect may 
have been caused by ezrin cleavage at other sites (such as before the GFPi 
insertion site, as seen in the in vitro assay (section 3.3.5)). Alternatively, the 
additional effect of the high level Ca2+ influx was unrelated to µ-calpain activity, 
and caused by an alternative mechanism which liberated ezrin from the cell 
edge. 
3.3.7 Ezrin release during phagocytosis  
Unlike the Ca2+ influx ‘cocktail’ approach, phagocytosis was shown to cause a 
localised and precisely timed release of ezrin from the base of phagocytic cups. 
In order to establish whether this was caused by ezrin cleavage, phagocytosis of 
C3bi zymosan particles was induced in cells co-expressing both ezrin-GFPi and 
ezrin-mCherry. In 7 out of 8 cells, in which live phagocytosis was observed, there 
was no measurable difference in the release of either fluorophore from the cell 
edge (fig. 3.3.7i). This suggested that ezrin was either: (i) released by the high 
influx mechanism identified in section 3.3.6, which may involve multiple   
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Figure 3.3.6i: Ezrin cleavage in RAW 264.7 cells treated with a high Ca
2+
 cocktail 
RAW 264.7 cell co-expressing both C-terminally tagged ezrin-mCherry and ezrin-
GFPi were exposed to a high Ca
2+
 cocktail (40 µM thapsigargin, 20 µM ionomycin 
and 65 mM Ca
2+
). Ezrin-mCherry was lost from the cell edge, whereas ezrin-GPFi 
remained at the edge in some locations, despite cell bloating. Scale bar 10 µm. 
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Figure 3.3.6ii: Delay in ezrin N-FERM domain release from cell edge 
RAW 264.7 cell co-expressing ezrin-GFPi and ezrin-mCherry. A high Ca
2+
 cocktail (40 
µM thapsigargin, 20 µM ionomycin and 65 mM Ca
2+
) was added at the (* and blue 
arrow). C-terminal ezrin (red) is lost from the cell edge concurrent with cell bloating. 
N-terminal domain ezrin is also lost with a delay of 25 s. Scale bar 10 µm. 
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Figure 3.3.6iii: Differential release of ezrin-GFPi and ezrin-mCherry after Ca
2+
 elevation 
(a) RAW 264.7 cell co-expressing ezrin-GFPi and ezrin-mCherry, with addition of the high 
Ca
2+
 cocktail, and subsequent additional Ca
2+ 
at the (*). (b) Ezrin-GFPi (green traces) and 
ezrin-mCherry (red traces) fluorescence intensity measured from the cell periphery 
(solid line) and the cytosol (dashed line) during the elevation of Ca
2+
 influx. At the first 
arrow, a Ca
2+
 elevating ‘cocktail’ (40 µM thapsigargin, 20 µM ionomycin and 65 mM 
Ca
2+
) was added; at the second arrow, the extracellular Ca
2+
 was stepped up by a second 
addition of 65 mM Ca
2+
.  
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cleavage events (therefore unable to be time-resolved, due to their rapid 
nature), or (ii) that the entire ezrin molecules was lost from the membrane 
intact.  
 
However, when cells attempted more complex phagocytosis (i.e. of multiple 
zymosan particles) the mCherry fragment could be lost without concomitant loss 
of the GFPi fragment. Occasionally, RAW 264.7 cells attempt to generate two 
phagocytic cups at once, and under these conditions, phagocytosis of one cup is 
able to pause while the other progresses (Dewitt et al., 2002; Dewitt et al., 
2006). In these experiments, during such a pause, the signature of ezrin cleavage 
at the linker region was observed. There was a small release of the C-terminal 
fluorophore (mCherry), while the N-terminal fluorophore (GFPi) remained 
attached to the base of the phagocytic cup (fig. 3.3.7ii). However, this was a 
temporary situation; within 30 s there was a decrease in GFPi fluorescence at 
the cup, and after 60 s both fluorophores were lost. It was concluded that during 
phagocytosis, the loss of ezrin from the base of the forming phagocytic cup 
involved at least two steps: (i) rapid cleavage of ezrin at the linker site, and (ii) a 
high Ca2+ influx signal. 
3.4 Discussion 
The work presented in this chapter has progressed our understanding of the role 
of ezrin in myeloid shape change, and especially during the process of 
phagocytosis. The loss of localised ezrin at the phagocytic cup was observed in 
both fixed human neutrophils, and dynamically in RAW 264.7 cells. The data 
here have shown that a similar loss of ezrin from the cell edge can be triggered 
over the entire cell surface by artificially inducing Ca2+ influx. Using a novel 
method, whereby two fluorophores are attached to ezrin molecules either side 
of the µ-calpain sensitive linker region, it was shown that cleavage of ezrin is 
involved in this mechanism. A second mechanism for the release of ezrin has 
also been established, which occurs at higher Ca2+ influx levels. This may also 
involve µ-calpain activation and cleavage of ezrin at loci other than the linker   
112 
 
  
Figure 3.3.7ii: The N-FERM domain of ezrin persists at the phagocytic cup  
RAW 264.7 cell co-expressing ezrin-GFPi and ezrin-mCherry, attempting complex 
phagocytosis of two zymosan particles (1 and 2). Insert: Phase contrast (PC) image shows 
location of two targeted zymosan. In phase 1 (Ph1) immediately following particle contact, 
ezrin-mCherry is released from the cup while ezrin-GFPi is retained. In phase 2 (Ph2) about 
25 sec later, both fluorophores are released in parallel. Scale bar 5 µm. 
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region. Alternatively, it may be the result of mechanisms not involving µ-calpain 
cleavage or proteolysis. When applied to phagocytosis, a similar picture 
emerged. There was a specific localised and temporally precise release of ezrin 
from the base of the forming phagocytic cup, which involved ezrin cleavage at 
the linker site, followed by a second release mechanism which may be similar to 
that seen with artificially induced higher Ca2+ influx. Work presented in 
subsequent chapters of this thesis will show that Ca2+ influx, which occurs locally 
near the forming phagocytic cup, can exceed levels achieved using the global 
‘cocktail’ approach. 
3.4.1 Mechanisms of ezrin release 
Before the work presented in this chapter, the hypothetical relationship 
between ezrin and µ-calpain activation, through Ca2+ influx, was simply that 
cleavage of ezrin occurred. In neutrophils this has been shown to occur when 
the cells were stimulated with the Ca2+ influx inducing agonist, fMLP (Shcherbina 
et al., 1999; This thesis Chapter 6). Although, this earlier report was a 
biochemical study and could not localise the event within the cell, or provide 
single cell dynamics. Western blot analysis has showed that the major ezrin 
fragment size was 56KDa (Yao et al., 1993; Shuster and Herman, 1995; Elumalai, 
2012), which is consistent with cleavage of ezrin at the linker region between 
the N-terminal FERM plasma membrane binding domain, and the C-terminal 
actin binding domain. However, in our lab, neutrophil ezrin often presents with 
multiple smaller degradation bands of varying size (Yao et al., 1993; Elumalai, 
2012). This would suggest that other µ-calpain cleavage sites also exist in ezrin. 
We have also found that hexa-peptides, from the linear linker region are in vitro 
substrates for µ-calpain proteolysis. This may not be unexpected as, when 
presented with a substrate in vitro, µ-calpain has little selectively. However, 
mass spectrum analysis of the resultant degradation of the ezrin derived 
peptides showed that while this region was prone to µ-calpain degradation, 
other sites were not cleaved by µ-calpain. Clearly, in the ‘dual fluor’ ezrin  
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approach, where the two ends of the ezrin molecule were separated in the cell, 
cleavage must have occurred somewhere in the linker region. This is the first 
demonstration of this event in a living cell. 
 
Additional issues arose when both the N- and C-terminal ends of ezrin were 
released. It was not possible to distinguish between cleavage at another non-
linker region site from another other non-proteolytic mechanism. The 
computational prediction of µ-calpain cleavage sites software, Multiple Kernel 
learning software (duVerle et al., 2011 – available at www.calpain.org), points to 
several high probability cleavage sites. These include loci within both the linker 
region, and outside; including loci which would liberate both fluorophores (fig. 
3.4.1). 
 
The possibility that other mechanisms which release ezrin exist, must also be 
considered as a result of this work. As ezrin binds to F-actin, conditions which 
depolymerise actin may cause ezrin to be released. For example, gelsolin which 
depolymerises F-actin by capping the growing ends, is a Ca2+ dependent protein 
with a Ca2+ binding EF hand (Kinosian et al., 1998), similarly to µ-calpain (see 
Chapter 1). However, the N-terminus and C-terminus binding states are clearly 
of different importance for maintaining ezrin at the cell edge. Whether the 
fluorophore is at the N- or C-termini has a profound influence on the localisation 
of ezrin, and shows that the FERM domain binding is far more important for 
maintaining ezrin at the cell periphery. Also, since the fluorophore on the actin 
binding domain probably interferes with its ability to bind to F-actin, ezrin-
mCherry may have no actin binding activity, and was found to be located at the 
plasma membrane simply by virtue of its intact FERM domain. In which case, any 
Ca2+-induced changes to actin polymerization would have no effect.  
 
If there is a non-µ-calpain effect, it is more likely to be through reduction of the 
FERM domain binding. The FERM domain binds to the plasma membrane, 
mainly via PIP2 (Barret et al., 2000; Gautreau et al., 2002). While initially  
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Figure 3.4.1: The most probable µ-calpain cleavage sites in ezrin  Cleavage sites 
predicted by the Multiple Kernel learning (duVerle et al, 2011) provided online by 
http://calpain.org/predict (re-mapped onto ezrin-GFPi). The (*) indicates the 
region in the linker which differs between ezrin and moesin (which is not a µ-
calpain substrate in vivo).  
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activated by GPCRs, PLCβ has a feed-forward loop whereby elevated Ca2+ 
activates it further (Horowitz et al., 2005); therefore artificially elevating 
cytosolic Ca2+ could activate PLCβ, and thereby temporarily deplete the inner 
leaflet of the plasma membrane of PIP2. However, it might be expected that 
intact ezrin would relocate to the membrane once the homeostatic mechanism 
for regenerating PIP2 (PI kinase) had restored PIP2. In these experiments, such a 
return of ezrin to the cell edge after its global loss following ‘cocktail’ treatment 
was not seen. The global release of ezrin from the cell periphery, after 
experimentally induced Ca2+ influx, was an irreversible step, as were the global 
cell shape changes such as cell bloating. During phagocytosis, PLCβ may also be 
activated locally and so deplete PIP2 and similarly underlie the release of ezrin. 
Once the phagosome has closed, this shuts off the possibility of PIP2 diffusing 
into the phagosomal membrane and may thus lead to a persistent reduction of 
PIP2. During phagocytosis there is a large production of PIP3 localised to the 
phagocytic cup (Dewitt et al., 2006; Ellson et al., 2001), caused by PI(3)kinase 
activity, which would also result in locally depleting the membrane of PIP2. Once 
formed, PIP3 stays associated with the phagosomal membrane (Dewitt et al., 
2006; Swanson, 2008; Blin et al., 2008; Maniti et al., 2012). While this could be a 
mechanism for ezrin release during phagocytosis, it should be remembered that 
the N-terminal FERM domain may also have an affinity for PIP3 in addition to 
PIP2, since both phospholipids have a charged head group. The FERM domain is 
also reported to bind to another charged phospholipid, phosphatidyl serine (PS), 
the concentration of which is unlikely to change (Yeung et al., 2009) unless PS is 
externalised, which occurs during apoptosis.  
3.4.2 Ca2+ hotspots in wrinkles and during phagocytosis  
The difference in the mechanism of ezrin release between the experimentally 
induced Ca2+ influx, and the physiological Ca2+ influx during phagocytosis, may be 
due to the extent of the Ca2+ signal. It has been shown by mathematical 
modelling that the cell surface topography is responsible for generating 
microdomains of high Ca2+ (Brasen et al., 2010). These domains are within 
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wrinkled microridge regions of the cell surface. The experimentally induced Ca2+ 
influx is a blunt instrument which would open Ca2+ channels at all locations on 
the cell surface. In contrast, the physiological route to phagocytosis is likely to be 
tuned to open channels where required in the microridge structures. In fact, the 
distribution of CD18 on human neutrophils (the binding partner for C3bi) may 
preferentially couple the Ca2+ channels at microridge structures (Erlandsen et al., 
1993). It is therefore likely that during phagocytosis the local Ca2+ concentration 
rises to higher levels, when release of ezrin by µ-calpain-mediated cleavage of 
the linker region, and other routes of ezrin release, are almost synchronous. 
Later in this thesis, work is presented which supports this supposition (Chapter 
5). Nunes and colleagues have also reported that hot spots of high Ca2+ 
concentration are generated near the phagosome (Nunes et al., 2012). Although 
it is difficult to quantify the Ca2+ concentration reached within these hotspots, 
since they are extremely localised and result from Ca2+ influx through open 
channels in the phagosomal membrane, it is likely to also be very high.
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4.1 Introduction 
The cytosolic cysteine protease µ-calpain has many different substrates. As 
previously described, there is no commonly recognised cleavage site among its 
substrates in different cell types. The lack of preference for a specific sequence 
suggests that other factors, such as its activation by Ca2+, are critical in directing 
µ-calpain activity to where it is required. Since Ca2+ is a ubiquitous secondary 
messenger in cells, the Ca2+-mediated activation of µ-calpain activation must be 
tightly regulated both spatially and temporally, because any unregulated µ-
calpain activity could result in the cleavage of many off-target proteins, with 
potentially disastrous downstream consequences for the cell. Establishing the 
nature of the Ca2+-regulation of µ-calpain cleavage of ezrin is thus crucial for a 
full understanding of the mechanism of changing neutrophil and myeloid cell 
morphology, for example during extravasation and phagocytosis.  
 
An important feature of µ-calpain is the concentration of Ca2+ required for its 
activation. The Kd for µ-calpain activation is in the range 20-60 µM Ca2+, and 
purified µ-calpain is active and able to cleave purified ezrin in assays when the 
Ca2+ concentration exceeds 30 µM (Michetti et al., 1997; Shcherbina, 1999). 
Although there have been significant obstacles in the quest to achieve accurate 
measurements of sub-plasma membrane Ca2+ fluctuations experimentally, high 
Ca2+ concentrations of at least 30 µM have been previously reported beneath 
the plasma membrane in neutrophil populations, using the membrane 
associated probe FFP-18 (Davies and Hallett, 1998). FFP-18 loaded neutrophils 
reported that the Ca2+ concentration within 0.1 µm of the plasma membrane 
increased much more rapidly than that of the global cytosol when stimulated 
with fMLP. This correlates with areas of proposed µ-calpain activity.  
 
Subsequently, there was an observed elevation of Ca2+ in the bulk cytosol, which 
coincided with subsidence of the cortical Ca2+ signal. However, limited by the 
relatively low fluorescent signal produced by FFP-18, these data could only be 
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calculated from populations, rather than measured in single cells. Furthermore, 
the optical resolution of membrane-associated FFP-18 and cytosolic Ca2+ 
indicators was not achievable in the same cell populations. Thus, the 
reconstructed data incorporate the accumulated micro-delays of individual 
neutrophil responses (Pettit and Hallett, 1995). At the single cell level, Ca2+ 
fluctuations in the bulk and the peripheral cytosol are likely to be faster than the 
rate suggested by population studies with FFP-18 (Pettit and Hallett, 1995). 
There is also speculation about whether the reported Ca2+ concentrations would 
actually be sufficient to activate µ-calpain (Goll et al., 2003). Interestingly, 
computer model simulations have predicted that microridges in the plasma 
membrane may provide the suitable microenvironments to foster Ca2+ 
concentrations in the higher micromolar range, up to 80 µM, and thus be 
capable of activating µ-calpain (Brasen et al., 2010). However, these modelling 
predictions have so far not been corroborated with experimental data obtained 
from single cell investigations. 
 
Cytosolic Ca2+ distribution is complex, and involved in many cellular processes. 
The Ca2+-dependent regulation of µ-calpain is likely a crucial regulator of 
neutrophil cell spreading, however, the Ca2+ signalling properties of this process 
are still not fully understood. The complexity of the mechanism, regarding the 
spatiotemporal organisation and the transient nature of the signal, mean that 
novel techniques are required to further investigate this phenomenon.  
4.1.2 CEPIA (calcium-measuring organelle-entrapped protein 
indicators) 
The calcium-measuring organelle-entrapped protein indicators (CEPIA) family 
(Suzuki et al., 2014) are genetically encoded Ca2+ indicators (GECIs) (Sun et al., 
2013), with specific targeting sequences which localise them to intracellular 
organelles. The CEPIA family was developed by Suzuki and colleagues (2014), 
based on the GCaMP family of Ca2+ sensing probes, to measure intraorganellar 
Ca2+ concentrations much higher than those achieved in the global cytosol. 
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Unlike small molecule Ca2+ indicators, which are dispersed throughout the cell 
cytosol, GECIs can be engineered to orientate themselves to specific locations 
within the cell. Thus, this family of GECIs represent new possibilities for high 
resolution Ca2+ imaging. 
 
CEPIA2 and CEPIA3 are based on the popular and robust Ca2+ indicating protein 
GCaMP2 (Nakai et al., 2001). At physiological temperatures, Ca2+ signalling via 
GCaMP2 proteins occurs within 100 ms, which is sufficient to detect many 
intracellular Ca2+ signalling processes. CEPIA proteins are made up of three 
functional domains; a cyclically permuted enhanced green fluorescent protein 
(cpEGFP), which is attached to the light chain of myosin kinase M13, and also the 
Ca2+ binding calmodulin domain (CaM) (fig. 4.1.2i). Fluorescence of cpEGFP is 
achieved through interactions between the CaM and cpEGFP domains, which 
arise when CaM binds Ca2+. This reorganisation of domains stabilises the 
deprotonated state of cpEGFP, allowing it to fluoresce under a 488 nm laser 
(Wang et al., 2008). The Ca2+ dependency of the domain interactions provide the 
basis for GECIs with different affinities for Ca2+. CEPIA2 and CEPIA3 were 
generated by site directed mutagenesis in the CaM domain, in order to reduce 
the binding affinity of the moiety, and therefore reduce the CaM/cpEGFP 
interactions at lower concentrations of Ca2+ (Suzuki et al., 2014). The CEPIAs 
were developed to have Ca2+ affinities specifically in the micromolar range, to be 
suitable for measuring Ca2+ within intracellular organelles. 
 
The specific features of the CEPIA family which make them relevant to this 
project, are their variability in sub-cellular localisation, the high spatiotemporal 
resolution which they can achieve, and their relatively low affinity for Ca2+. By 
adding a mitochondrial localisation sequence to the CEPIA coding sequences, 
they have been expressed in HeLa cells to report mitochondrial Ca2+ signalling, 
revealing heterogeneous Ca2+ dynamics (Suzuki et al., 2014). Therefore, addition 
of an alternative localisation sequence could repurpose the probe to measure 
Ca2+ concentrations at various distinct subcellular locations. Furthermore their 
high spatiotemporal resolution enables multiple simultaneous Ca2+   
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Figure 4.1.2i: Activation of CEPIA upon binding Ca
2+
  
CaM is attached to the cpEGFP via a new terminus in the centre, created by the fusing 
of the N- and C-termini. Ca
2+
 binding to calmodulin (CaM) causes a conformational 
change which brings cyclically permuted enhanced green fluorescent protein (cpEGFP), 
CaM and the light chain of myosin (M13) into contact, stabilising cpEGFP in the 
deprotonated state where it fluoresces. 
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measurements to be taken from different organelles/subcellular locations at the 
same time. Among the CEPIA family of proteins, two members have Ca2+ binding  
characteristics that would be capable of detecting Ca2+ fluctuations in the µ-
calpain activating Ca2+ concentration range observed in vitro; CEPIA2 and 
CEPIA3. CEPIA2 has a Ca2+-binding Kd of 0.16 µM, and CEPIA3 has a Kd of 11 µM. I 
hypothesised that by manipulating the targeting sequence of the CEPIA proteins, 
I could utilise their Ca2+ binding properties to detect Ca2+ in the micromolar 
range, at sub-plasma membrane/ezrin-rich locations (fig. 4.1.2ii). 
4.2 Aims of this chapter 
The aim of the work reported in this chapter was to generate a novel GECI, 
capable of measuring high Ca2+ concentration in ezrin-rich regions of the cell. 
 
The objectives were: 
1. To isolate the Ca2+ sensing domain of CEPIA2 and CEPIA3 using molecular 
biology techniques. 
2. To conjugate the Ca2+ sensing domains to the C-terminal domain of ezrin, 
and clone the novel GECIs into pcDNA3.1(-) expression vectors. 
3. To amplify and then purify the novel ezrin-GECI plasmids for further 
experiments investigating Ca2+ elevation events localised to ezrin rich 
regions of the cell, such as the plasma membrane and within surface 
microridges. 
4.2.1 Cardiff-KU Leuven bilateral agreement 
The work reported in this chapter was carried out under a bilateral agreement 
between Cardiff University and the Katholieke Universiteit (KU) Leuven, Belgium. 
The inspiration for the collaboration came from a small conference held 
between the Inter-school Calcium Signalling Group at Cardiff and the Calcium 
Signalling group in Leuven. The conference, held in Cardiff (October 2015), was   
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Figure 4.1.2:ii Ezrin-mCherry and EPIC fluorescence  
EPIC fluorescence intensity under a 488 nm laser is related to Ca
2+
 
binding. As Ca
2+
 concentration increases, reorganisation of the CEPIA 
domains causes the cpEGFP moiety to fluoresce.  
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independently organised between the two groups and funded though 
sponsorships.  
 
Prof. Jan Parys, from KU Leuven, presented his group’s recent work on localised 
GECIs; namely the CEPIA family of Ca2+ sensors, developed by Suzuki and  
colleagues (2014). I hypothesised that we could use the same idea to generate a 
Ca2+ sensing probe that would localise to the ezrin-rich regions of the plasma 
membrane, and crucially within the microridges at the plasma membrane of 
myeloid cells. I discussed the idea with Prof. Parys and submitted an application 
for funding to the Cardiff University selection panel. The application was 
successful and I secured funding to spend four weeks over March-April 2016 in 
Prof. Parys’ Laboratory of Molecular and Cellular Signalling in the Department of 
Cellular and Molecular Medicine, at the KU Leuven in Belgium. During this visit, I 
generated two new GECIs: EPIC2 and EPIC3, which I brought back to Cardiff for 
further experiments investigating Ca2+ concentrations in ezrin-rich cytosolic 
microdomains of myeloid cells.  
4.3 Specific Materials and Methods 
4.3.1 Generation of Ezrin-CEPIA conjugates for detection of localised 
calcium signalling 
The work in this chapter was carried out in Prof. Jan Parys’ Laboratory of 
Molecular and Cellular Signalling in the Department of Cellular and Molecular 
Medicine, KU Leuven (Leuven, Belgium). 
4.3.1.1 Primer design 
Plasmid vectors pCMV CEPIA2mt and CEPIA3mt were gifts from Masamitsu Lino 
(Addgene plasmid # 58218, 58219 and 58220). Plasmid vector mCherry-Ezrin-N-
14 was a gift from Michael Davidson (Addgene plasmid # 55043). 
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PCR primers were designed to amplify ezrin and CEPIA2 and CEPIA3, using the 
CLC Sequence Viewer (Qiagen), to include complementary restriction sites for 
the ligation of ezrin-CEPIA conjugates. The protein sequences were searched 
using SnapGene® and any restriction sites flagged within the protein sequences 
were not used. NotI and EcoRV were identified as suitable restriction sites for 
ezrin, and EcoRV and HindIII were suitable for the CEPIA variants. The 
pcDNA3.1(-) vector was a gift from Jan Parys, and has restriction sites for NotI 
and HindIII in its multiple cloning site (fig. 4.3.1.1). 
 
Approximately 20 bases from the beginning or end of each sequence to be 
amplified were incorporated in the Forward and Reverse primers respectively, 
each ending in either a C or G. Restriction sites for the appropriate restriction 
enzymes were incorporated, and a leader sequence of 6 non-coding C and G 
bases was added at the beginning of each primer to increase primer annealing, 
since C and G base pairs form 3 hydrogen bonds, making them stronger binding 
partners than A and T, with only 2 hydrogen bonds. The bespoke primers were 
ordered from Integrated DNA Technologies (IDT) (Leuven, Belgium).  
 
For Ezrin the primer designs were:  
Forward: CTAATAGCGGCCGCATGCCGAAACCAATCAATGTC   NotI 
Reverse: GTAATAGATATCCAGGGCCTCGAACTCGTCG   EcoRV 
 
For CEPIA2 and 3 the primer designs were (based on the GCaMP2 sequence): 
CEPIA forward: GCGGCGGATATCGGTTCTCATCATCATCATCATC   EcoRV 
CEPIA reverse: GCGGCGAAGCTTTTACTTCGCTGTCATCATTTG             HindIII 
4.3.1.2 PCR 
PCR was performed for two purposes: (i) to remove existing tags from the gifted 
ezrin and CEPIA variants, and (ii) to amplify DNA fragments for molecular 
cloning.   
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Figure 4.3.1.1: pcDNA3.1(-) plasmid map 
With ampicillin resistance gene. 
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The quantities of template DNA, primers and dNTPs are listed in table 4.3.1.2i, 
and the PCR program is detailed in table 4.3.1.2ii.  
4.3.1.3 PCR clean-up 
DNA from the PCR products and was purified using the GenElute™ PCR Clean-Up 
Kit (Sigma-Aldrich), to remove excess dNTPs and primers, and again after the 
restriction digests to remove DNA fragments. The PCR clean-up was performed 
according to the manufacturer’s protocol, and the DNA was recovered in ddH2O. 
4.3.1.4 Restriction and ligation of PCR products and pcDNA3.1(-) vector 
Ezrin PCR product was digested by NotI and EcoRV restriction enzymes. CEPIA2 
and CEPIA3 PCR products were digested with EcoRV and HindIII. The vector 
pcDNA3.1(-) was digested with NotI and HindIII. The quantities of PCR products 
and restriction enzymes are shown in table 4.3.1.4i. 1 µL of alkaline phosphatase 
was added to the vector samples, to prevent re-annealing of the sticky ends. The 
reaction was left to incubate for 30 mins at 37°C with gentle mixing after 15 
mins to ensure complete digestion. The PCR clean-up procedure was then 
repeated (as described in section 4.3.1.3). 
 
Ligation reactions were carried out using the fast acting enzymes from 
ThermoScientific. Digested pcDNA3.1(-) vector was incubated with ezrin and 
CEPIA2/3 for 10 mins at 22°C in a heat block. The reaction volumes are listed in 
table 4.3.1.4ii. For the negative control the digested pcDNA3.1(-) was ligated 
without the PCR products, to test the likelihood of the vector re-annealing 
without the inserts. 
4.3.1.5 Agarose gel electrophoresis 
Mini-preps were re-digested with NotI and HindIII to check for correct ezrin-
CEPIA insertion. Reaction volumes are described in table 4.3.1.5. The reaction   
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Table 4.3.1.2i: PCR set-up 
Table 4.3.1.2ii: PCR program 
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Table 4.3.1.4i: Restriction digest 
Table 4.3.1.4ii: Ligation reaction 
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Table 4.3.1.5: Re-digest  
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was performed in a water bath at 37°C for 10 minutes, so that the reaction did 
not go to completion, and was stopped by transferring the samples to ice. 
 
Agarose gels were prepared by heating 1.25 g agarose in 125 mL TAE buffer (for 
a 1% gel) in a conical flask in the microwave on full power for 1-3 minutes, until 
the agarose was completely dissolved. Care was taken not to over boil the 
solution, which would affect the gel composition. The dissolved agarose was 
cooled, to approximately 60°C, and 6.25 µL ethidium bromide was added. After 
pouring, the gel was left to set for at least 30 mins at room temperature, before 
the comb was removed.  
 
To perform electrophoresis, the gel was submerged in 1 x TAE buffer (4.84 g Tris-
base, 1.142 mL acetic acid (100%), 2 mL 0.5 M EDTA in I L ddH2O) plus 1-2 % 
ethidium bromide for even staining. 10 µL of ready-to-use DNA ladder was 
loaded in the first and last wells as a reference. DNA samples (10 µL) were 
prepared with loading buffer (4 µL) and ddH20 (6 µL). 10 µL of each prepared 
sample was loaded into wells. The gel was run at a constant 120 V for 30 mins, at 
which point the migration distance was assessed and the run time was extended 
if necessary. 
4.3.1.6 Transformation of DH5α cells 
50 µL of DH5α cells (gifts from Jan Parys) were thawed on ice and carefully 
mixed with 4 µL of ligation reaction and incubated on ice for 30 mins. The 
mixture was heat-shocked for 2 mins at 42°C in a heat block, followed by 2 mins 
on ice. 400 µL of sterile LB medium was added and the cells were incubated in a 
rotating incubator (225 rpm) for 1 hour at 37°C. The cells were then spread onto 
agar plates containing ampicillin, and incubated overnight at 37°C. 
4.3.1.7 Mini-preps 
Mini-preps were carried out using the GenEluteTM Plasmid Miniprep Kit (Sigma 
Aldrich) as per the manufacturer’s instructions, but the final plasmid was 
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recovered in dH2O, instead of the supplied Elution Solution (10 mM Tris-HCl, 1 
mM EDTA, pH approx. 8.0) because the DNA was immediately sent for 
sequencing (LGCgenomics), to confirm the correct insertion of the ezrin/CEPIA 
conjugates. Five colonies were picked from each agar plate and used to 
inoculate 5x2 mL LB broth overnight cultures (37°C, 225 rpm). The purified 
plasmid DNA was stored on ice prior to quantification. Long-term storage was at 
-20°C. 
4.3.1.8 Quantification of plasmid DNA 
Purified DNA from the mini and maxi-preps was assessed using the Qubit dsDNA 
BR Assay Kit® and Qubit® Fluorometer (Life Technologies), according to 
manufacturer’s instructions. 
4.3.2 Transfection of HeLa cells  
24 hrs post-seeding the novel GECI constructs were introduced into HeLa cells 
(gifts from Jan Parys) using the X-tremeGENE™ HP DNA Transfection Reagent 
(Sigma Aldrich), as per the manufacturer’s instructions. A ratio of 1:1.5 X-
tremeGENE™ to DNA was used. 
4.4 Results 
4.4.1 Generation of EPIC2 and EPIC3 
In order to generate a GECI-ezrin conjugate, the Ca2+ sensing-domain of CEPIA2 
and CEPIA3 first had to be removed from the organelle targeting sequence, to 
which it was attached. The mCherry domain of ezrin-mCherry was also removed 
to provide the ezrin sequence, for conjugation to the CEPIA sequence. PCR 
primers to the CEPIA2/3 and ezrin sequences were generated using CLC 
sequence viewer, and PCR was performed to isolate the genes of interest. 
Following the PCR clean-up procedure, the DNA fragments were digested with 
restriction enzymes NotI, EcoRV and HindIII, to generate appropriate sticky ends 
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for ligation with a pcDNA3.1(-) plasmid vector. The ezrin-CEPIA2/3 conjugate 
(fig. 4.4.1i) was cloned into the pcDNA3.1(-) plasmid vector and transformed into 
chemically competent DH5α E. coli, before being plated onto agar plates 
containing ampicillin. Only bacteria which had been successfully transformed 
with the pcDNA3.1(-) plasmid vector were able to grow, because they had 
acquired the gene for ampicillin antibiotic resistance. Five colonies were 
selected from each plate for further amplification. Cultures with the correct 
ezrin-CEPIA conjugate inserted into the plasmid vector were identified by 
agarose gel electrophoresis, after re-digestion with the restriction enzymes NotI 
and HindIII (fig. 4.4.1ii). Several colonies were identified as having successfully 
incorporated the new conjugate. Ezrin-CEPIA2a and ezrin-CEPIA3d had the 
strongest ‘insert’ bands, and therefore these mini-preps contained more plasmid 
DNA. Sequencing analysis confirmed the correct orientation of the ezrin-CEPIA2a 
and ezrin-CEPIA3d conjugates (figs. 4.4.1iii-vi), and the novel GECIs were named 
EPIC (Ezrin Peripheral Indicator of Ca2+) 2 and EPIC3, on account of their CEPIA2 
and CEPIA3-like properties respectively. EPIC2 and EPIC3 were successfully 
amplified via expansion of the broth culture and subsequent maxi-preps. 
4.5 Discussion 
This work has produced the first ezrin-associated GECIs, with Ca2+ binding 
affinities 0.16 µM and 11 µM (based on the Ca2+ titrations carried out by Suzuki 
and colleagues on the CEPIA2 and 3 GECIs (Suzuki et al.,2014) (fig. 4.5); named 
EPIC2 and EPIC3 respectively. The Ca2+ binding properties of the novel probes 
will be used in experiments investigating Ca2+ signalling and the relationship with 
ezrin activity during changes in myeloid cell morphology, during specific events 
such as phagocytosis. The assumption will be made that the Ca2+ binding 
properties of EPIC2 and 3 are akin to those of CEPIA2 and 3, as detailed by 
Suzuki and colleagues (2014) (fig. 4.5), based on their common GCaMP2-like 
domains. All estimations of Ca2+ concentrations in this thesis that are taken using 
the EPIC probes will be made with this assumption. 
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Figure 4.4.1i: Scheme of molecular cloning novel EPIC 
Ezrin and CEPIA2/3 were cloned into the pcDNA3.1(-) plasmid vector with 
restriction sites NotI and HindIII. 
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Figure 4.4.1ii: Agarose gel electrophoresis to identify successful vector ligations 
Samples were re-digested with NotI and HindIII and the resultant DNA bands were 
analysed for bands correlating with the molecular weight of the ezrin-CEPIA conjugate 
(3058bp). (a) Ezrin-CEPIA2a/c/d and (b) Ezrin-CEPIA3d, contained the correct size 
insert and were sent for further sequencing. 
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Figure 4.4.1iii: GCaMP2 sequencing  
alignment for EPIC2 
Sequenced by IDT (Leuven, Belgium), 
using CEPIA primers. Pink bars indicate 
sequence conservation, between 0 and 
100%. 
138 
 
  
139 
 
 
  
Figure 4.4.1iv: Ezrin sequencing  alignment for EPIC2 
Sequenced by IDT (Leuven, Belgium), using ezrin primers. Pink bars 
indicate sequence conservation, between 0 and 100%. 
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Figure 4.4.1v: GCaMP2 sequencing  
alignment for EPIC3 
Sequenced by IDT (Leuven, Belgium), 
using CEPIA primers. Pink bars 
indicate sequence conservation, 
between 0 and 100%. 
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Figure 4.4.1vi: Ezrin sequencing alignment for EPIC3 
Sequenced by IDT (Leuven, Belgium), using ezrin primers. Pink 
bars indicate sequence conservation, between 0 and 100%. 
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The relationship between ezrin and Ca2+ localisation is complex. It is important 
to recognise that the fluorescent activity of EPIC2 and EPIC3 is coupled to their 
Ca2+ sensing activities (0.16 µM and 11 µM respectively). Therefore, the 
fluorescent signal produced by intracellular EPIC3 would not be maximal in 
resting cells, when there is no net Ca2+ influx/efflux event. Furthermore, a 
cytosolic pool of free, unbound and unphosphorylated inactive ezrin exists. 
Therefore EPIC2 and EPIC3 should also be distributed in the cytosol. EPIC2, with 
a lower Kd of 0.16 µM Ca2+, would also be reporting the cytosolic free Ca2+ 
concentration in the resting cell (approx. 0.10 µM Ca2+). It is therefore likely that 
EPIC2 would become saturated at the cell edge upon Ca2+ influx, much faster 
than the imaging capacity of the confocal resonance scanner (high resolution 
imaging requires at least 4 seconds/frame). EPIC3 was selected for further 
immediate analysis, because of its 11 µM Kd for binding Ca2+, in the range of µ-
calpain activation. These Ca2+-binding properties were considered to be more 
useful for further Ca2+ measuring experiments in myeloid cells undergoing, for 
example, localised morphological changes such as phagocytosis.  
 
Furthermore, since ezrin is a substrate of µ-calpain, it is presumed that the EPIC 
ezrin variants will also be susceptible to Ca2+-mediated µ-calpain cleavage. Since 
it is predicted that the ezrin cleavage site lies somewhere between the two 
terminal functional domains (Dewitt and Hallett, 2007), ezrin cleavage would 
result in the GECI dissociating from the plasma membrane. In this way, the novel 
probes report both localised Ca2+ concentrations, and also ezrin cleavage events 
at the cell edge. This may be useful in single cell experiments, where the EPIC 
can act as both an indicator of localised elevations of Ca2+ concentration, and 
also as a secondary diffusible Ca2+ indicator in the global cytosol. 
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Figure 4.5: Assumed EPIC2 and EPIC3 titration curves 
Ca2+ titration curves for EPIC2 and 3 (based on calculations performed by 
Suzuki and colleagues (2014)). With the assumption that EPIC2 and 3 will have 
the same Ca2+ binding affinities as CEPIA2 and 3 respectively, EPIC2 will have a 
Kd of 0.16 µM and EPIC3 will have a Kd of 11 µM. Under physiological 
conditions EPIC2 will be at half maximal fluorescent activity, whilst EPIC3 will 
have minimal fluorescence activity. 
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5. Chapter 5 - Cytosolic microdomains of high 
Ca2+concnetration  
 
Chapter 5:  
Cytosolic microdomains of 
high Ca2+ concentration 
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5.1. Introduction 
The biphasic Ca2+ response in neutrophils undergoing cell spreading, such as 
during extravasation or during the process of phagocytosis, is similar. Both 
processes demand an apparent expansion of the cell surface area. In the 
spreading neutrophil, this is up to 200% (Hallett and Dewitt, 2007), which is far 
greater than the stretching capacity of the resting cell membrane of 4% (Hamill 
and Martinac, 2001). The force required to expand the plasma membrane is 
reduced during phagocytosis (Herant et al., 2003), a mechanism which would 
enable the membrane to expand into fillopodia (Atilgan et al., 2006). In this 
thesis, µ-calpain and ezrin have both been implicated as key players in the 
remodelling of the cytoskeletal and plasma membrane relationship. The Ca2+-
mediated activation of µ-calpain, in ezrin-rich regions at the plasma membrane, 
is proposed to disrupt the cross-linking role of ezrin. Cleavage of this tether 
between the cortical actin cytoskeleton and the plasma membrane would 
release the ‘reservoir’ of trapped membrane from within microridge structures, 
and provide both additional membrane for the increase in cell surface area, and 
also reduce the membrane tension which allows actin polymerisation to proceed 
(Cordova et al., 1992; Peskin et al., 1993), and so enable cell spreading.  
 
As previously discussed, the Kd of µ-calpain is in the range 20-60 µM Ca2+, and as 
such is higher than the physiological Ca2+ concentrations in the bulk cytosol. It is 
for this reason that we propose that the plasma membrane microridges serve a 
dual purpose. Not only do they provide (i) a storage mechanism for plasma 
membrane to be released when required, but they also provide (ii) a suitable 
microenvironment where localised cytosolic concentrations of Ca2+ in the mid-
decade micromolar range are attainable. This therefore provides a ‘safe’ and 
contained microenvironment for appropriate µ-calpain activation, where it can 
cleave ezrin cross-links to release tension in the plasma membrane. 
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5.1.1 Microridge Ca2+ domains 
Many cell types have microridge structures in their plasma membranes, serving 
a variety of different purposes. In neutrophils, as previously discussed, it is 
understood that the plasma membrane microridges provide the stored excess 
plasma membrane required for cell shape change events; specifically spreading 
and phagocytosis (fig. 5.1.1i). 
 
Computer simulations of neutrophil plasma membrane microridges have 
modelled the size of microridge structures on the neutrophil surface which are 
capable of generating Ca2+ microenvironments, with transient Ca2+ 
concentrations which are higher than that of the global cytosol. Brasen and 
colleagues have predicted that the Ca2+ concentrations in plasma membrane 
microridges could reach up to 80 µM in a 1 µm long microridge, upon Ca2+ influx 
during cell stimulation (fig. 5.1.1ii) (Brasen et al., 2010). This calculation is 
approximately 100-fold higher than the Ca2+ levels typically thought to be 
achievable in the global cytosol. It is also out of the range of detection by most 
conventional small molecule Ca2+ indicators. 
 
Total internal reflection fluorescence microscopy (TIRF) has measured 
intracellular Ca2+ signals within 100 nm of the plasma membrane, using the 
fluorescent Ca2+ indicator Fluo3, but the increase at the plasma membrane was 
small compared to the bulk cytosolic Ca2+ signal, at 20-60% (Omann et al., 1996). 
However, the Fluo3 signal becomes saturated at Ca2+ concentrations above 
approximately 3 µM, thereby giving a gross underestimate of the peak Ca2+ 
concentrations reached at the plasma membrane. Moreover, the TIRF technique 
requires the plasma membrane to be closely positioned to an adherent surface 
(i.e. within 100 nm of the reflection beam), thus this approach would only be 
capable of measuring the Ca2+ concentration beneath a flattened, and non-
wrinkled membrane. TIRF was therefore not able to measure the Ca2+ 
concentration in the microridge structures of the plasma membrane.  
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Figure 5.1.1ii: Estimation of Ca
2+
 concentration attainable beneath a wrinkled 
membrane 
 
  
The Ca
2+
 influx periods in a model cell with microridge structures. When the 
channel is open for 0.1 s, the Ca
2+ 
beneath the membrane microridges is 
estimated to reach 80 µM. (Figure reproduced with permission from Brasen et 
al., 2010.) 
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In an attempt to measure the Ca2+ concentration beneath the wrinkled plasma 
membrane of neutrophils, live cells in suspension have been loaded with FFP-18, 
a membrane-targeting fluorescent probe with a lower Ca2+ affinity (Davies and 
Hallett, 1998). This approach reported higher than global Ca2+ concentrations at 
the plasma membrane, of up to 30 µM (Davies and Hallett, 1998). However, 
these experiments were unable to produce data from individual cells during Ca2+ 
influx, due to the fluorescent signals being too weak. At the time of writing this 
thesis it is understood that no single cell experiments have been performed to 
measure the Ca2+ concentrations in sub-plasma membrane domains, formed by 
folds of the plasma membrane, in any cell type. Furthermore, this has never 
been achieved within the specific compartment of ezrin-rich microridge 
structures, in stimulated myeloid cells. 
5.1.2 Ezrin peripheral indicator of Ca2+ (EPIC) 
In the previous chapter, generation of a novel GECI, EPIC3, was reported, which 
has both ezrin localising properties and a low Ca2+ binding affinity Kd of 11 µM. 
This novel probe thus provides the opportunity to report Ca2+ concentrations in 
the higher micromolar range, feasible only during cytosolic Ca2+ elevation, as a 
result of Ca2+ influx. Because the Ca2+ sensing domain is conjugated to the C-
terminal domain of ezrin, it was anticipated that the probe would have the same 
plasma membrane interactions as native ezrin (fig. 5.1.2). This would place the 
Ca2+ sensor in the precise location where µ-calpain is postulated to be activated, 
and cleave ezrin to permit relaxation of the plasma membrane microridges.  
 
Furthermore, as shown in Chapter 3, ezrin is lost from the cell edge during Ca2+ 
influx (e.g. ezrin is lost from the phagocytic cup during phagocytosis, and almost 
uniformly from the cell edge during artificial Ca2+ influx stimulated by a high Ca2+ 
cocktail containing, thapsigargin and ionomycin). As EPIC is essentially a 
modified ezrin, it is also expected to be a substrate for µ-calpain. In this way,  
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Figure 5.1.2: EPIC3 signalling  
Ezrin-mCherry is constitutively fluorescent under a 587 nm laser. EPIC3 fluorescence 
intensity increases with elevated Ca
2+
 concentration. Both ezrin-mCherry and EPIC3 
have the same ezrin localising properties, which means that ezrin-mCherry can be 
used as a location marker for EPIC3, when Ca
2+
 concentration is below EPIC3 
sensitivity and fluorescence is low.  
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EPIC would both indicate the intra-microridge Ca2+ concentration, and be a 
marker of µ-calpain activity by ezrin cleavage. 
5.1.3 Aims of this chapter 
The activity of µ-calpain must be highly controlled, because of its lack of 
substrate specificity, and having many different potential substrates. Untimely 
or poorly restricted activation of µ-calpain could result in off target protein 
cleavage, and the potential disruption of multiple cellular processes. It is for 
these reasons we hypothesise that during morphological rearrangements of the 
plasma membrane and cortical actin cytoskeleton, µ-calpain is transiently and 
locally activated specifically beneath microridges in the plasma membrane, 
which provide a microenvironment in which the Ca2+ concentration is capable of 
transiently reaching higher micromolar Ca2+ concentrations; within the range 
required to activate µ-calpain.  
 
The aim of this chapter, therefore, was to use the novel probe developed in 
Chapter 4, in order to experimentally measure the intra-microridge Ca2+ 
concentration in myeloid cells, specifically at the point of Ca2+ influx, where µ-
calpain is thought to be activated. 
 
The objectives were: 
1. To express the novel EPIC3 in RAW 264.7 cells by nucleofection. 
2. To measure localised EPIC3 signal within ezrin-rich cytosolic 
microdomains beneath plasma membrane microridges, during Ca2+ 
influx events. 
3. To quantify changes in Ca2+ concentration using the Ca2+ binding 
properties of EPIC3. 
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5.2 Specific Materials and Methods 
5.2.1 Transfection of RAW 264.7 cells  
RAW 264.7 cells (2x106) were transfected with 3 µg of ezrin-mCherry, and 3 µg 
EPIC3 plasmid DNA, using programme D-032 on the Cell Line Nucleofector™ 
Device (Lonza), as previously described in Chapter 2. 
5.2.2 Artificial elevation of Ca2+ concentration in RAW 264.7 cells 
Transfected RAW 264.7 cells were seeded onto glass-bottomed petri dishes 
(approx. 6x105 cells) and incubated for 3-4 hrs at 37°C with 5% CO2, to allow for 
EPIC3 and ezrin-mCherry protein expression. Artificial Ca2+ influx was stimulated 
by extracellular addition of a high Ca2+ cocktail of thapsigargin (40 µM), 
ionomycin (20 µM) and Ca2+ (65-130 mM). 
5.2.3 Physiological stimulation of RAW 264.7 cells (phagocytosis) 
Zymosan particles (1 mg) were opsonised with mouse C3bi as previously 
described (Chapter 2). RAW 264.7 cells, transfected with EPIC3 and ezrin-
mCherry, were seeded into glass-bottomed petri dishes, and kept at 4°C for 15 
mins prior to the addition of excess C3bi-opsonised zymosan (200 µL). The cold 
RAW 264.7 cells were then left at 4°C for a further 15 mins, to allow the 
zymosan particles to sediment and bind to the adherent RAW 264.7 cells, 
without triggering phagocytosis. The chilled media was then aspirated and 
replaced with 200 µL of pre-warmed DMEM (37°C), to allow for phagocytosis to 
proceed. The cells were then imaged by confocal microscopy. 
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5.2.4 Measurement of dynamic changes in cytosolic Ca2+ as reported 
by novel EPIC3 
5.2.4.1 Confocal microscopy 
Confocal images were taken using the Leica SP5 confocal inverted microscope 
(Leica Microsystems, Heidelberg) with resonance scanner, laser scanning [63x 
objective; 633 nm and 488 nm argon laser] in a perfusion chamber at 37°C. 
Images were acquired from the two lasers by sequentially scanning alternate 
lines with each laser. In this way, each image line was the result of a single laser 
excitation, and there was no possibility of cross-talk (i.e. the inadvertent 
excitation of both fluorophores at the same time). Sequential line imaging also 
gave simultaneous images from each laser excitation, as previously described in 
Chapter 2. 
5.2.4.2 ImageJ EPIC3 image processing 
Two approaches have been used to process the image files: (A) a ratio calculated 
of EPIC3 and ezrin-mCherry to give a Ca2+ dependent ratio image, at each time 
point; (B) a dynamic mask of the cell edge applied to exclude cytosolic signals, 
and so allow only imaging of fluorescent signals from the ezrin rich periphery of 
the cell.  
 
The dynamic masks were generated using ImageJ, in order to automate the 
image processing, and acquire data from the same region of a cell over several 
minutes of a time series. This was beneficial because the software was able to 
calculate the perimeter of the mask between frames, which was more efficient 
than manually adjusting the region of interest by eye, and between frames. The 
dynamic mask was used to process the EPIC3 signal from co-transfected cells. 
This enabled a more accurate description of changes in EPIC3 fluorescence. 
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A. EPIC3/ezrin-mCherry ratio 
Avi. files of the EPIC3 and ezrin-mCherry were imported as gray scale. The image 
was smoothed twice (‘Process’ > ‘Smooth’) and image brightness was improved 
using the controls in the ‘Image’ > ‘Adjust’ menu (e.g. 15 min: 82 max). A ratio of 
the EPIC3 signal by the ezrin-mCherry signal was calculated using the ‘Ratio Plus’ 
plugin (https://imagej.nih.gov/ij/plugins), with clipping and threshold values set 
to approximately background level. A look up table (LUT) was applied and the 
file was smoothed as necessary. Changes in the EPIC3 signal were quantified 
using the ‘Measure Stacks’ function, as before. When the cell was moving it was 
sometimes also necessary to also use a dynamic mask, so that only the 
phagocytic cup was above the threshold of the mask, and therefore visible. Data 
were exported to Microsoft Excel for further analysis. 
B. Dynamic mask using ezrin-mCherry and EPIC3 ratio 
Avi files of the ezrin-mCherry signal were created and converted into binary 
masks. Avi fles were created from the ezrin-mCherry Leica .lif files. Files were 
imported into ImageJ as gray scale, smoothed, and brightness adjusted as 
described, then converted to binary (‘Process’ > ‘Binary’ > ‘Make Binary’; 
calculated individually for each image in a series, with a black background). The 
binary images were dilated up to five times, if necessary to fill the mask 
(‘Process’ > ‘Binary’ > ‘Dilate’), and the ‘Fill Holes’ function was applied (‘Process’ 
> ‘Binary’ > ‘Fill Holes’). The ‘Find Edge’ function was selected (‘Process’ > ‘Find 
Edge’) and the mask was dilated a further three times and adjusted as 
necessary. Image files containing the EPIC3 signal data and ezrin-mCherry signal 
data were imported into ImageJ as gray scale, then smoothed and brightness 
adjusted. A ratio of the EPIC3 file by the ezrin-mCherry file was calculated using 
the ‘Ratio Plus’ plugin. The clipping and threshold values were set to 
approximately background level, and the ratio file was smoothed. The resultant 
mask was then multiplied by the ratio data image (‘Process’ > ‘Image 
Calculator’), in 32 bit floating format, and a LUT was selected. Changes in EPIC3 
signal were quantified using the ‘Measure Stacks’ function. A region of interest 
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was drawn around the cell (or region of cell) being analysed. Data were exported 
to Microsoft Excel for further analysis. 
5.2.4.3 Calculating the Ca2+ concentration reported by EPIC3 
EPIC3 fluorescence intensity was converted into approximate Ca2+ concentration 
by observing the following equations. 
A. The relationship between free Ca2+ + EPIC3 ↔ (Ca2+EPIC3) 
a) The fraction of EPIC3 with Ca2+ bound (f) is given by the standard Law of Mass 
Action equation for binding:  
 f = 1/(1+(Kd/Ca2+))   
b) Note when Ca2+ = Kd the equation is: 
f  = 1/(1+1) i.e.  f = 0.5 (that is half maximal binding) 
c) This can be rearranged to give: 
Ca2+ = Kd/((1/f)-1) ………………………………   Equation 1 
 
B. The relationship between EPIC3 fluorescence and f 
a) The minimum fluorescence of EPIC3 (in the absence of Ca2+, or 0.1 µM Ca2+) is 
Fmin. 
b) The max fluorescence of EPIC3 (in the presence of saturating Ca2+ e.g. > 200 
µM Ca2+) is Fmax. 
c) The dynamic range of EPIC3 fluorescence is 2.6 (Suzuki et al., 2014). Thus the 
maximum fluorescence attainable with EPIC3, under saturating Ca2+, is 2.6 times 
greater than Fmin. Therefore Equation 2 is: 
Fmax = approx. 2.6Fmin  ………………………………  Equation 2 
C. The relationship between measured EPIC3 intensity and Ca2+ 
concentration 
a) The f (fractional binding) is between zero and 1 as Ca2+ changes from the 
resting cytosolic level to saturating. 
b) The intensity of EPIC3 at any time or in any location is F. So: 
157 
 
 f = (F-Fmin)/(Fmax-Fmin)   
c) However as Fmax is 2.6 times Fmin. Equation 3 can be derived as follows: 
             f = (F-Fmin)/(2.6Fmin-Fmin) 
Ö f = (F-Fmin)/(1.6Fmin) 
Ö f = F/1.6Fmin – Fmin/1.6Fmin 
Ö f = 1/1.6 ((F/Fmin)-1) 
 
Ö f = (F/Fmin)-1)/1.6  ………………………………  Equation 3 
e) The value of f from Equation 3, was inserted into Equation 1, to give the Ca2+ 
concentration reported by EPIC3.  
5.2.5 Calculating the cell footprint (2D area) 
Avi. fles were created from the ezrin-mCherry Leica .lif files, imported into 
ImageJ as gray scale, and converted into binary masks. The image was smoothed 
twice (‘Process’ > ‘Smooth’) and image brightness was improved using the 
controls in the ‘Image’ > ‘Adjust’ menu. Files were converted to binary (‘Process’ 
> ‘Binary’ > ‘Make Binary’). It was important that the binary images 
corresponded to the cell outline and, if necessary the ‘Fill Holes’ function was 
applied (‘Process’ > ‘Binary’ > ‘Fill Holes’). In the binary image, all pixels within 
the cells had a value of 1 and all pixels outside the cell had a value of zero. 
Consequently, the number of non-zero pixels in each image of the time series 
corresponded to the cell footprint, or 2D area. This was measured using the 
‘Measure Stacks’ function, which gave the mean pixel number in each frame. 
The data were exported to Microsoft Excel for further analysis, and processed 
using the formula: 𝑁𝑥≠0 =
?̅?
255 × 𝑛. Where 𝑁𝑥≠0 is the number of non-zero 
pixels, n is the total number of pixels and 255 is the value of a pixel. 
5.2.6 Calibrating the LUTs 
The LUTs were individually calibrated by hand for each cell, by first observing 
Equation 1 (section 5.2.4.3), rearranged to give: 
f = 1/(1+(Kd/Ca2+)) 
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Where the Kd is 11 µM. For defined Ca2+ concentrations (e.g. 0.1 µM – 200 µM) 
the F was then calculated using Equation 3, rearranged to give: 
 F = Fmin(1.6f + 1) 
Where F is the pixel value on the LUT (in gray scale). This was converted in to 
pixel distance (from 0-255) along the LUT, and Ca2+ concentration was labelled 
accordingly. 
5.3 Results 
5.3.1 EPIC3 reports Ca2+ activity at the cell edge in myeloid cells 
Due to the limitations of working with human neutrophils, in that they cannot be 
transfected to produce novel proteins in sufficient quantities for these 
experiments, a RAW 264.7 cell line was used to model the behaviour of 
microridge domains in myeloid cells. RAW 264.7 cells are a suitable model for 
these experiments because they are capable of changing morphology and 
performing phagocytosis of C3bi-opsonised zymosan particles; and are also able 
to undergo cell spreading, involving an apparent expansion of the cell 
membrane, similar to neutrophils.  
 
Initially, the novel EPIC3 alone was transfected into RAW 264.7 cells, using 
nucleofection. Artificial Ca2+ elevation was stimulated by addition of a cocktail 
containing thapsigargin (40 µM), to inhibit intracellular store re-filling via the 
SERCA pump, ionomycin (20 µM) to transport Ca2+ across the cell membrane, in 
combination with or followed by a Ca2+ concentration step-up (∆ 65-130 mM) to 
provide a temporally-defined and rapid Ca2+ influx.  
 
EPIC3 fluorescence intensity is Ca2+ dependent, and minimal (i.e. Fmin) at the 
cytosolic Ca2+ levels in a resting cell. However, even in unstimulated conditions, 
25% of the cells had an elevated EPIC3 signal at the cell edge. This may indicate 
that even at rest, sub-plasma membrane Ca2+ is sufficiently high to cause 
detectable EPIC3 fluorescence in some cells. In 94% of cells in which EPIC3 was 
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detected, EPIC3 intensity increased following artificial elevation of cytosolic Ca2+ 
(fig. 5.3.1i). 87% of cells that responded to Ca2+ influx changed morphology, 
often becoming round, concomitantly with an increase in cell footprint (fig. 
5.3.1ii). 
 
The intensity of EPIC3 fluorescence increased, reporting elevated global Ca2+ 
concentrations within 10 s of extracellular Ca2+ elevation (15/16 cells). Peak 
EPIC3 intensity typically occurred within 30s of extracellular Ca2+ addition (fig. 
5.3.1ii). Cell imaging by confocal microscopy revealed the EPIC3 signal was 
transiently higher at regions of the cell edge (fig. 5.3.1iii; blue=low Ca2+, 
green=high Ca2+). The Ca2+ concentration at the cell edge was estimated to reach 
19.2 ±5.3 µM (SEM) at 10 s after Ca2+ elevation. Despite the morphological 
changes which accompanied the Ca2+ increase, and which are indicative of µ-
calpain activation and ezrin cleavage, the sub-plasma membrane Ca2+ estimated 
by these measurements may not be sufficient to fully activate µ-calpain (Kd=20-
60 µM). However, as ezrin cleavage occurs at the cells edge, as a result of Ca2+ 
elevation (discussed in Chapter 3), EPIC3 would be progressively lost from the 
cell edge under these conditions, giving a lower fluorescent signal from that 
location, regardless of the Ca2+ concentration reached. Also, the Ca2+ sensing 
domain of EPIC3 would move away from the areas of high Ca2+, at the cell edge, 
and into the relatively lower Ca2+ concentration of the bulk cytosol. This 
approach is therefore likely to underestimate the Ca2+ concentrations within 
high Ca2+ microdomains. The initial estimate of 19.2 ±5.3 µM, should therefore 
be taken as a minimum value of Ca2+ concentration within the ezrin-rich sub- 
membranous microdomain, with the expectation that a more refined estimate 
would yield a higher value. 
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Fig 5.3.1i: RAW 264.7 cells expressing EPIC3  
Of 16 cells expressing EPIC3 (a) only 4 had a elevated signal at the cell edge under 
resting conditions. (b) In 94% of the cells measured (15/16) EPIC3 reported a rise in 
overall cell Ca
2+ 
concentration. (c) 87 % of cells (13/15) had a morphological change, 
bloated and rounded up. 
≥3:1 ratio of 
EPIC3 at edge 
to cytosol 
(a) (b) 
(c) 
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Figure 5.3.1ii: EPIC3 reports elevation in Ca
2+
 prior to cell spreading 
RAW 264.7 cell transfected with EPIC3 and pre-treated with thapsigargin (40 µM). Before 
addition of Ca
2+
 the cell had a large diameter of 14.5 µm and a smaller diameter of 11.6 µm. 
Ca
2+
 (65 mM) was added at the blue arrows. EPIC3 reports elevated Ca
2+ 
at the cell edge 
(estimated to reach 19.2 ±5.3 µM) within 10 s after elevation of extracellular Ca
2+
. Within 40 
s the cell begins to bleb and Ca
2+
 is elevated in the cytosol. At T + 3 m 31 s (8 s after the 
second Ca2+ addition) the cell has rounded up (approx. 26% larger) and continues to 
increase in size whilst Ca
2+
 levels remain elevated. At T + 4 m 12 s EPIC3 signal is cytosolic, 
the cell is round and has expanded to a diameter of 13 µm. Scale bar 5 µm. 
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Figure 5.3.1iii: EPIC3 reports elevated Ca
2+
 at the cell edge 
RAW 264.7 cell transfected with EPIC3, shown after treatment with a high Ca
2+
 cocktail 
containing thapsigargin (40 µM), ionomycin (20 µM) and Ca
2+
(65 mM). Top panels: Raw 
data. Bottom panels: Green-fire-blue LUT identifies Ca
2+
 hotspots at the cell edge. Ca
2+
 
concentration at the cell edge was estimated to reach 9.4 ±2.4 µM, 3 mins post stimulation 
with the cocktail. A global rise in cytosolic Ca
2+
 (estimated from 0.4 µM to 6.3 µM) was 
seen in cells expressing EPIC3 (alone), after treatment with the high Ca
2+
 cocktail. Insert: 30 
s snapshot of Ca
2+
 concentration at the cell edge rising more rapidly and reaching 3 µM 
higher than in the cytosol. Scale bar 5 µm.  
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Secondary to Ca2+ influx, cells were observed to undergo morphological 
rearrangements, involving an increase in cell area. The cell footprint was defined 
as the number of non-zero pixels in frame. Cells typically began to round-up 
within 10-15 s after the observed Ca2+ influx (approx. 30 s post extracellular Ca2+ 
elevation), and some cells began to bleb (fig. 5.3.1ii). In spreading cells, the 
EPIC3 signal was lost from the cell edge concurrent with cell expansion, the 
EPIC3 signal becoming dispersed in the global cytosol. A similar response was 
previously described in RAW 264.7 cells expressing ezrin-mEmerald, post Ca2+ 
influx (Chapter 3), and so probably represented loss of EPIC3 binding at the cell 
edge, rather than lowering of Ca2+ concentration. Therefore, these estimates of 
Ca2+ concentration from EPIC3 may be lower than the true value. Rounding-up 
and a detectable increase in cell footprint was observed in 13/15 cells expressing 
EPIC3, which responded to artificial elevation of cytosolic Ca2+ concentration. 
This response is indicative of µ-calpain activation, and cleavage of the ezrin 
cross-links. 
 
The global Ca2+ response in RAW 264.7 cells expressing EPIC3 typically reported 
an increase in Ca2+ over the first 90 s, followed by a secondary rise in Ca2+ which 
was less steep, and continued to increase gradually over the next 90 s (fig. 
5.3.1iii). However, it was often difficult to obtain accurate measurements of 
EPIC3 intensity at the cell edge, as the cellular response to Ca2+ influx resulted in 
morphological changes. However, in at least 4 cells, it was possible to take 
accurate measurements at defined cellular regions over 20-30 s intervals. These 
revealed diverging Ca2+ responses at the cell edge, compared to the cell cytosol, 
post treatment with the stimulating cocktail (fig. 5.3.1iii). EPIC3 reported rising 
Ca2+ concentration at the cell edge, when cytosolic signal was decreasing, and 
the global Ca2+ response appeared to plateau (fig. 5.3.1iii). The maximum Ca2+ 
concentration measured at the cell edge ranged from 5.4 – 34.4 µM between 
individual cells. In the example shown in figure 5.3.2iii the global Ca2+ 
concentration was estimated to reach 6.3 µM, and the concentration at the cell 
edge was estimated to reach 9.4 ±2.4 µM. Although, these values are again not 
in the range capable of activating µ-calpain, they should as previously stated, be 
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considered minimum estimates, which are artefactually decreased by the re-
distribution of ezrin into the bulk cytosol. 
 
The Ca2+ traces recorded in these experiments were shallower than typical 
intracellular Ca2+ measurements, which can be achieved using probes with a 
physiological range, because the Kd of EPIC3 is 11 µM Ca2+. The Ca2+ estimates 
recorded at the cell edge in these experiments were significantly higher than in 
the cell cytosol, but lower than expected for the full activation of µ-calpain (Kd 
20-60 µM). However, the morphological changes in the cell, and the loss of ezrin 
at the cell edge both suggested that µ-calpain activation had occurred. Taken 
together this suggested that the present methodology of measuring the EPIC3 
signal was not sufficient to capture the full Ca2+ activity at the cell edge. It was 
obviously important to take into account any changes in fluorescence which 
were due to fluctuations in EPIC3 distribution, rather than changes in Ca2+. 
5.3.2 Dual expression ratio imaging of EPIC3 and ezrin-mCherry 
In order to provide a non Ca2+-sensing control probe with excitation and 
emission properties which allowed it to be used in conjugation with the Ca2+-
sensing probes, ezrin conjugated to an mCherry fluorophore, at the C-terminal 
end, was used. RAW 264.7 cells were transfected with both EPIC3 and ezrin-
mCherry (fig. 5.3.2i). A ratio of the two fluorescence intensities was taken, so 
that EPIC3 fluorescence could be normalised to exclude changes due to ezrin  
movement, and LUTs were applied to visualise the gradient of cytosolic Ca2+ 
concentration at the cell edge (fig. 5.3.2ii).  
 
ALL RAW 264.7 cells co-transfected with EPIC3 and ezrin-mCherry had a 
detectable ezrin-mCherry signal at the cell edge, but only 50% of cells had a 
detectable peripheral EPIC3 signal. This lack of correlation between the 
subcellular distributions of intensities of the non-Ca2+-sensing ezrin, and the  
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Figure 5.3.2i: EPIC3 and ezrin-mCherry co-transfected RAW 264.7 cells 
In unstimulated cells the ezrin-mCherry reports ezrin location at the cell edge, where 
there is no detectable EPIC3 signal. Representative of 8 cells. Scale bar 5 µm. 
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Figure 5.3.2ii: EPIC3 and ezrin-mCherry co-transfected RAW 264.7 cells report 
differential Ca
2+
 concentration at the cell edge and cytosol 
Both the raw EPIC3 signal and the ratio of the two probes reported a global rise in 
Ca
2+
 concentration following addition of the high Ca
2+ 
cocktail, added at the blue 
arrow (*). Insert: 20 s snapshot of rising Ca
2+
 concentration at the cell edge, 
concurrent with falling Ca
2+
 concentration in the cytosol (estimated difference of 5.95 
µM). Scale bars both 5 µm. 
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Ca2+-sensing ezrin, provided good evidence that (i) EPIC3 intensity was not 
simply reporting ezrin location, but also included information about local Ca2+ 
concentrations, and (ii) some cells had low level sub-plasma membrane Ca2+, 
while in other cells the elevation of sub-plasma membrane Ca2+ was apparent, 
and upon Ca2+ influx. 
 
Co-transfected cells mostly behaved in a similar way to singly-transfected cells. 
In 88% of cells, artificially induced Ca2+ influx resulted in an increase in EPIC3 
intensity. 71% of cells responded to the Ca2+ influx by changing morphology. 
However, no cells were seen to bloat, bleb or spread, as with the singly-
transfected cells (fig. 5.3.2iii). It is possible that the introduction of multiple ezrin 
constructs may have reduced the ability of the cell to change morphology in 
response to Ca2+, by complementing endogenous ezrin. The extra F-actin-plasma 
membrane cross-links provided by the additional ezrin would also have to be 
cleaved in addition to the endogenous proteins. 
 
By taking a ratio of the EPIC3 and ezrin-mCherry signals, it became apparent that 
rises in EPIC3 fluorescence intensity were masked by ezrin redistribution, and 
the true signal was typically higher (fig. 5.3.2ii). Furthermore, it was again 
possible to obtain data from the cell edge. In 4/6 cells the ratio of the 
EPIC3/ezrin-mCherry signal at the cell edge diverged from the cytosolic signal, 
and reported higher peripheral Ca2+ concentrations, of up to 30.4 ±7.6 µM, when 
the overall cell ratio appeared to plateau and then decrease (fig. 5.3.2ii). The 
total ezrin-mCherry signal decreased over time in all cells, which may have been 
a result of extended laser exposure and fluorophore bleaching. 
 
By taking ratios (EPIC3/ezrin-mCherry) of all images within a time series, it was 
possible to visualise regions of high EPIC3 signal in the tips of cell protrusions, 
microridges and pseudopodia (fig. 5.3.2iv). The Ca2+ concentration in these 
microdomains after artificial stimulation of Ca2+ influx was estimated to reach up 
to 61 µM (fig. 5.3.2ivb), which would be capable of activating µ-calpain (Kd 20-60 
µM).  
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Figure 5.3.2iv: Ratio of EPIC3 and ezrin-mCherry signals 
RAW 264.7 cell co-transfected with EPIC3 and ezrin-mCherry, treated with a high Ca
2+
 
cocktail containing thapsigargin and ionomycin. (a) A ratio of the EPIC3 and ezrin-
mCherry signals was taken using ImageJ, and the LUT JET was applied. Scale bar 5 µm. 
(b) Ca
2+
 hotspots (yellow-red) can be seen at the tips of microridge, estimated to reach 
61 µM. Scale bar 1 µm 
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Figure 5.3.2iv: Ratio of EPIC and ezrin-mCherry 
signals  
* Data points begin 64 s post elevation of 
extracellular Ca
2+
. ImageJ was used to generate a 
dynamic mask based on the ezrin-mCherry signal, 
which was applied (c) the raw EPIC3 signal, and (e) 
to the ratio of the EPIC3 and ezrin-mCherry data. 
(d) The average Ca
2+
 concentration from the 
masked region was estimated to reach 23 µM, 2 
mins 20 s after addition of extracellular Ca
2+
. Insert: 
regions of high Ca
2+
 concentration, estimated to 
reach 73 µM, can be seen at the peaks of 
microridges. Scale bars 5 µm, and insert 1 µm.  
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However, while the ezrin-mCherry probe is useful and important in accounting 
for any signal fluctuation caused by ezrin re-distribution, it also produces two 
artefacts. Firstly, the total ezrin-mCherry signal decreased over time in all cells, 
which may have been a result of extended laser exposure and fluorophore 
bleaching. Without any changes in the EPIC3 signal intensity, the ratio would  
therefore increase. This problem was negated by only taking reliable data from 
short time periods of laser exposure, typically 0-50s. Secondly, the ratio 
calculated when the cytosolic ezrin-mCherry signal is very low (i.e. before 
cleavage, when the majority of active ezrin is located at the cell edge), can be 
over-estimated. This is evident in the cytosol of the cell shown in figures 5.3.2ii 
& 5.3.2iva. To overcome this, and also the problem of measuring fluorescence 
intensity at the edge of a moving cell across an image stack of up to one 
thousand frames, a dynamic mask was generated. ImageJ was used to record 
fluctuating fluorescence intensity within a region of the cell edge defined by a 
dynamic mask, based on the ezrin-mCherry signal (fig. 5.3.2ivc). When the mask 
was applied to the whole cell ratio data (EPIC3/ezrin-mCherry), only the signal 
coming from the regions of highest ezrin intensity was recorded (fig. 5.3.2ivd,e). 
In this way, the ezrin-mCherry was used to define a threshold ezrin intensity, 
through which to measure changes in Ca2+ concentration, in ezrin-rich sub-
membrane cytosolic microdomains. 
 
In cells artificially stimulated to elevate cytosolic Ca2+ concentration, the ratio of 
EPIC3 and ezrin-mCherry reported a higher average Ca2+ concentration in the 
peripheral cytosol, at the cell edge, increasing up to 23 µM over 60 s post 
stimulation (fig. 5.3.2iv), which is in the µ-calpain-activating range. Whereas data 
from the whole cell ratio, without application of the high intensity ezrin mask as 
a threshold, reported a maximum Ca2+ concentration of 1 µM, which is 
consistent with previous cytosolic measurements (Demaurex et al., 1992). The 
data from the cell edge and the global Ca2+ signals were significantly different at 
all time points (Two-tailed, paired, T-test; p < 0.0001).  
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Further application of the dynamic mask in an inverse manner – so that only 
cytosolic signal was being measured – made it possible to compare changes in 
both the bulk and peripheral cytosol, with the same probe (fig. 5.3.2va,b). From 
such measurements, the average Ca2+ concentration in the bulk cytosol was 
found to rise steadily after the Ca2+ injection, up to an estimated 8 µM (fig. 
5.3.2vc) before slowing, and then gradually decreasing. The signal at the cell 
edge also rose steadily, and up to a maximum 26 µM, before decreasing rapidly. 
The point at which both signals stopped rising is perhaps linked to the threshold 
Ca2+ concentration required for µ-calpain activation and ezrin cleavage. Since 
both EPIC3 and the control ezrin-mCherry are susceptible to calpain cleavage, 
both will also be lost from the cell edge upon µ-calpain activation (as discussed 
in Chapter 3). Therefore, EPIC3 reports not only the Ca2+ concentration achieved 
in cytosolic microdomains during Ca2+ influx, and bulk cytosol, but also the Ca2+ 
concentration at which µ-calpain-activated cleavage of ezrin occurs.  
 
It was decided that using the dynamic mask was a suitable way to measure 
EPIC3 fluorescence at the cell edge in moving cells, and cells undergoing 
morphological changes. The Ca2+ estimations generated using the ‘ratio + mask’ 
method suggested that peripheral cytosolic Ca2+ reached mid-decade 
micromolar concentrations, capable of activating µ-calpain. 
5.3.3 Ca2+ responses during phagocytosis 
It was previously observed that doubly-transfected cells were less able to 
undertake dramatic shape changes, following Ca2+ influx. The morphological 
response of the transfected RAW 264.7 cell line may have been compromised by 
the introduction of extra ezrin constructs. The activity of µ-calpain and elevated 
Ca2+ concentration were instead investigated in localised membrane expansion 
events, such as phagocytosis. This approach also provided a more physiological 
method to stimulate Ca2+ influx. Zymosan particles were C3bi-opsonised by 
incubation with mouse serum, and introduced to glass-bottomed petri dishes   
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Figure 5.3.2v: Elevated Ca
2+
 leads to ezrin release 
(c) Estimated Ca
2+
 concentration at the cell edge (orange), and in the cytosol (blue). The 
point of ezrin release is suggested at 2 mins 18 s (dashed line), when Ca
2+
 concentration 
at the cell edge is estimated to be 23 µM. 
176 
 
 
containing the transfected RAW 264.7 cells. Phagocytosis events were captured 
on the Leica SP5, at 63x magnification. 
 
As before, cells were initially assessed for their phagocytic activity when 
expressing EPIC3 alone. Transfection with the EPIC3 probe did not inhibit 
phagocytosis, and areas of high EPIC3 intensity were identified at the forming 
phagocytic cup (fig. 5.3.3i). The Ca2+ concentration in these regions near the site 
of active phagocytosis, were estimated to reach between 29.3 ±16.9 µM – 
capable of activating µ-calpain to cleave ezrin, and so facilitate localised 
expansions of the plasma membrane (fig. 5.3.3i and ii). 
 
RAW 264.7 cells co-expressing both EPIC3 and ezrin-mCherry were then 
assessed. A ratio of the two signals was taken and a dynamic mask based on the 
ezrin-mCherry signal was applied, as previously described. Similarly to the co-
transfected cells which were artificially stimulated to elevate cytosolic Ca2+ 
levels, a non-typical morphological behaviour was again observed. Of the 106 
cells co-expressing EPIC3 and ezrin-mCherry, which were considered capable of 
performing phagocytosis (i.e. touching or <2 µm away from a zymosan particle), 
only 22% of cells successfully completed phagocytosis (fig. 5.3.3iii). In addition, a 
further 29% of the cells ‘attempted’ phagocytosis, by the extension of 
pseudopodia towards, and/or encircling of proximal zymosan, and the formation 
but then retraction of phagocytic cups. It is likely that similarly to disrupting 
whole cell spreading, the transfection with multiple ezrin constructs interfered 
with typical morphological outcomes. 
 
Out of the 23 cells which had internalised zymosan within their cytosols, 
occasions of only 6 dynamic phagocytosis events were captured in motion. The 
‘ratio + mask’ technique was applied to Avi. files, and Ca2+ concentration was 
estimated to reach up to 55 µM in distinct regions of peripheral cytosol, at sites 
of phagocytic cup formation (fig. 5.3.3iv). This is in keeping with the hypothesis 
that Ca2+ is locally elevated to activate µ-calpain and release the ezrin bridges at  
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Figure 5.3.3i: Ca
2+
 hotspots at phagocytic cup 
RAW 264.7, cell expressing EPIC3, performing phagocytosis of an opsonised zymosan 
particle. Areas of high Ca
2+ 
estimated to reach up to 74 µM at the phagocytic cup. Scale 
bar 5 µm.  
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Figure 5.3.3iii: Phagocytosis by co-transfected RAW 264.7 cells 
Of the cells co-expressing EPIC3 and ezrin-mCherry, 106 were considered capable of 
performing phagocytosis i.e. touching or in close proximity (<2 µm from an opsonised 
zymosan). Of these 31 cells attempted phagocytosis, but were unsuccessful. Only 23 cells 
had evidence of zymosan in the cytosol. 
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Figure 5.3.3iv: Ca
2+
 hotspots at phagocytic cup 
RAW 264.7, cell co-expressing EPIC3 and ezrin-mCherry, performing phagocytosis of an 
opsonised zymosan particle. (a) Image processed (EPIC3/ezrin-mCherry ratio, with 
applied dynamic mask) and Green Fire Blue LUT applied. High Ca
2+ 
hotspots at the 
phagocytic cup estimated to reach up to 55 µM. Scale bar 5 µm. Insert: EPIC3 signal 
increase at the phagocytic cup. Ezrin-mCherry remains constant. (b) Estimated Ca
2+ 
concentration at the phagocytic cup rises to 36 µM. 
181 
 
the phagocytic cup, to enable localised membrane expansion and facilitate 
phagocytosis. 
 
RAW 264.7 cells co-expressing EPIC3 and ezrin-mCherry were also assessed for 
other localised shape change events, such as the extension of pseudopodia and 
local membrane expansion at the leading edge of moving cells (fig. 5.3.3v). Cells 
attempting to perform phagocytosis of proximal zymosan particles produced 
pseudopodia extensions, and often had a defined leading edge. In these regions 
of active morphology change, the Ca2+ concentration in ezrin-rich domains (i.e. 
in plasma membrane microridges) was estimated to reach 94 ±54.3 µM, in the 
range sufficient to fully activate µ-calpain. 
5.4 Discussion 
The work in this chapter represents the first ever measurements of sub-
membranous cytosolic Ca2+ concentrations, within microridge structures at the 
plasma membrane of live myeloid cells. These estimations were achieved by 
transfecting RAW 264.7 cells with the novel probe EPIC3, with a Ca2+ binding Kd 
of 11 µM. RAW 264.7 cells were used to model the effect of elevating cytosolic 
Ca2+ in myeloid cells on the subsequent morphological changes, akin to those 
experienced by neutrophils during cell spreading and extravasation. 
 
In RAW 264.7 cells both artificially stimulated to produce a Ca2+ influx, and those 
performing phagocytosis of C3bi-opsonised zymosan, EPIC3 reported elevated 
Ca2+ concentrations at the cell edge in the mid-decade micromolar range, 
capable of activating µ-calpain (Kd 20-60 µM). However, whilst the ezrin-like 
properties of EPIC3 make it a useful and suitable tool to measure the Ca2+ 
concentrations achieved in ezrin-rich areas of sub-membranous cytosol, they 
also make it vulnerable to other properties of ezrin; namely cleavage by µ-
calapin, and re-distribution in the cytosol. Therefore, using EPIC3 alone typically 
reported lower estimates of Ca2+ at the cell edge, where the reduced signal was 
probably a result of ezrin re-distribution, rather than falling Ca2+ concentration.   
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To overcome this problem, the ezrin-mCherry probe was introduced into cells at 
the same time as the EPIC3 probe. This provided a non Ca2+-sensing control, to 
account for cellular re-distribution of ezrin during the Ca2+ signal – an expected 
and physiological response. Taking a ratio of these two probes revealed that 
elevation of Ca2+ concentration was sustained at the cell edge during stimulated 
Ca2+ influx, and was estimated to reach the mid-decade micromolar range, 
capable of activating µ-calpain.  
 
Since the nature of the Ca2+ influx in myeloid cells is to evoke a change in cell 
morphology, measuring distinct regions of interest in moving cells was a 
problem. This was overcome by employing advanced imaging techniques, and 
generating bespoke dynamic masks (in ImageJ) for individual cells. In this way, 
the EPIC3 response to Ca2+ was only reported in ezrin-rich areas, at the cell edge. 
This technique also corrected for the artefact produced by taking a ratio of the 
whole cell, which included the pool of dormant cytosolic ezrin. By recording only 
the ratio of EPIC3/ezrin-mCherry, through the ezrin-mCherry rich defined 
dynamic mask (referred to as the ‘ratio + mask’ method), the Ca2+ concentration 
at the cell edge was found to readily exceed that of the global cytosol, and reach 
upwards of 50 µM. 
 
It is worth noting that some cells expressing EPIC3 (13/15) some cells expressing 
both EPIC3 and ezrin-mCherry (5/7) had reduced ability to perform 
morphological rearrangements. This may be because the introduction of 
additional ezrin into the cell also strengthened the ezrin cross-linking activity. 
This meant that the morphological changes such as cell bloating, spreading and 
phagocytosis, were not always evident, even when cytosolic Ca2+ concentrations 
at the cell edge were estimated to be capable of activating µ-calpain. Another 
limitation in these experiments, was the relative transfection efficiency of both 
EPIC3 and ezrin-mCherry (fig. 5.4). The percentage of co-transfected cells among 
the populations was typically around 10-20 %, often favouring ezrin-mCherry 
expression over EPIC3.  
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Figure 5.4: Co-transfection efficiency 
The percentage of co-transfected cells among the populations was typically around 
10%. Scale bar 10 µm. 
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The Ca2+ concentrations reported here are estimations, based on the Ca2+ 
binding affinity of EPIC3, and the ratio of two fluorescently-tagged ezrin probes, 
to account for ezrin redistribution. However, the findings are in line with 
previous estimations by Brasen and colleagues, based on computer models of 
cells with defined microridge structures (Brasen et al., 2010). Since ezrin is an 
important cross-linking protein, and important in the architecture and regulation 
of plasma membrane microridge structures, measuring the Ca2+ concentration in 
ezrin-rich regions of the cell gives important insight into the mechanism of 
membrane expansion and the µ-calpain-ezrin axis.
186 
6. Chapter 6- Molecular and cellular effects of ezrin 
phosphorylation inhibition 
  
 
Chapter 6:  
Molecular and cellular 
effects of ezrin 
phosphorylation 
inhibition 
 
187 
 
6.1 Introduction 
In neutrophils and other myeloid cells, ezrin forms crucial cross-links between 
the plasma membrane and cortical F-actin (Algrain et al., 1993; Bretscher, 1983; 
Gould et al., 1989). It is thought to play an important role in maintaining the 
structure of cell surface microridges, which act as a reservoir of stored plasma 
membrane for release upon cell spreading. A key step in regulating its activity is 
the phosphorylation of ezrin at Thr567 (Gautreau et al., 2000). Recently, a small 
molecule inhibitor of ezrin phosphorylation, NSC668394 (10 µM), has been 
shown to inhibit this step (Bulut et al., 2012; Prentice-Mott et al., 2016). As 
explored in previous chapters, there is also evidence that another key regulatory 
step in breaking the ezrin cross-link in neutrophils, is its cleavage by the neutral 
Ca2+-activated cysteine-protease, µ-calpain. Since ezrin is a known substrate of 
Ca2+-activated µ-calpain (Shcherbina et al., 1999), it is suggested that µ-calpain 
activation upon Ca2+ influx, as a consequence of cell stimulation, severs the ezrin 
tether between the actin cytoskeleton and the plasma membrane; releasing the 
stored membrane and enabling cell spreading (Dewitt et al., 2013). 
 
In epithelial cells, NSC668394 has recently been shown to reduce membrane 
tension (Bruckner et al., 2015), maintained by the ezrin-regulated strength of 
cell surface wrinkles (Bruckner et al., 2015). These two factors offer the 
possibility that NSC668394 may interfere with morphological changes in 
neutrophils, and this activity may be beneficial in an anti-inflammatory agent. 
Furthermore, using NSC668394 to manipulate the phosphorylation status of 
ezrin in neutrophils and myeloid cells enables experimental investigations of the 
interplay between the Ca2+-mediated regulation of ezrin cleavage and ezrin 
phosphorylation. 
 
In many cell types, ezrin exists as a pool of dormant protein in the cytosol, but as 
active protein where it functions at the cell cortex. It was hypothesised that 
preventing ezrin activation, and therefore inhibiting its function as a cross-link at 
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the cell cortex, may have a consequential effect on the ability of the cell to 
maintain, or indeed change, its morphology. To test this hypothesis, the inhibitor 
of ezrin phosphorylation NSC668394 was used in neutrophils for the first time, 
as an experimental tool to probe the µ-calpain-ezrin axis, and investigate the 
interplay between these two steps in regulating neutrophil shape change. 
6.1.1 Conformational states of ezrin 
Ezrin exists in two conformational states (Bretscher et al., 1997); an un-
phosphorylated closed, inactive conformation where the N-terminal ERM 
domain self-associates with the C-terminal actin binding domain (ABD), and an 
open, active conformation where phosphorylation at Thr567 facilitates ezrin 
self-dissociation and enables F-actin binding (Viswanatha et al., 2013).  
 
Ezrin cross-linking of the cortical actin network to the plasma membrane is 
achieved through binding of the N terminal FERM domain (N-ERMAD) to the 
plasma membrane, and the C-terminal (C-ERMAD) binding to polymerized actin 
at the cell cortex (Gould et al. 1989; Shuster and Herman, 1995). The two 
domains are connected by a µ-calpain sensitive linker region. This cross-linking 
ability is thus lost by Ca2+-activation of µ-calpain and cleavage of ezrin at the cell 
periphery (Shuster and Herman, 1995; Yao et al., 1993). Ezrin, but not the 
structurally similar ERM family protein moesin, is susceptible to cleavage by µ-
calpain (Shcherbina et al., 1999), and as such ezrin is implicated as a key protein 
in the reorganisation of the neutrophil cell membrane. 
 
Phosphorylation of ezrin at Thr567 disrupts the self-association of the N-ERMAD 
and C-ERMAD ends of the inert molecule to allow it to participate in cortical 
binding (Bretscher et al. 1997; Shuster and Herman, 1995). This latter event can 
be disrupted by the inhibition of ezrin phosphorylation at Thr567.  
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6.1.2 The ezrin inhibitor NSC668394 
NSC668394 is a reversible inhibitor of PKCI-mediated phosphorylation of Thr567 
on ezrin, inhibiting ezrin-F-actin binding. It is a cell permeable quinoline 
derivative, with a Kd of 12.6 µM. The compound has a red-orange colour in 
DMSO, and when prepared in this way is capable of freely diffusing across the 
phospholipid bilayer of cell membranes. Bulut and colleagues have shown that 
NSC668394 reduces motility and metastasis in osteosarcoma cells with high 
ezrin expression (Bulut et al., 2012). NSC668394 activity prevents endogenous 
ezrin binding to actin without altering cellular levels of actin (Bulut et al., 2012).  
6.1.3 Aims of this chapter 
1. To use molecular biology techniques to analyse the subcellular 
localisation of ezrin in neutrophils and RAW 264.7 cells that have been 
incubated with the ezrin inhibitor of phosphorylation, NSC668394. 
2. To investigate the effect of the ezrin inhibitor NSC668394 on the 
behaviour of live neutrophils, when stimulated to undergo phagocytosis 
and chemotaxis. 
6.2 Specific Materials and Methods 
6.2.1 Immunocytochemistry 
Human neutrophils were isolated from healthy donor blood, as previously 
described in Chapter 2. Fixed and permeabilised neutrophils were stained with 
mouse anti-ezrin primary antibody (Santa Cruz (3C12)) and goat anti-mouse FITC 
conjugated secondary antibody (Santa Cruz IgG1-FITC). Cell staining was 
analysed using the Leica SP5 confocal microscope with 488 nm argon laser. 
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6.2.2 Plasmid amplification 
The ezrin-mEmerald (mEmerald-Ezrin-N-14, #54090) high copy number plasmid 
was a gift from Michael Davidson (Addgene). Plasmid DNA was amplified as 
described in Chapter 2. Kanamycin was added to both the agar plates and the LB 
culture medium to select for transformed E. coli, because the vector backbone 
of ezrin-mEmerald contains the gene for selective Kanamycin resistance. 1 L of 
LB culture was inoculated as a compromise between the high copy number of 
the plasmids and the volume of culture which could be suitably processed by 
maxi prep. The plasmids were purified by maxi prep, as described in Chapter 2. 
6.2.3 RAW 264.7 cell transfection 
RAW 264.7 cells (2x106), were harvested by scraping and were then 
electroporated to introduce ezrin-mEmerald plasmid DNA (2-4 µg/100 µL) using 
the Cell Line Nucleofector™ Device (Lonza) as previously described (Chapter 2). 
Cells were incubated at 37°C in 5% CO2 for 3-4 hours before imaging on the Leica 
SP5 confocal microscope. 
6.2.4 Pre-treatment with NSC6683934 inhibitor of ezrin 
phosphorylation 
A 10 mM stock of NSC668394 was made by dissolving in DMSO. Neutrophils and 
RAW 264.7 cells were pre-treated with 10 µM NSC668394 (1 µL in 1 mL cell 
suspension), or an equal volume of DMSO (i.e. 1 µL), for 10 mins at 37°. 
6.2.5 Confocal microscopy  
Transfected RAW 264.7 cells were imaged on the Leica SP5 confocal inverted 
microscope (Leica Microsystems, Heidelberg) with resonance scanner and 
perfusion chamber at 37°C. The 488 nm argon laser was used. 
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6.2.6 Protein extraction and preparation of cell lysates and Western 
blotting 
Isolated human neutrophils (Chapter 2) were spun down and re-suspended in 
neutrophil lysis buffer (50 mM HEPES, 150 mM NaCl, 10% Glycerol, 1% Triton 
X100, 5 mM EDTA, 5 mM EGTA, 1 mM Na3VO4, 1.5 mM NaF, 0.1% SDS, 1.5 mM 
MgCl2) and PIC was added at 1:1000. Samples were incubated on ice for 1 hour 
and vortexed every 15 minutes to increase the efficacy of cell lysis, before being 
boiled for 10 minutes and then centrifuged for 5 minutes at 14,000 rpm. Band 
densitometry analysis was performed using ImageJ (Analyse>Gels), migration 
distances were calculated using ImageJ and the molecular weights were 
calculated using the formulas:  
Rf = distance migrated (pixels)/gel length (pixels) 
MW = e (gradient of line x Rf) + y intercept 
6.2.7 Neutrophil Phagocytosis 
Isolated human neutrophils (Chapter 2) were loaded with Fluo4 (1µM in 1x106 
cells/mL) for 30 mins at room temperature. 100 µL of isolated neutrophils, in 
Krebs-BSA, were pipetted onto glass slides and placed on the Leica SP5 confocal 
stage in a perfusion chamber at 37°C. The cells were left to adhere for 2 mins, 
then the medium was aspirated and replaced with fresh Krebs-BSA, to leave only 
adherent neutrophils. 
 
Zymosan were opsonised by incubation with excess NHS (prepared as described 
in Chapter 2), at 37°C for 30 mins. The zymosan were then spun down and re-
suspended in 1 mL Krebs-BSA. 100 µL zymosan suspension was added to the 
neutrophils on the cover slide and allowed to ‘rain down’ onto the cells. Cells 
within proximity of the opsonised zymosan (i.e. <5 µm) were imaged on the 
Leica SP5 confocal inverted microscope, using the 488 nm laser to record 
changes in Ca2+ concentration. 
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6.2.8 Preparation of zymosan filled collagen beads  
Glass micropipettes were pulled from 10 cm borosilicate glass capillaries, with 
an outer diameter of 1 mm and an inner lumen diameter of 0.5 mm, using the P-
2000 laser micropipette puller, pre-set programme 11 (Sutter Instrument, 
California, US) and loaded with 15 µL of zymosan in BSS (1: 10 dilution). The 
micropipettes were manoeuvred using the InjectMan (Eppendorf, Hamburg, 
Germany) and suitable collagen beads (2BScientific) were injected using the 
Eppendorf® InjectMan®, with a counter pressure of >120ppi. 
6.2.9 Neutrophil chemotaxis experiments 
100 µL isolated neutrophils (Chapter 2) at 3x106 cell/mL in Krebs-BSA were 
loaded with CellTraceTM Calcein Green, AM (Life Technologies) and 10 µM ezrin 
inhibitor NSC668394, or equal volume of a DMSO control, and pipetted onto 
glass slides with 8 µL of NHS (diluted 1:20 in BSS) and 60 µL of pre-prepared 
zymosan injected collagen beads. A cover slip was applied with some pressure, 
to immobilise the collagen beads on the slide, and maintain a fixed point of C5a 
stimulus. The ‘chamber’ was sealed by applying grease around the seal between 
the cover slip and the glass slide, to hold the cover slip in place and prevent 
evaporation during the experiment. Chemotaxis was monitored using the Leica 
SP5 confocal inverted microscope (Leica Microsystems, Heidelberg) with 
resonance scanner, laser scanning [10x objective; 488 nm argon laser; 64 frame 
average; 1 frame/4 seconds; 90 mins] in a perfusion chamber at 37°C. 
6.2.10 Imagestream 
Human neutrophils from healthy donors were isolated from whole blood 
(Chapter 2), and immunocytochemistry was performed as previously described 
(Chapter 2) using the anti-ezrin Cy5-conjugated antibody (1:100) (Bioss 
Antibodies) and the anti-CD18 FITC-conjugated antibody (1:100) (BD Biosciences 
Pharmingen). Cells were loaded onto the AMNIS® ImageStream®X Mark II 
Imaging Flow Cytometer (Merck), at approximately 5x106 cells/mL. Cells were 
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imaged using Channels 1, 2, 6 and 11 (bright field, 480-560 nm, 745-800 nm 
(side scatter) and 642-745 nm wavelengths respectively). Data were acquired at 
60x magnification, and laser intensities were adjusted relative to individually 
stained controls for compensation. The data were analysed using the IDEAS® 
software. 
6.3 Results 
6.3.1 Effect of NSC668394 on ezrin distribution at the plasma 
membrane in neutrophils 
As previously discussed in Chapter 3, fluorescent ezrin constructs have been 
expressed in the model myeloid cell line (RAW 264.7) in order to visualise the 
subcellular location of ezrin. Cells were transfected by nucleofection with the 
Cell Line Nucleofector™ Device (Lonza), as before, and imaged on the Leica SP5 
confocal microscope. From the results in Chapter 3, we know that C-terminally-
tagged fluorescent ezrin displays typical ezrin localising properties. To see if the 
ezrin inhibitor of phosphorylation, NSC668394, has any effect on ezrin 
distribution in the cell, RAW264.7 cells were incubated with the inhibitor (10 
µM) before being transfected with ezrin-mEmerald. This meant that all ezrin-
mEmerald was expressed under the influence of the phosphorylation inhibitor.  
 
There was no effect of NSC668394 on the peripheral location of expressed ezrin-
mEmerald either after expression, or in RAW 267.4 cells pre-treated with 
NSC668394 before transfection and maintained during the subsequent 3 hours 
(fig. 6.3.1i). As under these latter conditions, phosphorylation of newly 
synthesised ezrin-mEmerald would be suppressed, it was concluded that 
constructs with the fluorophore at the actin-binding C-terminus did not require 
phosphorylation to activate them for peripheral binding. Thus, ezrin constructs 
would not be useful models in which to test the effects of NSC668394.  
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Figure 6.3.1i: Ezrin-mEmerald expression in RAW 264.7 cell treated with NSC668394 
before transfection 
First panel: A single RAW 264.7 cell expressing ezrin-mEmerald (green) at the cell 
edge, pre-treated with NSC668394 (10 µM). The relative fluorescence trace of ezrin-
mEmerald distribution within a defined ROI (yellow shaded box; 4 µm) at the cell edge 
is shown. Fluorescence intensity remains highest at the cell edge, decreasing towards 
the cytosol. Second panel: Pseudo-coloured look-up table (LUT) applied to the same 
cell. Ezrin is primarily located at the cell edge. Scale bar 5 µm. Representative of at 
least 10 cells.  
Cell edge 
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The subcellular location of ezrin was therefore established in human neutrophils 
by immunocytochemistry. Ideally, the distribution of ezrin in large populations 
of neutrophils would be quantified using Imagestream technology. This is a 
relatively new technology, and was used in this project as a means of generating 
larger data sets about ezrin distribution in neutrophils. This entailed fixing and 
staining neutrophils in suspension for quantitation by Imagestream. A Cy5-
conjugated anti-ezrin antibody was used in conjugation with an anti-CD18 FITC-
conjugated antibody as a marker for the cell edge. Analysis of the data from 
20,000 cells in the IDEAS software suite did not indicate a marked loss of 
peripheral ezrin, post incubation with the inhibitor of ezrin phosphorylation, 
NSC668394 (fig. 6.3.1ii). However, inspection of the cells by confocal microscopy 
revealed that ezrin staining with the Cy5 conjugated antibody did not report 
strong peripheral staining (fig. 6.3.1iii). This prevented accurate quantitation of 
peripheral ezrin in the cells. It was concluded that the immunocytochemistry 
protocol for staining ezrin in neutrophils in suspension should be further 
optimised before useful data sets could be generated using this technique. 
Therefore, although the technology offers enormous potential for experimental 
upscaling and high-throughput data acquisition, it was concluded that the 
further optimisation necessary was not suitable for this work.  
 
However, using the immunocytochemistry on loosely adherent cells, the 
peripheral location of ezrin was easily observed (fig. 6.3.1iv). Ezrin was located at 
the cell periphery of 65.7 % ± 8.8 % (SEM) cells (n=41). After neutrophils were 
pre-treated with NSC668394 this was reduced to only 11.7 % ± 5.7 % (n=39) and 
was significantly different from untreated cells (P<0.001) (fig. 6.3.1v).  
 
Using a blind scoring system for peripheral ezrin (0=no peripheral ezrin; 
1=peripheral ezrin at less than 75% of cortex; 2=peripheral ezrin at more than 
75% of cortex), 16.1 ± 4.9 % of the control population scored 0, compared to 
70.3 ± 10.5 % of the NSC668394 pre-treated population (P<0.001). Within the 
control population, significantly more neutrophils ranked the highest score 2,   
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Figure 6.3.1ii: Imagestream analysis of ezrin distribution in neutrophils 
There was no significant difference in the ezrin distribution between (a) DMSO 
control cells and (b) NSC668394 pre-treated cells (10 µM, 10 mins, 37°C). 
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Figure 6.3.1iii: Confocal microscopy inspection of ezrin distribution in neutrophils 
Confocal images of neutrophil populations that were run on the Imagestream. CD18 
staining marks the cell edge. Ezrin staining with the Cy5-conjugated anti-ezrin antibody 
is largely cytosolic and shows less peripheral staining of ezrin in the control sample. 
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Figure 6.3.1iv: Ezrin subcellular location in myeloid cells  
Immunocytochemistry of unstimulated neutrophils pre-treated with (left) DMSO 
control); (right) NSC668394 (10 µM). Scale bar top panels: 1 µm, lower panels: 10 
µm.  
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Figure 6.3.1v: Ezrin subcellular location in myeloid cells  
(a) Mean scores of peripheral ezrin (from lowest score 0, to highest score 2) in 
neutrophils pre-treated with DMSO control, and NSC668394 (10 µM) (n=41 and n=39 
respectively). *** = P<0.0001 (Two-tailed unpaired t-test). (b) Percentage of 
neutrophils in either DMSO control or NSC668394 (10 µM) pre-treated populations 
ranked with scores 0, 1 or 2. *** = P<0.0001 (Two-way ANOVA with Bonferroni post-
test).  
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than the lowest score 0 (P<0.001). In the NSC668394 treated population 
significantly more neutrophils ranked the lowest score 0, than highest score 2  
 (P<0.001). The control cells had a mean score of 1.5 ± 0.13 whereas NSC66394 
pre-treated neutrophils had a mean score of only 0.4 ± 0.14, which was 
significantly different (P<0.0001). Inadvertent activation of some neutrophils in 
the untreated population may account for cells which had no peripheral ezrin, as 
neutrophils lacking cytochemically detectable peripheral ezrin often had larger 
diameters (fig. 6.3.1iv). Thus, these cells may represent a subpopulation of 
activated and spreading cells. However, the effect of NSC668394 in further 
reducing the percentage of neutrophils with peripheral ezrin suggested that in 
human neutrophils, phosphorylation of ezrin was responsible for maintaining its 
location at the cell periphery.  
6.3.2 Effect of NSC668394 on ezrin cleavage 
Having shown that, in neutrophils, an NSC668394-sensitive step was important 
for locating ezrin at the cell periphery, the molecular consequences on ezrin in 
NSC668394 pre-treated neutrophils were investigated.  
 
It was not possible to directly monitor ezrin phosphorylation at Thr567 because 
antibodies specific for this site also detected the identical site around Thr558 of 
moesin, a related and more abundant protein in neutrophils. Instead, ezrin was 
detected with a monoclonal antibody for amino acid residues 362-585 of human 
ezrin (abcam [3C12] ab4069). In human neutrophils, full length ezrin runs at a 
molecular size close to the predicted amino acid weight (72 KDa). This is 
different from in other cell types, where ezrin was called p81 because it runs 
near to 81kDa (fig. 6.3.2i). In these experiments in neutrophils, Ca2+-activated µ-
calpain cleavage generated detectable ezrin fragments of approx 55-62 KDa 
(fig6.3.2ii). This suggests that in other cell lines there is significant post-
translation modification which is absent in neutrophils. It is unclear whether this 
difference explains the reliance on phosphorylation for activation or effectivenes 
of the ezrin inhibitor.  
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Figure 6.3.2i: Molecular weights of ezrin  
Various cell types have been found to have different molecular weight ezrin. Human 
neutrophils showed the lowest molecular weight ezrin, at 72 kDa. (Roberts et al., 
2017 – unpublished data). 
(i) HL60 cells 
(ii) RAW 264.7 cells 
(iii) Human neutrophils 
(iv) PZHPV7 cells 
(v) 3T3 cells 
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Unstimulated neutrophils treated with NSC668394 showed no significant 
increase in detectable ezrin (fig. 6.3.2ii). Although in resting neutrophils where 
there is no great demand for ezrin turnover, it is likely that the inhibition of 
phosphorylation in the ezrin pool did not have opportunity to impact the 
phosphorylation status of peripheral ezrin, because of the slow turnover rate. 
We have therefore used the Ca2+-stimulated generation of the ezrin fragment as 
an ‘inverse surrogate’ measure of Thr567 phosphorylation within neutrophils. 
After physiological elevation of cytosolic Ca2+, triggered by the neutrophil 
agonist fMLP, there was no significant increase in ezrin of 62 kDa, however ezrin 
fragments of 50-55 kDa were detectable (fig.6.3.2iii), as expected from 
activation of µ-calpain. These data do not conflict with the effect of NSC668394 
reducing phosphorylation of ezrin within treated neutrophils, and may suggest 
an increased vulnerability to Ca2+-dependent cleavage. 
6.3.3 Effect of NSC668394 on neutrophil phagocytic ability 
Since NSC668394 was found to have an effect on neutrophil ezrin subcellular 
localisation, and on its sensitivity to Ca2+-activated cleavage within neutrophils, 
the impact of these biochemical events on two neutrophil behaviours, 
phagocytosis and chemotaxis, was examined. 
 
Neutrophils treated with NSC668394 were able to undertake phagocytosis of 
C3bi-opsinised zymosan particles (fig. 6.3.3b) with a phagocytic index of 1.972 
±0.588 (n=20), which was not significantly different from in control cells, 2.417 
±1 .003 (n=10) (fig. 6.3.3c). Ca2+ signalling upon zymosan binding was intact after 
treatment with NSC668394 (fig. 6.3.3b,c) with similar characteristics at the 
individual cell level. The times between cell-particle contact, phagocytic cup 
formation and phagosome closure were not different in untreated and drug 
treated cells (fig. 6.3.3d,e). As each phagocytic event takes only ~100s from 
initial contact to internalisation (Campbell and Hallett, 2015), there may be no 
requirement for additional recruitment of ezrin by phosphorylation of cytosolic 
ezrin over this timescale. 
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Figure 6.3.3: Phagocytosis of opsonised zymosan by neutrophils pre-treated with 
NSC668394 
Confocal (left) and phase contrast (right) images of neutrophils loaded with Fluo-4 
performing phagocytosis of opsonised zymosan particles (indicated by arrows), pre-
treated with (a) DMSO control or (b) NSC668394 (10 µM). (c) The phagocytic index of 
neutrophils that were pre-treated with DMSO (n=10) control or NSC668394 (n=20) at 
10, 50 and 100 µM.  
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6.3.4 Effect of ezrin phosphorylation inhibition on neutrophil 
chemotactic ability 
In order to test whether ezrin phosphorylation may be required over longer 
timescales, chemotaxis over several hours was investigated. Previous members 
of our laboratory have identified cavities in some collagen beads (from 
2BScientific), and found that these can be exploited for the purpose of 
generating focal points of stimuli in neutrophil chemotaxis experiments. The 
collagen bead cavities were injected with zymosan particles, so that when serum 
is added, they generate a gradient of C5a chemoattractant around the beads. 3-
4 beads were loaded onto each slide. Prior to the experiment, beads were 
located on the slide using a Bright-field microscope, and their position was 
marked at the edge of the slide with a marker pen. If beads were at sufficient 
distance from each other (i.e. more than 5mm), to not produce conflicting 
gradients of C5a which may have confused the path of the neutrophils, then the 
experiment proceeded. The 10x objective was chosen because it was necessary 
to image the volume of the chamber, and a large field of view was beneficial, in 
order to record neutrophils migrating from some distance towards the stimulus. 
 
Chemotaxis of neutrophils towards the single focal point of C5a generation in 
either the continued presence of NSC668394 (10 µM), or an equal volume of 
DMSO, was assessed in fluorescently labelled neutrophils by quantitation of the 
increase in fluorescence intensity at the target. The NSC668394 treated cells 
initially migrated towards C5a with a similar speed to the untreated cells, but the 
recruitment of further cells declined. After 90 minutes, 34% fewer treated cells 
than untreated cells had accumulated around the bead (fig. 6.3.4a). This was the 
result of cessation of chemotaxis of a significant number of treated neutrophils, 
as can be seen from tracking individual cells. Immediately before the cells 
stopped moving, they acquired an elongated and abnormal shape (fig. 6.3.4b). 
The neutrophils which travelled to the target were not significantly different in 
the speed of chemotaxis or in their overall directional persistence (as defined by 
Petrie and colleagues (2009)) from untreated neutrophils (fig. 6.3.4c). 
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Figure 6.3.4: Chemotaxis of neutrophils pre-treated with NSC668394 
(c) The average speed and persistence of neutrophils pre-treated with either 
the DMSO control or NSC668394 (10 µM) (n=210 and 170 respectively).  
(c) 
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6.4 Discussion 
Because of the important structural role of ezrin in neutrophils, in linking the 
cortical F-actin to the plasma membrane, and its involvement in the 
architectural maintenance and rearrangement of neutrophil microridges (during 
extravasation) (Herant et al., 2005; Herant et al., 2006; Dewitt et al., 2013), the 
pharmacological inhibition of ezrin activation (through phosphorylation at 
Thr567) was investigated. The work reported here has shown that inhibition of 
ezrin phosphorylation by NSC668394 increases the detectable amount of 
cleaved ezrin, but does not totally inhibit either neutrophil phagocytosis, or the 
initial ability of neutrophils to undergo chemotaxis. However, it was clear that 
prolonged chemotaxis by neutrophils was restricted. 
 
The Imagestream technology provides the possibility of high throughput large 
data sets, combined with the imaging capabilities that provide details 
comparable to confocal imaging (fig. 6.4). In this work the technology was 
trialled to see if it was capable of differentiating between different subcellular 
locations of ezrin, predicted by the previous single-cell immunocytochemistry 
investigations. The quality of the captured images was impressive, and sufficient 
to show peripheral ezrin staining in some cells. However, only a minority of cells 
displayed specific staining at the cell edge. Further confocal investigation found 
that among the population of neutrophils only a few cells displayed peripheral 
ezrin staining. Therefore it was concluded that the limiting factor was not the 
Imagestream technology, but the immunocytochemistry step. It was decided 
that further optimisation of the staining protocol was required, but the 
information this would provide did not justify further exploration   
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Figure 6.4: Comparison of Imagestream and confocal imaging 
Neutrophils stained with Cy5-conjugated anti-ezrin antibody. Left: Image 
acquired by Imagestream shows peripheral ezrin staining. Right: Confocal 
image also shows ezrin at the cell edge. Scale bar 10 µm. 
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in this project. However, Imagestream remains an innovative technology for 
achieving larger data sets to support the conclusions drawn from smaller scale 
immunocytochemistry experiments. 
 
The data reported here show that NSC668394 reduced the amount of ezrin at 
the neutrophil periphery. It was not clear that NSC668394 had an effect on the 
sensitivity of unphosphorylated ezrin to cytosolic Ca2+-signalled cleavage. 
Although, stimulation with fMLP did generate detectable ezrin fragments of 50-
62 kDa, suggesting unphosphorylated ezrin was a substrate for cytosolic Ca2+-
signalled cleavage. These events may be related, as both the lack of Thr567 
phosphorylation of ezrin in the cytosol or cleavage of ezrin at the periphery 
would result in a decrease in peripheral ezrin. Cleavage of ezrin between the N- 
and C- termini would therefore destabilise the binding by separating the high 
affinity and low affinity components, and ezrin fragments would be released.  
 
Despite these changes in ezrin handling within neutrophils, phagocytosis and 
short term chemotaxis was able to continue. An explanation for this may be that 
phosphorylation at Thr567 of ezrin is initially required to unfold ezrin for cross-
linking of the cortical actin to the plasma membrane, and for maintaining ezrin 
in a µ-calpain-insensitive state (Bretscher et al., 1997). This would provide a 
mechanism for maintaining a static and stable cell surface morphology in 
microvilli, in cells types such as intestinal epithelial cells (Saotome et al., 2004). 
Moreover, mutation of the ezrin at Thr567 to a phosphomimetic active Thr567D 
or to an unphosphorylatable inactive Thr567A (Ruppelt et al., 2007) has a 
profound effect on sensitivity to µ-calpain cleavage, and demonstrates that 
phosphorylation at this site is strongly protective against cleavage (McRobert et 
al., 2012). In neutrophils, the role of ezrin in regulating rapid cell shape may be 
achieved through a pool of peripheral ezrin which is susceptible to Ca2+-
activated µ-calpain cleavage, and so can release a membrane reservoir rapidly 
on demand in response to localised elevation of Ca2+ (Dewitt et al., 2013). Ezrin 
in this pool may have become un-phosphorylated, but is retained at the cell 
periphery within surface microridges, and so becomes the releasable pool of 
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ezrin which facilitates rapid shape change, due to the acquisition of sensitivity to 
µ-calpain cleavage.   
 
Perhaps the most interesting finding in this study was that neutrophils treated 
with NSC668394 were unable to maintain the normal chemotactic morphology 
required for continued chemotaxis. This effect is similar to that reported 
recently (Prentice-Mott et al., 2016), in which it was found that NSC668394 
reduced ‘directional memory’ of neutrophil-like HL-60 cells from 90% to 60%. In 
our study, it was seen that human neutrophils treated with NSC668394 could not 
maintain the polarised morphology over long periods and this resulted in rounding up 
of the neutrophils. This is the minimum surface area to volume configuration that is 
expected if the cell surface topography is unregulated due to lack of peripheral ezrin to 
maintain cell surface micro-ridges. It was observed that neutrophils that lack peripheral 
ezrin adopt this spherical configuration with a larger diameter. Presumably the 
presence of the inhibitor and the continued demand for replacement of ezrin at the cell 
edge, as a result of either µ-calpain cleavage or the slow depletion of the regulatory 
pool of periphery ezrin, which occurred over this time period, meant that lost ezrin 
could not be replaced by unphosphorylated folded ezrin from the cytosol. This latter 
effect may be beneficial in the treatment of chronic inflammatory disease, by slowing 
the influx of neutrophils into chronic inflammatory sites without inhibition of 
phagocytosis and acute inflammation. 
 
It was therefore concluded from the work reported here, that phosphorylation 
of ezrin plays only a minor role in ezrin-regulation of rapid cell shape change in 
neutrophils. However, when multiple and prolonged cell shape changes are 
required, such as during prolonged chemotaxis, the dependency on the pool of 
unphosphorylated ezrin was evident and inhibition was observed. Although, 
NSC668394 did not abolish neutrophil chemotaxis towards a focal stimulus, the 
number of neutrophils able to continue movement over a long range was 
reduced. This suggested that there was a role of peripheral ezrin turnover for 
maintaining prolonged shape change activity. It has been postulated that 
peripheral ezrin is cleaved by elevated µ-calpain activity (Shuster and Herman, 
1995). If this is prolonged, it may be necessary for the replacement of ezrin from 
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the cytosolic pool which may require activation of ‘inactive’ ezrin, 
phosphorylation. This phenomenon, and its susceptibility to inhibition, may 
prove a useful target for anti-inflammatory therapy. Inhibition of neutrophil 
chemotaxis towards chronically inflamed sites, without compromising their 
ability to undergo phagocytosis, would be a beneficially selective effect on 
neutrophil behaviours. 
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7. General Discussion 
The work presented in this thesis has aimed to shed light on the µ-calpain-ezrin 
axis, in the regulation of myeloid cell morphology changes, and in response to 
elevated cytosolic Ca2+ concentrations. This mechanism is particularly relevant to 
neutrophils at the point of extravasation from the bloodstream, where their 
transition to a flattened and adherent cell morphology requires an apparent 
membrane expansion of approximately 200% (Dewitt and Hallett, 2007).  
 
The accumulation and infiltration of neutrophils in tissues is a somewhat double-
edged sword. On the one hand, the process is entirely necessary, and 
appropriate recruitment of neutrophils at sites of infection protect the body via 
phagocytosis of invasive pathogens, and resolution of inflammation. On the 
other hand, the unregulated recruitment of neutrophils to tissues presenting 
with chronic inflammation only contributes to the propagation of the 
inflammatory state; leading to further tissue damage. Autoimmune diseases, 
such as rheumatoid arthritis, fall into this latter category. Excessive neutrophil 
infiltration into the joints leads to cartilage erosion and propagation of the 
inflammatory state, which causes pain upon movement, architectural 
rearrangement of the joint and ultimately fusion of the joints. This joint 
destruction is irreversible, and current therapies are insufficient at preventing 
the onset of the disease. There is therefore a need for further research in this 
area, in order to design more appropriate and effective treatments. 
 
Despite the obvious hurdle that changing morphology presents to the migrating 
neutrophil, very little is known about the molecular mechanisms governing it. 
With further understanding of this mechanism, and the relationship between µ-
calpain, ezrin and Ca2+ concentration, we would be better placed to inform and 
guide the development of targeted therapies for autoimmune conditions, such 
as rheumatoid arthritis. Such therapies may specifically interfere with the 
mechanism of changing neutrophil morphology, with the aim of reducing 
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extravasation, and therefore also inappropriate accumulation of inflammatory 
cells during chronic inflammation. 
7.1 Overall research strategy 
Primary scientific research with neutrophils poses a number of challenges, not 
least because the cells are terminally differentiated, have a short lifespan and 
easily become activated. All of these factors make conducting experiments to 
investigate intracellular molecular processes challenging. Previous work by this 
lab has found the RAW 264.7 myeloid cell line a suitable compromise between 
amenability of experimental approach, and information output (e.g. limited 
ability to perform phagocytosis). 
7.2 Summary of progress made by this work 
In this thesis, it was shown that elevating cytosolic Ca2+ had a large effect on 
ezrin distribution in RAW 264.7 cells expressing fluorescently-tagged ezrin 
constructs. Since ezrin is a crucial cross-linking protein which maintains the 
structure of plasma membrane microridges, this work points to a key role for 
Ca2+ influx in regulating cell surface topography. Furthermore, these microridges 
are proposed to provide the mechanism for apparent membrane expansion, by 
acting as ‘reservoirs’ of extra membrane; amenable to release when the cell 
requires a change in morphology (Dewitt and Hallett, 2007). Ca2+ influx is 
implicated as the switch that releases this stored excess membrane, and it is 
suggested to act via the Ca2+-mediated activation of the ubiquitous cytosolic 
protease, µ-calpain. Since the in vitro Ca2+ concentrations required to activate µ-
calpain exceed those which can be achieved in the global cytosol (Goll et al., 
2003), there is an obvious need for careful regulation of the both the Ca2+ signal 
and the activated µ-calpain response. 
 
The data presented in this thesis have also provided evidence of ezrin loss from 
the cell edge in myeloid cells, in agreement with ezrin cleavage by µ-calpain 
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upon elevation of cytosolic Ca2+ (fig. 7.2); be it via artificial stimulation of Ca2+ 
influx via SOCE, or via physiological activation through receptor-mediated 
phagocytosis. The precise cleavage site in ezrin is not known, however this thesis 
has investigated potential cleavage sites (using the CaMPDB algorithm) in ezrin, 
which differs from moesin (another structurally similar ERM protein) in its 
sensitivity to µ-calpain cleavage (Shcherbina et al., 1999). In myeloid cells ezrin 
was found to be cleaved by µ-calpain, at least once, in the linker region between 
the two functional domains; the N-ERMAD and C-ERMAD domains respectively. 
Cleavage of ezrin in this region would sever its cross-linking activity between the 
plasma membrane and the cortical F-actin cytoskeleton, thereby releasing the 
constraints which maintain cell surface microridges (fig. 7.2). This provision of 
additional plasma membrane, from ‘reservoirs’ would also transiently reduce 
membrane tension, which is rapidly restored due to remodelling of the sub-
membranous F-actin network (Pietuch and Janshoff, 2013). Thus the provision of 
additional membrane for events requiring a change in cell shape, e.g. 
phagocytosis or extravasation, is in cooperation with interactions between the 
plasma membrane and the actin cytoskeleton; where ezrin provides important 
structural cross-links. Consequently, a decrease in active ezrin at the cell edge 
leads to a reduction in membrane tension, and a loss of cell height (Brückner et 
al., 2015), similar to those observed in a neutrophil undergoing a morphological 
change such a s cell spreading (Dewitt et al., 2013). 
 
The question of µ-calpain activation in vivo then arose, since its Kd is in the range 
20-60 µM Ca2+. Whilst the Ca2+ concentration within cytosolic microdomains 
beneath plasma membrane microridge structures has been predicted to reach 
within this µ-calpain activating range, such measurements have, to date, never 
been achieved in live single cells. This thesis reports the development of a new 
methodology, specifically to measure the Ca2+ concentration within these ezrin-
rich cytosolic microdomains. EPIC3 was generated, because of its ezrin localising 
properties, and its GCaMP2-like Ca2+-sensing domain. By expressing EPIC3 in a 
model myeloid cell line (RAW 264.7), cytosolic Ca2+ was recorded within ezrin-
rich cytosolic microdomains, beneath plasma membrane microridges, during   
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Figure 7.2: Neutrophil microridge plasma membrane reservoirs 
A neutrophil with localised membrane expansion at the point of phagocytosis. 
Microridges in the neutrophil plasma membrane are released during elevations of 
cytosolic Ca
2+
, via activity of the Ca
2+
-activated protease µ-calpain, which cleaves the 
cross-linker ezrin. 
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SOCE Ca2+ influx events. Within these sub-membranous cytosolic domains, the 
Ca2+ concentration was recorded to reach mid-decade micromolar levels – 
capable of activating µ-calpain. 
 
The cross-linking activity of ezrin is dependent on its activation, by 
phosphorylation. Therefore, the effect of inhibiting ezrin phosphorylation in 
neutrophils was also investigated. The small molecule inhibitor of ezrin 
phosphorylation at Thr567, NSC668394, was used in neutrophils, for the first 
time, as an experimental tool to probe the µ-calpain-ezrin axis, and investigate 
the interplay between ezrin phosphorylation and Ca2+-mediated µ-calpain 
activation in regulating neutrophil shape change. The phosphorylation status of 
ezrin did not dictate localised membrane reorganisations, for the purpose of 
phagocytosis, and inhibition of ezrin phosphorylation was found to have only a 
limiting effect on neutrophil migration. However, this latter event may be useful 
for the design of future pharmacological interventions to reduce neutrophil 
migration in chronic inflammatory conditions. 
7.3 Hypothesis 
It is therefore interesting to postulate that, in myeloid cells at least, ezrin exerts 
its cross-linking activity between the plasma membrane and the actin 
cytoskeleton via the “molecular clutch” (Mitchison and Kirschner, 1988; Case 
and Waterman, 2015). In this model, ezrin provides the crucial connection 
between the actin cytoskeleton and integrin-containing focal adhesions at the 
plasma membrane when the clutch is engaged. Disengagement of the clutch, 
perhaps via µ-calpain-mediated ezrin cleavage (Dewitt and Hallett, 2002), would 
decrease the retrograde cytoskeletal flow (Mitchison and Kirschner, 1988; Case 
and Waterman, 2015), thereby reducing the forces generated by actin 
polymerisation on the cell edge and causing a transient decrease in membrane 
tension (Brückner et al., 2015); whereby the release of stored plasma membrane 
from cell surface microridges would be possible, for the purpose of cell 
spreading, extravasation and phagocytosis (fig. 7.2). Inhibition of µ-calpain 
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activity has also been to shown to limit pseudopodia extension in neutrophils 
performing phagocytosis (Dewitt and Hallett, 2002), reinforcing the concept that 
ezrin release from the molecular clutch is the trigger for release of stored 
plasma membrane reservoirs. 
7.4 Future work 
There are three lines of future research which could be followed from the 
progress reported here. The first two involve modifying and refining the probes 
reported in Chapters 3 and 4. The third line of investigation is a novel approach 
which has not been tried here. 
7.4.1 Refined probe for in vivo ezrin cleavage 
The use of ezrin with attached fluorescent tags, either before or after the µ-
calpain-sensitive linker region, provided the evidence for µ-calpain-mediated 
cleavage of ezrin in vivo. However, there were three problems with this 
approach: (i) two probes had to be co-expressed in the same cell, in order to 
obtain simultaneous data signals, which formed the basis of the ratio 
determination; (ii) the percentage of cells displaying dual expression of both 
probes was low, therefore the number of cells which could be used from each 
transfection event was low, also the ratio technique assumed that both probes 
were equally distributed at identical loci within the cell; (iii) cells expressing 
more than one ezrin variant often failed to perform phagocytosis, which may 
have been an inhibitory result of excessive ezrin competing with or 
complementing endogenous ezrin cross-links, thereby stabilising microridge 
structures in the face of high Ca2+ and activated µ-calpain. All three of these 
concerns could be overcome by amalgamating the concept of the probes used in 
this work into one single ezrin construct; by generating a plasmid to express 
ezrin with two fluorescent tags: (i) GFPi at the intra-FERM domain position, 
which doesn’t interfere with N-terminal interactions with the plasma 
membrane, and (ii) an mCherry fluorophore attached to the C-terminus. In this 
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way, a single successfully transfected cell would provide information about both 
the N- and C-functional domains of ezrin, from exactly the same loci inside the 
cell, and without the need for expression of multiple ezrin constructs, as long as 
the two fluorophores in the single ezrin construct have fluorophores with 
excitation/emission wavelengths at opposing sides of the spectrum. 
7.4.2 Refined probe for intra-microridge Ca2+ measurement and 
imaging 
The novel approach of linking a low affinity Ca2+-sensing probe to ezrin was 
successful in this work (Chapters 4 and 5). However, further investigation into 
the µ-calpain-ezrin axis in the context of neutrophil morphology change, for the 
purpose of extravasation, may seek to refine the cytosolic Ca2+ measurements 
obtained from ezrin-rich microdomains. As discussed in this thesis (Chapter 3), 
the addition of a fluorophore at the N-terminus of ezrin prevented localisation 
to the plasma membrane. Whilst C-terminally tagged ezrin appeared to behave 
as endogenous protein, it is not unreasonable to speculate that a fluorophore on 
the C-terminus, such as EPIC3, may also limit some typical ezrin interactions, e.g. 
firm binding with the F-actin cytoskeleton. The intra-tagged ezrin construct, 
ezrin-GFPi (Marion et al., 2011) has been used to successfully report typical ezrin 
behaviours in the live cell. This thesis has found evidence that the N-FERM 
domain of ezrin persists at the cell edge, presumably through firmer interactions 
with the plasma membrane (Fritzsche et al., 2014), typically 25 s longer than C-
terminally tagged ezrin fragments, generated by µ-calpain-mediated cleavage.  
 
Therefore, future efforts may aim to introduce a Ca2+-sensing domain at the 
intra-FERM domain position, as has been achieved with ezrin-GFPi. This would 
also overcome the problem of the Ca2+-sensing domain being released during 
the crucial 25 s after initial µ-calpain activation and ezrin linker cleavage (where 
the N-ERMAD was found to persist at the cell edge, but the C-ERMAD became 
cytosolic). Furthermore, new generations of EPIC with different affinities for Ca2+ 
would also provide more information about the Ca2+ concentrations which can 
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be achieved in these ezrin-rich cytosolic microdomains. One such probe may 
incorporate the Ca2+ sensing domain of CEPIA4, with a Kd of 54 µM Ca2+ (Suzuki 
et al., 2014). It is predicted that this would report the elevated Ca2+ 
concentrations achieved in the microridges (estimated here to be typically 
between 30-100 µM), but would be insensitive to the global cytosolic free Ca2+ 
concentration, even at several micromolar; thus giving an enhancement 
between the signals from beneath the cell surface, and elsewhere in the cell. 
7.4.3 Interference of ezrin cleavage as a test of the hypothesis 
In order to test the µ-calpain-ezrin cleavage hypothesis, it would be necessary to 
generate fluorescently tagged ezrin constructs which were insensitive to µ-
calpain proteolysis. The hypothesis would be that without severing of the ezrin 
cross-link, the “molecular clutch” would remain engaged; stored plasma 
membrane would not be released from surface microridges, and the cell would 
be unable to respond to Ca2+ influx and signals to change morphology. The main 
limitation to this approach is that the exact µ-calpain cleavage site in ezrin is 
unknown. This thesis has speculated that cleavage occurs primarily within the 
linker region, where the sequence of ezrin differs from its µ-calpain insensitive 
cousin, moesin. However, it has also been acknowledged that ezrin is likely 
cleaved by Ca2+-activated µ-calpain at multiple sites. Therefore, development of 
a µ-calpain insensitive ezrin would require further optimisation. 
 
However, the effect of point mutations altering single amino acids in the ezrin 
specific sequence of the linker region would in itself produce crucial information 
about the µ-calpain-mediated mechanism of ezrin cleavage in vivo. Also, such a 
non-cleavable ezrin construct would be ideal for the basis of designing a further 
peripheral Ca2+-sensing probe; one which would not be released by µ-calpain 
activity, and therefore faithfully report the Ca2+ concentrations in the peripheral 
cytosol, beneath plasma membrane microridges, throughout elevation of Ca2+ 
and the activation of µ-calpain. 
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7.5 Conclusions 
In conclusion, the µ-calpain-ezrin axis is clearly important in the mechanism by 
which myeloid cells, including neutrophils, carry out effector functions which 
require changes in cell morphology, with a dramatic increase in available plasma 
membrane. This apparent membrane expansion required by neutrophils to 
perform cell spreading, the necessary prelude to extravasation, may be a 
common hurdle in the exit of leukocytes from the bloodstream during excessive 
recruitment in chronic inflammatory conditions. Disruption of this mechanism, 
at the µ-calpain-ezrin axis, may be a useful target for the development of novel 
pharmacological therapies, aimed at reducing propagation of the inflammatory 
response in chronic immune disease.  
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Appendix I – Ezrin-GFPi sequencing results  
Appendix I: Sequenced ezrin-GFPi  
372 amino acids returned from Sanger sequencing results were entered as query in 
NCBI Protein Blast. Residues 4-24 align with FERM C-terminal PH-like domain (88% 
Identity, E-value 2.41e-03). Residues 31-252 align with GFP (E-value 3.72e-105). 
Residues 256-330 align with FERM domain C-lobe/F3 of the ERM family (76% Identity, 
E-value 4.72e-44). 
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Appendix II – Materials and Reagents 
Reagent Source 
4x NuPAGE Novex LDS sample buffer Invitrogen 
7% NuPAGE® Tris-Acetate Gel Life Technologies 
Agar Sigma-Aldrich, Poole, UK 
Amaxa N ucleofector solution V Lonza Cologne, Germany 
Amersham™ Hybond™ P 0.45 GE Healthcare, 10600023 
Ampicillin Sigma-Aldrich, Poole, UK 
Anti-mouse IgG-FITC conjugated 
antibody 
Santa Cruz Biotechnology, inc. SC-
2047 
Anti-rabbit IgG peroxidase conjugated 
antibody 
Santa Cruz Biotechnology, inc. SC-
2004 
Bovine Serum Album in (BSA) Sigma-Aldrich, Poole, UK 
CaCI2 Sigma-Aldrich, Poole, UK 
CellTraceTM Calcein Green, AM Life Technologies 
CEPIA2 Addgene: pCMV CEPIA2mt (Plasmid 
#58218) 
CEPIA3 Addgene: pCMV CEPIA3mt (Plasmid 
#58219) 
Collagen Microspheres 2BScientific, 516064 
ECL developing film: Amersham 
Hyperfilm ECL 
GE Healthcare Life Sciences, 28-9068-
36 
ECL detection reagent: Amersham ECL 
Western Blotting Detection Reagent 
GE Healthcare Life Sciences, RPN2109 
ECL developing film: Amersham 
Hyperfilm  
GE Healthcare Life Sciences, 28-9068-
36 
ECL™ peroxidase labelled donkey anti-
rabbit secondary antibody 
GE healthcare 
ECL Western Blotting Detection Reagent GE Healthcare Life Sciences, RPN2109 
Ezrin-mCherry Addgene: mCherry-Ezrin-N-14 
(Plasmid #55043) 
Ezrin-mEmerald Addgene: mEmerald-Ezrin-N-14 
(Plasmid #54090) 
Ezrin-GFPi Gift from Sabrina Marion 
Dextran (m ol. W t. 70,000) Sigma-Aldrich, Poole, UK 
DH5α cells Gift from Prof. Jan Parys lab 
Dimethyl sulphoxide (DMSO) Sigma-Aldrich, Poole, UK 
DMEM  
EDTA Sigma-Aldrich, Poole, UK 
EGTA Sigma-Aldrich, Poole, UK 
Ethanol Fisher Scientific, Leicester, UK 
Ethidium bromide Sigma-Aldrich 
Ezrin Polyclonal Antibody, Cy5 
Conjugated 
Bioss Antibody (bs-1343r-cy5) 
Fetal Calf Serum (FCS) Sigma-Aldrich, Poole, UK 
FastDigest Eco32I (EcoRV) Thermo Fisher Scientific, FD0303 
FastDigest NotI Thermo Fisher Scientific, FD0593 
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FastDigest HindIII Thermo Fisher Scientific, FD0504 
Fluo-4-AM Invitrogen, Carlsbad, California, USA 
fMLP Sigma-Aldrich, Poole, UK 
GeneElute™ PCR clean-up kit Sigma-Aldrich, NA1020 
GenElute™ Plasmid Miniprep Kit Sigma-Aldrich, PLN350 
Glycerol Sigma-Aldrich, Poole, UK 
HeLa cells Gift from Prof. Jan Parys lab 
Heparin C P Pharmaceuticals Ltd, Wrexham , 
UK 
Hepes Fisher Scientific, Leicester, UK 
Horse Serum Sigma-Aldrich, Poole, UK 
lonomycin Calbiochem, Nottingham, UK 
Isopropanol Sigma-Aldrich, Poole, UK 
Kanamycin Sigma-Aldrich, Poole, UK 
 
KCI Sigma-Aldrich, Poole, UK 
KH2PO4 Sigma-Aldrich, Poole, UK 
mCherry-ezrin mCherry-Ezrin-C-14 (Plasmid #55042) 
Milk powder Marvel 
MgCI2 Sigma-Aldrich, Poole, UK 
 
MgS04 Sigma-Aldrich, Poole, UK 
 
NaCI Sigma-Aldrich, Poole, UK 
NaOH Sigma-Aldrich, Poole, UK 
NuPAGE Antioxidant reagent Invitrogen 
NuPAGE Reducing Agent 10x Invitrogen 
NuPAGE® Tris-Acetate SDS running 
buffer 20x 
Invitrogen 
Na2HP04 Sigma-Aldrich, Poole, UK 
NaOH Sigma-Aldrich, Poole, UK 
OneShot®Top10 E.coli Invitrogen, Paisly, UK 
Paraformaldehyde Sigma-Aldrich, Poole, UK 
pcDNA3.1(-) Gift from Prof. Jan Parys lab 
Penicillin Sigma-Aldrich, Poole, UK 
PfuUltra HF DNA polymerase (2.5 U/ μl) Agilent, 600380 
Pierce
TM
 BCA Protein Assay Kit Life Technologies 
Pierce™ Co-Immunoprecipitation Kit ThermoFisher Scientific, 26149 
PureLink® HiPure Plasmid Filter 
Maxiprep Kit 
Invitrogen (Thermo Fisher Scientific), 
K210017 
Primers Integrated DNA Technologies (IDT), 
bespoke 
Protease Inhibitor Cocktail Sigma-Aldrich, Poole, UK 
Qubit dsDNA BR Assay Kit® Life Technologies, Q32853 
Rabbit anti-ezrin polyclonal antibody Cell Signalling, 3145 
Rabbit anti-ezrin monoclonal [EP924Y] 
antibody 
Abcam, ab75840 
Rabbit anti-phosphorylated ERM family 
monoclonal antibody (41A3) 
Cell Signalling, 3149 
Rabbit anti-moesin polyclonal antibody  Cell Signalling, 3146 
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Rat anti-CD18 (Integrin β2 chain) 
monoclonal antibody 
BD Biosciences Pharmingen, 01661D 
RAW 264.7 cells American Type Culture Collection 
Streptomycin Sigma-Aldrich, Poole, UK 
SuperSignalTM West Dura Extended 
Duration Substrate 
Life Technologies 
T4 DNA Ligase (5 U/µL) Thermo Fisher Scientific, EL0014 
Thapsigargin Sigma-Aldrich, Poole, UK 
Triton-X100 Sigma-Aldrich, Poole, UK 
Tween-20 Sigma-Aldrich, Poole, UK 
X-tremeGENE™ HP DNA Transfection 
Reagent 
Sigma-Aldrich, 06366546001 
Zymosan A Sigma-Aldrich, Poole, UK 
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Appendix III – Buffers  
  
Buffer Reagents 
Balanced salt solution (BSS) 130 mM NaCl, 2.65 mM KCl, 8 mM Na2HPO4, 
adjusted to pH 7.4 
Cell growth media DMEM, 10% FBS, 1% PenStrep 
Dextran 6 g/100 mL BSS 
Electroblotting buffer 25 mM Tris, 182 mM Glcine, 20% methanol. 
Cooled to -20°C prior to use. 
Hepes Buffered Krebs (HBK) 120 mM NaCl, 4.8 mM KCl, 1.2 mM 
KH2PO4, 1.2 mM MgSO4, 1.3 mM CaCl2, 25 
mM Hepes pH 7.4 and 0.1% BSA, adjusted to 
pH 7.4 with NaOH stored at 4°C 
Neutrophil lysis Buffer 50 mM Hepes pH 7.4, 150 mM NaCl, 10% 
glycerol, 1% Triton X100, 1.5 mM MgCl2, 5 
mM EGTA, 5 mM EDTA, 1 mM Na3VO4, 1.5 
mM NaF, 0.1% SDS, 1:10 PIC 
Running Buffer for SDS-PAGE 25 mL NuPAGE Tris Acetate SDS running 
buffer (20x), 475 mL ddH2O (0.5 mL NuPAGE 
Antioxidant added to 200 mL of prepared 
running buffer loaded in upper chamber of 
gel tank) 
Running buffer for agarose gel 
electrophoresis  
1 xTAE buffer, plus ethidium bromide (1-2 %) 
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Appendix IV – Equipment 
Specific equipment Source 
Amaxa nulceofector device Lonza, Cologne, Germany  
BMG FLUOstar OPTIMA BMG Labtech 
CLSM Confocal microscope SP5 
 
Leica, Milton Keynes, UK 
 
Eppendorf FemtoJet® pressure 
controller 
Eppendorf, Hamburg, Germany 
 
Eppendorf Injectman micromanipulator Eppendorf, Hamburg, Germany  
 
Micropipette Puller P2000 
 
Sutter Instruments, Novato, 
California, USA 
Micropipette borosilicate glass 
capillaries  
Sutter Instruments, Novato, 
California, USA 
NanoDrop™ Lite spectrophotometer Thermo Scientific 
Nexcelom Cellometer  Nexcelom Bioscience, MA, USA 
Filters, dichroic mirrors 
 
Omega Optical Inc F ilters,, 
Stanmore, UK 
Single 488nm line laser Laser Physics, Milton Green, UK 
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Appendix V - Software 
 
 
Software Source 
AMNIS® IDEAS® Merck, UK 
AMNIS® INSPIRE® Merck, UK 
CLC Sequence Viewer Qiagen, California, USA 
Chromas version 2.9.2 Technelysium, Australia 
Gif Animator (32-bit) Alchemy Mindworks Inc., Ontario, 
Canada 
GraphPad Prism 5 for Windows, 
version 5.00 
San Diego California USA 
HyperCam version 2.29.01 Hyperionics Technology, USA 
ImageJ NIH, Bethesda, Pennsylvania, USA 
Leica Applications Suite Advanced 
Fluorescence Lite 
Leica Microsystems 
 
Microsoft Excel 2013 Microsoft, Redmond, Washington, USA 
Microsoft Word 2013 Microsoft, Redmond, Washington, USA 
Microsoft PowerPoint 2013 Microsoft, Redmond, Washington, USA 
SnapGene® Viewer GSL Biotech, Chicago, USA 
